BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, Swartz M, Fukumura D, Jain RK, Alitalo K. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science. 1997;276:1423-1425. [PMID: 9162011 DOI: 10.1126/science.276.5317.1423] [Cited by in Crossref: 899] [Cited by in F6Publishing: 789] [Article Influence: 37.5] [Reference Citation Analysis]
Number Citing Articles
1 Jones A, Fujiyama C, Turner K, Fuggle S, Cranston D, Turley H, Valtola R, Bicknell R, Harris AL. Angiogenesis and lymphangiogenesis in stage 1 germ cell tumours of the testis. BJU Int 2000;86:80-6. [PMID: 10886088 DOI: 10.1046/j.1464-410x.2000.00660.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 1.4] [Reference Citation Analysis]
2 Partanen TA, Paavonen K. Lymphatic versus blood vascular endothelial growth factors and receptors in humans. Microsc Res Tech 2001;55:108-21. [DOI: 10.1002/jemt.1162] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 1.8] [Reference Citation Analysis]
3 Clarijs R, Ruiter DJ, de Waal RMW. Lymphangiogenesis in malignant tumours: does it occur? J Pathol 2001;193:143-6. [DOI: 10.1002/path.808] [Cited by in Crossref: 69] [Cited by in F6Publishing: 60] [Article Influence: 3.5] [Reference Citation Analysis]
4 Tammela T, He Y, Lyytikkä J, Jeltsch M, Markkanen J, Pajusola K, Ylä-herttuala S, Alitalo K. Distinct Architecture of Lymphatic Vessels Induced by Chimeric Vascular Endothelial Growth Factor-C/Vascular Endothelial Growth Factor Heparin-Binding Domain Fusion Proteins. Circulation Research 2007;100:1468-75. [DOI: 10.1161/01.res.0000269043.51272.6d] [Cited by in Crossref: 29] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
5 Lei Y, Li B, Tong S, Qi L, Hu X, Cui Y, Li Z, He W, Zu X, Wang Z, Chen M. miR-101 suppresses vascular endothelial growth factor C that inhibits migration and invasion and enhances cisplatin chemosensitivity of bladder cancer cells. PLoS One 2015;10:e0117809. [PMID: 25658842 DOI: 10.1371/journal.pone.0117809] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
6 Kudo Y, Iizuka S, Yoshida M, Nguyen PT, Siriwardena SB, Tsunematsu T, Ohbayashi M, Ando T, Hatakeyama D, Shibata T, Koizumi K, Maeda M, Ishimaru N, Ogawa I, Takata T. Periostin directly and indirectly promotes tumor lymphangiogenesis of head and neck cancer. PLoS One 2012;7:e44488. [PMID: 22952986 DOI: 10.1371/journal.pone.0044488] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
7 Koyama Y, Kaneko K, Akazawa K, Kanbayashi C, Kanda T, Hatakeyama K. Vascular Endothelial Growth Factor-C and Vascular Endothelial Growth Factor-D mRNA Expression in Breast Cancer: Association with Lymph Node Metastasis. Clinical Breast Cancer 2003;4:354-60. [DOI: 10.3816/cbc.2003.n.041] [Cited by in Crossref: 34] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
8 Breiteneder-Geleff S, Soleiman A, Kowalski H, Horvat R, Amann G, Kriehuber E, Diem K, Weninger W, Tschachler E, Alitalo K. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol. 1999;154:385-394. [PMID: 10027397 DOI: 10.1016/s0002-9440(10)65285-6] [Cited by in Crossref: 737] [Cited by in F6Publishing: 245] [Article Influence: 33.5] [Reference Citation Analysis]
9 Van Trappen PO, Ryan A, Carroll M, Lecoeur C, Goff L, Gyselman VG, Young BD, Lowe DG, Pepper MS, Shepherd JH, Jacobs IJ. A model for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancer. Br J Cancer 2002;87:537-44. [PMID: 12189553 DOI: 10.1038/sj.bjc.6600471] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 2.9] [Reference Citation Analysis]
10 Tammela T, Saaristo A, Holopainen T, Ylä-Herttuala S, Andersson LC, Virolainen S, Immonen I, Alitalo K. Photodynamic ablation of lymphatic vessels and intralymphatic cancer cells prevents metastasis. Sci Transl Med 2011;3:69ra11. [PMID: 21307301 DOI: 10.1126/scitranslmed.3001699] [Cited by in Crossref: 72] [Cited by in F6Publishing: 62] [Article Influence: 7.2] [Reference Citation Analysis]
11 Poliakova L, Kovesdi I, Wang X, Capogrossi MC, Talan M. Vascular permeability effect of adenovirus-mediated vascular endothelial growth factor gene transfer to the rabbit and rat skeletal muscle. The Journal of Thoracic and Cardiovascular Surgery 1999;118:339-47. [DOI: 10.1016/s0022-5223(99)70225-4] [Cited by in Crossref: 27] [Article Influence: 1.2] [Reference Citation Analysis]
12 Morita H, Ishikawa Y, Akishima-Fukasawa Y, Ito K, Akasaka Y, Nishimura C, Igarashi Y, Miki K, Ishii T. Histopathological predictor for regional lymph node metastasis in gastric cancer. Virchows Arch. 2009;454:143-151. [PMID: 19104832 DOI: 10.1007/s00428-008-0717-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
13 Nomiya T, Nemoto K, Miyachi H, Fujimoto K, Takeda K, Ogawa Y, Takai Y, Yamada S. Relationships between radiosensitivity and microvascular density in esophageal carcinoma: significance of hypoxic fraction. International Journal of Radiation Oncology*Biology*Physics 2004;58:589-96. [DOI: 10.1016/j.ijrobp.2003.09.037] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
14 Chaplin DD, Fu Y. Cytokine regulation of secondary lymphoid organ development. Current Opinion in Immunology 1998;10:289-97. [DOI: 10.1016/s0952-7915(98)80167-2] [Cited by in Crossref: 88] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
15 Yao LC, Testini C, Tvorogov D, Anisimov A, Vargas SO, Baluk P, Pytowski B, Claesson-Welsh L, Alitalo K, McDonald DM. Pulmonary lymphangiectasia resulting from vascular endothelial growth factor-C overexpression during a critical period. Circ Res 2014;114:806-22. [PMID: 24429550 DOI: 10.1161/CIRCRESAHA.114.303119] [Cited by in Crossref: 41] [Cited by in F6Publishing: 24] [Article Influence: 5.9] [Reference Citation Analysis]
16 Inbal A, Teven CM, Chang DW. Latissimus dorsi flap with vascularized lymph node transfer for lymphedema treatment: Technique, outcomes, indications and review of literature. J Surg Oncol 2017;115:72-7. [PMID: 27943281 DOI: 10.1002/jso.24347] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
17 Choi JH, Oh YH, Park YW, Baik HK, Lee YY, Kim IS. Correlation of vascular endothelial growth factor-D expression and VEGFR-3-positive vessel density with lymph node metastasis in gastric carcinoma. J Korean Med Sci 2008;23:592-7. [PMID: 18756043 DOI: 10.3346/jkms.2008.23.4.592] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
18 McTigue MA, Wickersham JA, Pinko C, Showalter RE, Parast CV, Tempczyk-Russell A, Gehring MR, Mroczkowski B, Kan CC, Villafranca JE, Appelt K. Crystal structure of the kinase domain of human vascular endothelial growth factor receptor 2: a key enzyme in angiogenesis. Structure 1999;7:319-30. [PMID: 10368301 DOI: 10.1016/s0969-2126(99)80042-2] [Cited by in Crossref: 134] [Cited by in F6Publishing: 34] [Article Influence: 6.1] [Reference Citation Analysis]
19 Buttler K, Badar M, Seiffart V, Laggies S, Gross G, Wilting J, Weich HA. De novo hem- and lymphangiogenesis by endothelial progenitor and mesenchymal stem cells in immunocompetent mice. Cell Mol Life Sci 2014;71:1513-27. [PMID: 23995988 DOI: 10.1007/s00018-013-1460-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
20 Erten F, Yenice E, Orhan C, Er B, Demirel Öner P, Defo Deeh PB, Şahin K. Genistein suppresses the inflammation and GSK-3 pathway in an animal model of spontaneous ovarian cancer. Turk J Med Sci 2021;51:1465-71. [PMID: 33550763 DOI: 10.3906/sag-2007-254] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Rutkowski JM, Moya M, Johannes J, Goldman J, Swartz MA. Secondary lymphedema in the mouse tail: Lymphatic hyperplasia, VEGF-C upregulation, and the protective role of MMP-9. Microvasc Res 2006;72:161-71. [PMID: 16876204 DOI: 10.1016/j.mvr.2006.05.009] [Cited by in Crossref: 149] [Cited by in F6Publishing: 138] [Article Influence: 9.9] [Reference Citation Analysis]
22 Jell G, Kerjaschki D, Revell P, Al-Saffar N. Lymphangiogenesis in the bone-implant interface of orthopedic implants: importance and consequence. J Biomed Mater Res A 2006;77:119-27. [PMID: 16392126 DOI: 10.1002/jbm.a.30548] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
23 Stacker SA, Stenvers K, Caesar C, Vitali A, Domagala T, Nice E, Roufail S, Simpson RJ, Moritz R, Karpanen T. Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers. J Biol Chem. 1999;274:32127-32136. [PMID: 10542248 DOI: 10.1074/jbc.274.45.32127] [Cited by in Crossref: 230] [Cited by in F6Publishing: 218] [Article Influence: 10.5] [Reference Citation Analysis]
24 Mura M, dos Santos CC, Stewart D, Liu M. Vascular endothelial growth factor and related molecules in acute lung injury. J Appl Physiol. 2004;97:1605-1617. [PMID: 15475552 DOI: 10.1152/japplphysiol.00202.2004] [Cited by in Crossref: 131] [Cited by in F6Publishing: 118] [Article Influence: 8.2] [Reference Citation Analysis]
25 Scavelli C, Vacca A, Di Pietro G, Dammacco F, Ribatti D. Crosstalk between angiogenesis and lymphangiogenesis in tumor progression. Leukemia 2004;18:1054-8. [DOI: 10.1038/sj.leu.2403355] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 2.8] [Reference Citation Analysis]
26 Asaad M, Hanson SE. Tissue Engineering Strategies for Cancer-Related Lymphedema. Tissue Eng Part A 2021;27:489-99. [PMID: 33563108 DOI: 10.1089/ten.TEA.2020.0378] [Reference Citation Analysis]
27 Makhoul IR, Sujov P, Ghanem N, Bronshtein M. Prenatal diagnosis of Milroy's primary congenital lymphedema. Prenat Diagn 2002;22:823-6. [DOI: 10.1002/pd.418] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
28 Mohammed RA, Green A, El-Shikh S, Paish EC, Ellis IO, Martin SG. Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesis. Br J Cancer. 2007;96:1092-1100. [PMID: 17353919 DOI: 10.1038/sj.bjc.6603678] [Cited by in Crossref: 128] [Cited by in F6Publishing: 118] [Article Influence: 9.1] [Reference Citation Analysis]
29 Wise LM, Stuart GS, Real NC, Fleming SB, Mercer AA. VEGF Receptor-2 Activation Mediated by VEGF-E Limits Scar Tissue Formation Following Cutaneous Injury. Adv Wound Care (New Rochelle) 2018;7:283-97. [PMID: 30087804 DOI: 10.1089/wound.2016.0721] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
30 Cheung L, Han J, Beilhack A, Joshi S, Wilburn P, Dua A, An A, Rockson SG. An experimental model for the study of lymphedema and its response to therapeutic lymphangiogenesis. BioDrugs 2006;20:363-70. [PMID: 17176124 DOI: 10.2165/00063030-200620060-00007] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
31 Yamashita M. Lymphangiogenesis and Lesion Heterogeneity in Interstitial Lung Diseases. Clin Med Insights Circ Respir Pulm Med 2015;9:111-21. [PMID: 26823655 DOI: 10.4137/CCRPM.S33856] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
32 Zheng W, Aspelund A, Alitalo K. Lymphangiogenic factors, mechanisms, and applications. J Clin Invest. 2014;124:878-887. [PMID: 24590272 DOI: 10.1172/jci71603] [Cited by in Crossref: 188] [Cited by in F6Publishing: 118] [Article Influence: 26.9] [Reference Citation Analysis]
33 Le Guen L, Karpanen T, Schulte D, Harris NC, Koltowska K, Roukens G, Bower NI, van Impel A, Stacker SA, Achen MG, Schulte-Merker S, Hogan BM. Ccbe1 regulates Vegfc-mediated induction of Vegfr3 signaling during embryonic lymphangiogenesis. Development. 2014;141:1239-1249. [PMID: 24523457 DOI: 10.1242/dev.100495] [Cited by in Crossref: 106] [Cited by in F6Publishing: 96] [Article Influence: 15.1] [Reference Citation Analysis]
34 Mäkinen T, Jussila L, Veikkola T, Karpanen T, Kettunen MI, Pulkkanen KJ, Kauppinen R, Jackson DG, Kubo H, Nishikawa S. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med. 2001;7:199-205. [PMID: 11175851 DOI: 10.1038/84651] [Cited by in Crossref: 510] [Cited by in F6Publishing: 467] [Article Influence: 25.5] [Reference Citation Analysis]
35 Cao Y, Linden P, Farnebo J, Cao R, Eriksson A, Kumar V, Qi JH, Claesson-Welsh L, Alitalo K. Vascular endothelial growth factor C induces angiogenesis in vivo. Proc Natl Acad Sci USA. 1998;95:14389-14394. [PMID: 9826710 DOI: 10.1073/pnas.95.24.14389] [Cited by in Crossref: 381] [Cited by in F6Publishing: 357] [Article Influence: 16.6] [Reference Citation Analysis]
36 Machnik A, Neuhofer W, Jantsch J, Dahlmann A, Tammela T, Machura K, Park JK, Beck FX, Müller DN, Derer W, Goss J, Ziomber A, Dietsch P, Wagner H, van Rooijen N, Kurtz A, Hilgers KF, Alitalo K, Eckardt KU, Luft FC, Kerjaschki D, Titze J. Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat Med 2009;15:545-52. [PMID: 19412173 DOI: 10.1038/nm.1960] [Cited by in Crossref: 622] [Cited by in F6Publishing: 505] [Article Influence: 51.8] [Reference Citation Analysis]
37 Semo J, Nicenboim J, Yaniv K. Development of the lymphatic system: new questions and paradigms. Development. 2016;143:924-935. [PMID: 26980792 DOI: 10.1242/dev.132431] [Cited by in Crossref: 52] [Cited by in F6Publishing: 34] [Article Influence: 10.4] [Reference Citation Analysis]
38 Laakkonen P, Akerman ME, Biliran H, Yang M, Ferrer F, Karpanen T, Hoffman RM, Ruoslahti E. Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells. Proc Natl Acad Sci U S A 2004;101:9381-6. [PMID: 15197262 DOI: 10.1073/pnas.0403317101] [Cited by in Crossref: 205] [Cited by in F6Publishing: 177] [Article Influence: 12.1] [Reference Citation Analysis]
39 Hayashida K, Yoshida S, Yoshimoto H, Fujioka M, Saijo H, Migita K, Kumaya M, Akita S. Adipose-Derived Stem Cells and Vascularized Lymph Node Transfers Successfully Treat Mouse Hindlimb Secondary Lymphedema by Early Reconnection of the Lymphatic System and Lymphangiogenesis. Plast Reconstr Surg 2017;139:639-51. [PMID: 28234840 DOI: 10.1097/PRS.0000000000003110] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
40 Luong MX, Tam J, Lin Q, Hagendoorn J, Moore KJ, Padera TP, Seed B, Fukumura D, Kucherlapati R, Jain RK. Lack of lymphatic vessel phenotype in LYVE-1/CD44 double knockout mice. J Cell Physiol. 2009;219:430-437. [PMID: 19170073 DOI: 10.1002/jcp.21686] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
41 Kakeji Y, Maehara Y, Sumiyoshi Y, Oda S, Emi Y. Angiogenesis as a target for gastric cancer. Surgery. 2002;131:S48-S54. [PMID: 11821787 DOI: 10.1067/msy.2002.119304] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
42 Lin M, Lin HZ, Ma SP, Ji P, Xie D, Yu JX. Vascular endothelial growth factor-A and -C: expression and correlations with lymphatic metastasis and prognosis in colorectal cancer. Med Oncol 2011;28:151-8. [PMID: 20107934 DOI: 10.1007/s12032-010-9427-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
43 Sun Y, Jia J, Zhang W, Liu B, Zhang Z, Zhao Y. A Reproducible In-vivo Model of Lymphatic Malformation in Rats. Journal of Comparative Pathology 2011;145:390-8. [DOI: 10.1016/j.jcpa.2011.02.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
44 Yan H, Yuan J, Peng R, Wang T, Deng J, Li W, Ling S. The Blockade of Vascular Endothelial Growth Factor C Effectively Inhibits Corneal Lymphangiogenesis and Promotes Allograft Survival. J Ocul Pharmacol Ther 2015;31:546-54. [PMID: 26172526 DOI: 10.1089/jop.2015.0007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
45 Skobe M, Detmar M. Structure, Function, and Molecular Control of the Skin Lymphatic System. Journal of Investigative Dermatology Symposium Proceedings 2000;5:14-9. [DOI: 10.1046/j.1087-0024.2000.00001.x] [Cited by in Crossref: 160] [Cited by in F6Publishing: 121] [Article Influence: 7.6] [Reference Citation Analysis]
46 Karaman S, Buschle D, Luciani P, Leroux JC, Detmar M, Proulx ST. Decline of lymphatic vessel density and function in murine skin during aging. Angiogenesis 2015;18:489-98. [PMID: 26260189 DOI: 10.1007/s10456-015-9479-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
47 Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB j 1999;13:9-22. [DOI: 10.1096/fasebj.13.1.9] [Cited by in Crossref: 2373] [Cited by in F6Publishing: 1474] [Article Influence: 107.9] [Reference Citation Analysis]
48 Cui J, Liu L, Lu H, Wei D, Jiao Y, Jablonski MM, Williams RW, Gu W, Chen H. Potential effect on molecular pathways in different targeted genes in the VEGF family in retina - From the genomic point of view. Exp Eye Res 2018;176:78-87. [PMID: 29944851 DOI: 10.1016/j.exer.2018.06.024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Yamaoka Y, Sawa Y, Ebata N, Yoshida S, Kawasaki T. Desmosomal proteins in cultured and intact human periodontal ligament fibroblasts. Tissue and Cell 1999;31:605-9. [DOI: 10.1054/tice.1999.0079] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
50 Morisada T, Oike Y, Yamada Y, Urano T, Akao M, Kubota Y, Maekawa H, Kimura Y, Ohmura M, Miyamoto T. Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation. Blood. 2005;105:4649-4656. [PMID: 15705793 DOI: 10.1182/blood-2004-08-3382] [Cited by in Crossref: 176] [Cited by in F6Publishing: 149] [Article Influence: 11.0] [Reference Citation Analysis]
51 Park HR, Min K, Kim HS, Jung WW, Park YK. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas. Pathol Res Pract 2008;204:575-82. [PMID: 18440723 DOI: 10.1016/j.prp.2008.01.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
52 Zarjou A, Black LM, Bolisetty S, Traylor AM, Bowhay SA, Zhang MZ, Harris RC, Agarwal A. Dynamic signature of lymphangiogenesis during acute kidney injury and chronic kidney disease. Lab Invest 2019;99:1376-88. [PMID: 31019289 DOI: 10.1038/s41374-019-0259-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
53 Hagedorn M, Bikfalvi A. Target molecules for anti-angiogenic therapy: from basic research to clinical trials. Crit Rev Oncol Hematol. 2000;34:89-110. [PMID: 10799835 DOI: 10.1016/s1040-8428(00)00056-1] [Cited by in Crossref: 70] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
54 Jackson DG. Lymphatic markers, tumour lymphangiogenesis and lymph node metastasis. Cancer Treat Res 2007;135:39-53. [PMID: 17953407 DOI: 10.1007/978-0-387-69219-7_4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
55 Persaud K, Tille JC, Liu M, Zhu Z, Jimenez X, Pereira DS, Miao HQ, Brennan LA, Witte L, Pepper MS. Involvement of the VEGF receptor 3 in tubular morphogenesis demonstrated with a human anti-human VEGFR-3 monoclonal antibody that antagonizes receptor activation by VEGF-C. J Cell Sci. 2004;117:2745-2756. [PMID: 15150322 DOI: 10.1242/jcs.01138] [Cited by in Crossref: 57] [Cited by in F6Publishing: 47] [Article Influence: 3.4] [Reference Citation Analysis]
56 Podgrabinska S, Skobe M. Role of lymphatic vasculature in regional and distant metastases. Microvasc Res 2014;95:46-52. [PMID: 25026412 DOI: 10.1016/j.mvr.2014.07.004] [Cited by in Crossref: 55] [Cited by in F6Publishing: 39] [Article Influence: 7.9] [Reference Citation Analysis]
57 Yang JF, Walia A, Huang YH, Han KY, Rosenblatt MI, Azar DT, Chang JH. Understanding lymphangiogenesis in knockout models, the cornea, and ocular diseases for the development of therapeutic interventions. Surv Ophthalmol 2016;61:272-96. [PMID: 26706194 DOI: 10.1016/j.survophthal.2015.12.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
58 Mimura T, Amano S, Usui T, Kaji Y, Oshika T, Ishii Y. Expression of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in corneal lymphangiogenesis. Exp Eye Res. 2001;72:71-78. [PMID: 11133184 DOI: 10.1006/exer.2000.0925] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 2.0] [Reference Citation Analysis]
59 Rutkowski JM, Boardman KC, Swartz MA. Characterization of lymphangiogenesis in a model of adult skin regeneration. Am J Physiol Heart Circ Physiol 2006;291:H1402-10. [PMID: 16648194 DOI: 10.1152/ajpheart.00038.2006] [Cited by in Crossref: 103] [Cited by in F6Publishing: 91] [Article Influence: 6.9] [Reference Citation Analysis]
60 Allan AL, George R, Vantyghem SA, Lee MW, Hodgson NC, Engel CJ, Holliday RL, Girvan DP, Scott LA, Postenka CO. Role of the integrin-binding protein osteopontin in lymphatic metastasis of breast cancer. Am J Pathol. 2006;169:233-246. [PMID: 16816376 DOI: 10.2353/ajpath.2006.051152] [Cited by in Crossref: 71] [Cited by in F6Publishing: 65] [Article Influence: 4.7] [Reference Citation Analysis]
61 Sipos B, Kojima M, Tiemann K, Klapper W, Kruse ML, Kalthoff H, Schniewind B, Tepel J, Weich H, Kerjaschki D, Klöppel G. Lymphatic spread of ductal pancreatic adenocarcinoma is independent of lymphangiogenesis. J Pathol 2005;207:301-12. [PMID: 16161179 DOI: 10.1002/path.1840] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
62 Bae O, Ahn S, Jin SH, Hong SH, Lee J, Kim E, Jeong TC, Chun Y, Lee A, Noh M. Chemical allergens stimulate human epidermal keratinocytes to produce lymphangiogenic vascular endothelial growth factor. Toxicology and Applied Pharmacology 2015;283:147-55. [DOI: 10.1016/j.taap.2015.01.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
63 Niki T, Iba S, Yamada T, Matsuno Y, Enholm B, Hirohashi S. Expression of vascular endothelial growth factor receptor 3 in blood and lymphatic vessels of lung adenocarcinoma. J Pathol 2001;193:450-7. [PMID: 11276003 DOI: 10.1002/path.828] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
64 Saaristo A, Veikkola T, Enholm B, Hytönen M, Arola J, Pajusola K, Turunen P, Jeltsch M, Karkkainen MJ, Kerjaschki D, Bueler H, Yla‐herttuala S, Alitalo K. Adenoviral VEGF‐C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes. FASEB j 2002;16:1041-9. [DOI: 10.1096/fj.01-1042com] [Cited by in Crossref: 125] [Cited by in F6Publishing: 109] [Article Influence: 6.6] [Reference Citation Analysis]
65 Kataru RP, Jung K, Jang C, Yang H, Schwendener RA, Baik JE, Han SH, Alitalo K, Koh GY. Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. Blood. 2009;113:5650-5659. [PMID: 19346498 DOI: 10.1182/blood-2008-09-176776] [Cited by in Crossref: 259] [Cited by in F6Publishing: 245] [Article Influence: 21.6] [Reference Citation Analysis]
66 Jain RK, Munn LL, Fukumura D. Dissecting tumour pathophysiology using intravital microscopy. Nat Rev Cancer 2002;2:266-76. [DOI: 10.1038/nrc778] [Cited by in Crossref: 427] [Cited by in F6Publishing: 337] [Article Influence: 22.5] [Reference Citation Analysis]
67 Yoon YS, Murayama T, Gravereaux E, Tkebuchava T, Silver M, Curry C, Wecker A, Kirchmair R, Hu CS, Kearney M, Ashare A, Jackson DG, Kubo H, Isner JM, Losordo DW. VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. J Clin Invest 2003;111:717-25. [PMID: 12618526 DOI: 10.1172/JCI15830] [Cited by in Crossref: 178] [Cited by in F6Publishing: 67] [Article Influence: 9.9] [Reference Citation Analysis]
68 Takizawa H, Kondo K, Fujino H, Kenzaki K, Miyoshi T, Sakiyama S, Tangoku A. The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer. Br J Cancer. 2006;95:75-79. [PMID: 16755294 DOI: 10.1038/sj.bjc.6603209] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
69 Sleeman JP. The Lymph Node as a Bridgehead in the Metastatic Dissemination of Tumors. In: Schlag PM, Veronesi U, editors. Lymphatic Metastasis and Sentinel Lymphonodectomy. Berlin: Springer Berlin Heidelberg; 2000. pp. 55-81. [DOI: 10.1007/978-3-642-57151-0_6] [Cited by in Crossref: 132] [Cited by in F6Publishing: 114] [Article Influence: 6.3] [Reference Citation Analysis]
70 Boucher J, Simonneau C, Denet G, Clarhaut J, Balandre AC, Mesnil M, Cronier L, Monvoisin A. Pannexin-1 in Human Lymphatic Endothelial Cells Regulates Lymphangiogenesis. Int J Mol Sci 2018;19:E1558. [PMID: 29882918 DOI: 10.3390/ijms19061558] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
71 Achen MG, Roufail S, Domagala T, Catimel B, Nice EC, Geleick DM, Murphy R, Scott AM, Caesar C, Makinen T. Monoclonal antibodies to vascular endothelial growth factor-D block its interactions with both VEGF receptor-2 and VEGF receptor-3. Eur J Biochem. 2000;267:2505-2515. [PMID: 10785369 DOI: 10.1046/j.1432-1327.2000.01257.x] [Cited by in Crossref: 79] [Cited by in F6Publishing: 70] [Article Influence: 3.8] [Reference Citation Analysis]
72 Carmeliet P, Collen D. Role of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptors in Vascular Development. In: Claesson-welsh L, editor. Vascular Growth Factors and Angiogenesis. Berlin: Springer Berlin Heidelberg; 1999. pp. 133-58. [DOI: 10.1007/978-3-642-59953-8_7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 47] [Article Influence: 1.7] [Reference Citation Analysis]
73 Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, Riccardi L, Alitalo K, Claffey K, Detmar M. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med. 2001;7:192-198. [PMID: 11175850 DOI: 10.1038/84643] [Cited by in Crossref: 1193] [Cited by in F6Publishing: 1034] [Article Influence: 59.7] [Reference Citation Analysis]
74 Hamada K, Oike Y, Takakura N, Ito Y, Jussila L, Dumont DJ, Alitalo K, Suda T. VEGF-C signaling pathways through VEGFR-2 and VEGFR-3 in vasculoangiogenesis and hematopoiesis. Blood 2000;96:3793-800. [DOI: 10.1182/blood.v96.12.3793] [Cited by in Crossref: 111] [Article Influence: 5.3] [Reference Citation Analysis]
75 Ling S, Qi C, Li W, Xu J, Kuang W. The expression of vascular endothelial growth factor C in transplanted corneas. Curr Eye Res 2009;34:553-61. [PMID: 19899968 DOI: 10.1080/02713680902963159] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
76 Yanguas A, Garasa S, Teijeira Á, Aubá C, Melero I, Rouzaut A. ICAM-1-LFA-1 Dependent CD8+ T-Lymphocyte Aggregation in Tumor Tissue Prevents Recirculation to Draining Lymph Nodes. Front Immunol 2018;9:2084. [PMID: 30258446 DOI: 10.3389/fimmu.2018.02084] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
77 Fang C, Miguel MA, Avis I, Martinez A, Zudaire E, Cuttitta F. Non-peptide small molecule regulators of lymphangiogenesis. Lymphat Res Biol 2009;7:189-96. [PMID: 20143917 DOI: 10.1089/lrb.2009.0033] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
78 Yuanming L, Feng G, Lei T, Ying W. Quantitative analysis of lymphangiogenic markers in human gastroenteric tumor. Arch Med Res. 2007;38:106-112. [PMID: 17174733 DOI: 10.1016/j.arcmed.2006.08.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
79 Zhan P, Qian Q, Yu LK. Prognostic significance of vascular endothelial growth factor expression in hepatocellular carcinoma tissue: a meta-analysis. Hepatobiliary Surg Nutr. 2013;2:148-155. [PMID: 24570933 DOI: 10.3978/j.issn.2304-3881.2013.06.06] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
80 Lee RT. Lessons From Lymph: Flow-Guided Vessel Formation. Circulation Research 2003;92:701-3. [DOI: 10.1161/01.res.0000069361.79586.12] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
81 Yong C, Bridenbaugh EA, Zawieja DC, Swartz MA. Microarray Analysis of VEGF-C Responsive Genes in Human Lymphatic Endothelial Cells. Lymphatic Research and Biology 2005;3:183-207. [DOI: 10.1089/lrb.2005.3.183] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
82 Pfarr KM, Debrah AY, Specht S, Hoerauf A. Filariasis and lymphoedema. Parasite Immunol 2009;31:664-72. [PMID: 19825106 DOI: 10.1111/j.1365-3024.2009.01133.x] [Cited by in Crossref: 94] [Cited by in F6Publishing: 70] [Article Influence: 8.5] [Reference Citation Analysis]
83 Yu H, Zhang S, Zhang R, Zhang L. The role of VEGF-C/D and Flt-4 in the lymphatic metastasis of early-stage invasive cervical carcinoma. J Exp Clin Cancer Res 2009;28:98. [PMID: 19589137 DOI: 10.1186/1756-9966-28-98] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
84 Campbell KT, Curtis MB, Massey JM, Wysoczynski K, Hadley DJ, George SC, Silva EA. Isolating and characterizing lymphatic endothelial progenitor cells for potential therapeutic lymphangiogenic applications. Acta Biomater 2021:S1742-7061(21)00525-0. [PMID: 34384911 DOI: 10.1016/j.actbio.2021.08.005] [Reference Citation Analysis]
85 Papadakou P, Bletsa A, Yassin MA, Karlsen TV, Wiig H, Berggreen E. Role of Hyperplasia of Gingival Lymphatics in Periodontal Inflammation. J Dent Res 2017;96:467-76. [PMID: 28081372 DOI: 10.1177/0022034516681762] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
86 Barbucci R, Lamponi S, Magnani A, Piras FM, Rossi A, Weber E. Role of the Hyal−Cu (II) Complex on Bovine Aortic and Lymphatic Endothelial Cells Behavior on Microstructured Surfaces. Biomacromolecules 2005;6:212-9. [DOI: 10.1021/bm049568g] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
87 Shields JD. Lymphatics: at the interface of immunity, tolerance, and tumor metastasis. Microcirculation 2011;18:517-31. [PMID: 21575093 DOI: 10.1111/j.1549-8719.2011.00113.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
88 Proulx ST, Luciani P, Alitalo A, Mumprecht V, Christiansen AJ, Huggenberger R, Leroux JC, Detmar M. Non-invasive dynamic near-infrared imaging and quantification of vascular leakage in vivo. Angiogenesis 2013;16:525-40. [PMID: 23325334 DOI: 10.1007/s10456-013-9332-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
89 Sello CT, Liu C, Sun Y, Msuthwana P, Hu J, Sui Y, Chen S, Zhou Y, Lu H, Xu C, Sun Y, Liu J, Li S, Yang W. De Novo Assembly and Comparative Transcriptome Profiling of Anser anser and Anser cygnoides Geese Species' Embryonic Skin Feather Follicles. Genes (Basel) 2019;10:E351. [PMID: 31072014 DOI: 10.3390/genes10050351] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
90 Qi S, Yang C, Zhu M, Chen H. Effect of oral mucosal transplantation on the expression of EGF and VEGF-C during skin wound repair. Exp Ther Med 2019;18:320-5. [PMID: 31258668 DOI: 10.3892/etm.2019.7546] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
91 Zhou Y, Bellingard V, Feng KT, McMaster M, Fisher SJ. Human cytotrophoblasts promote endothelial survival and vascular remodeling through secretion of Ang2, PlGF, and VEGF-C. Dev Biol 2003;263:114-25. [PMID: 14568550 DOI: 10.1016/s0012-1606(03)00449-4] [Cited by in Crossref: 100] [Cited by in F6Publishing: 37] [Article Influence: 5.6] [Reference Citation Analysis]
92 Karaman S, Hollmén M, Yoon SY, Alkan HF, Alitalo K, Wolfrum C, Detmar M. Transgenic overexpression of VEGF-C induces weight gain and insulin resistance in mice. Sci Rep 2016;6:31566. [PMID: 27511834 DOI: 10.1038/srep31566] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
93 Hassan BB, Elshafae SM, Supsavhad W, Simmons JK, Dirksen WP, Sokkar SM, Rosol TJ. Feline Mammary Cancer. Vet Pathol 2017;54:32-43. [PMID: 27281014 DOI: 10.1177/0300985816650243] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
94 Wada H, Ura S, Kitaoka S, Satoh-Asahara N, Horie T, Ono K, Takaya T, Takanabe-Mori R, Akao M, Abe M, Morimoto T, Murayama T, Yokode M, Fujita M, Shimatsu A, Hasegawa K. Distinct characteristics of circulating vascular endothelial growth factor-a and C levels in human subjects. PLoS One 2011;6:e29351. [PMID: 22206010 DOI: 10.1371/journal.pone.0029351] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
95 Butler MG, Isogai S, Weinstein BM. Lymphatic development. Birth Defects Res C Embryo Today 2009;87:222-31. [PMID: 19750516 DOI: 10.1002/bdrc.20155] [Cited by in Crossref: 48] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
96 Arenberg D. In search of the holy grail: lung cancer biomarkers. Chest 2004;126:325-6. [PMID: 15302707 DOI: 10.1378/chest.126.2.325] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
97 Alessi C, Scapulatempo Neto C, Viana CR, Vazquez VDL. PD-1/PD-L1 and VEGF-A/VEGF-C expression in lymph node microenvironment and association with melanoma metastasis and survival. Melanoma Research 2017;27:565-72. [DOI: 10.1097/cmr.0000000000000396] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
98 Noh Y, Rho M, Yoo Y, Jung SJ, Lee S. Isolation and Morphological Features of Primo Vessels in Rabbit Lymph Vessels. Journal of Acupuncture and Meridian Studies 2012;5:201-5. [DOI: 10.1016/j.jams.2012.07.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
99 Hwang JH, Kim IG, Lee JY, Piao S, Lee DS, Lee TS, Ra JC, Lee JY. Therapeutic lymphangiogenesis using stem cell and VEGF-C hydrogel. Biomaterials 2011;32:4415-23. [PMID: 21421266 DOI: 10.1016/j.biomaterials.2011.02.051] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 5.6] [Reference Citation Analysis]
100 Nitschké M, Bell A, Karaman S, Amouzgar M, Rutkowski JM, Scherer PE, Alitalo K, McDonald DM. Retrograde Lymph Flow Leads to Chylothorax in Transgenic Mice with Lymphatic Malformations. Am J Pathol 2017;187:1984-97. [PMID: 28683257 DOI: 10.1016/j.ajpath.2017.05.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
101 Choi I, Lee S, Hong YK. The new era of the lymphatic system: no longer secondary to the blood vascular system. Cold Spring Harb Perspect Med 2012;2:a006445. [PMID: 22474611 DOI: 10.1101/cshperspect.a006445] [Cited by in Crossref: 71] [Cited by in F6Publishing: 57] [Article Influence: 8.9] [Reference Citation Analysis]
102 Kajiya K, Hirakawa S, Detmar M. Vascular endothelial growth factor-A mediates ultraviolet B-induced impairment of lymphatic vessel function. Am J Pathol 2006;169:1496-503. [PMID: 17003502 DOI: 10.2353/ajpath.2006.060197] [Cited by in Crossref: 68] [Cited by in F6Publishing: 61] [Article Influence: 4.5] [Reference Citation Analysis]
103 Achen MG, Stacker SA. Molecular control of lymphatic metastasis. Ann N Y Acad Sci. 2008;1131:225-234. [PMID: 18519975 DOI: 10.1196/annals.1413.020] [Cited by in Crossref: 172] [Cited by in F6Publishing: 142] [Article Influence: 13.2] [Reference Citation Analysis]
104 Hominick D, Silva A, Khurana N, Liu Y, Dechow PC, Feng JQ, Pytowski B, Rutkowski JM, Alitalo K, Dellinger MT. VEGF-C promotes the development of lymphatics in bone and bone loss. Elife 2018;7:e34323. [PMID: 29620526 DOI: 10.7554/eLife.34323] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 8.3] [Reference Citation Analysis]
105 Jackowski S, Janusch M, Fiedler E, Marsch WC, Ulbrich EJ, Gaisbauer G, Dunst J, Kerjaschki D, Helmbold P. Radiogenic lymphangiogenesis in the skin. Am J Pathol 2007;171:338-48. [PMID: 17591978 DOI: 10.2353/ajpath.2007.060589] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
106 Xu H, Becker CM, Lui WT, Chu CY, Davis TN, Kung AL, Birsner AE, D'Amato RJ, Wai Man GC, Wang CC. Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo. Fertil Steril 2011;96:1021-8. [PMID: 21821246 DOI: 10.1016/j.fertnstert.2011.07.008] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 4.9] [Reference Citation Analysis]
107 Paku S. Current concepts of tumor-induced angiogenesis. Pathol Oncol Res 1998;4:62-75. [PMID: 9555124 DOI: 10.1007/BF02904699] [Cited by in Crossref: 35] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
108 Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV, Jeltsch M, Jackson DG, Talikka M, Rauvala H, Betsholtz C, Alitalo K. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 2004;5:74-80. [PMID: 14634646 DOI: 10.1038/ni1013] [Cited by in Crossref: 939] [Cited by in F6Publishing: 832] [Article Influence: 52.2] [Reference Citation Analysis]
109 Yoon CM, Hong BS, Moon HG, Lim S, Suh PG, Kim YK, Chae CB, Gho YS. Sphingosine-1-phosphate promotes lymphangiogenesis by stimulating S1P1/Gi/PLC/Ca2+ signaling pathways. Blood. 2008;112:1129-1138. [PMID: 18541717 DOI: 10.1182/blood-2007-11-125203] [Cited by in Crossref: 75] [Cited by in F6Publishing: 71] [Article Influence: 5.8] [Reference Citation Analysis]
110 Wilting J, Papoutsi M, Othman-Hassan K, Rodriguez-Niedenführ M, Pröls F, Tomarev SI, Eichmann A. Development of the avian lymphatic system. Microsc Res Tech 2001;55:81-91. [PMID: 11596153 DOI: 10.1002/jemt.1159] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 2.0] [Reference Citation Analysis]
111 Hamrah P, Chen L, Cursiefen C, Zhang Q, Joyce NC, Dana MR. Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) on monocytic bone marrow-derived cells in the conjunctiva. Experimental Eye Research 2004;79:553-61. [DOI: 10.1016/j.exer.2004.06.028] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.2] [Reference Citation Analysis]
112 Ren SX, Ren ZJ, Zhao MY, Wang XB, Zuo SG, Yu F. Antitumor activity of endogenous mFlt4 displayed on a T4 phage nanoparticle surface. Acta Pharmacol Sin 2009;30:637-45. [PMID: 19417736 DOI: 10.1038/aps.2009.44] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
113 Nathanson SD. Preclinical Models of Regional Lymph Node Tumor Metastasis. In: Leong SPL, editor. Cancer Metastasis And The Lymphovascular System: Basis For Rational Therapy. Boston: Springer US; 2007. pp. 129-56. [DOI: 10.1007/978-0-387-69219-7_10] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
114 Han FH, Li HM, Zheng DH, He YL, Zhan WH. The effect of the expression of vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 on the clinical outcome in patients with gastric carcinoma. Eur J Surg Oncol. 2010;36:1172-1179. [PMID: 20888167 DOI: 10.1016/j.ejso.2010.09.002] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
115 Ito R, Suami H. Overview of Lymph Node Transfer for Lymphedema Treatment: . Plastic and Reconstructive Surgery 2014;134:548-56. [DOI: 10.1097/prs.0000000000000383] [Cited by in Crossref: 49] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
116 Yokoyama Y, Charnock-Jones DS, Licence D, Yanaihara A, Hastings JM, Holland CM, Emoto M, Umemoto M, Sakamoto T, Sato S. Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma. Br J Cancer. 2003;88:237-244. [PMID: 12610509 DOI: 10.1038/sj.bjc.6600701] [Cited by in Crossref: 107] [Cited by in F6Publishing: 123] [Article Influence: 5.9] [Reference Citation Analysis]
117 Liu F, Mu J, Yuan Z, Lian Q, Zheng S, Wu G, Liu E. Involvement of the lymphatic system in salt-sensitive hypertension in humans. Med Sci Monit 2011;17:CR542-6. [PMID: 21959606 DOI: 10.12659/msm.881978] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
118 Muller YA, Christinger HW, Keyt BA, de Vos AM. The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93 A resolution: multiple copy flexibility and receptor binding. Structure 1997;5:1325-38. [PMID: 9351807 DOI: 10.1016/s0969-2126(97)00284-0] [Cited by in Crossref: 163] [Cited by in F6Publishing: 48] [Article Influence: 7.1] [Reference Citation Analysis]
119 Kawakami M, Furuhata T, Kimura Y, Yamaguchi K, Hata F, Sasaki K, Hirata K. Quantification of vascular endothelial growth factor-C and its receptor-3 messenger RNA with real-time quantitative polymerase chain reaction as a predictor of lymph node metastasis in human colorectal cancer. Surgery. 2003;133:300-308. [PMID: 12660643 DOI: 10.1067/msy.2003.45] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 2.0] [Reference Citation Analysis]
120 Weinkopff T, Mackenzie C, Eversole R, Lammie PJ. Filarial excretory-secretory products induce human monocytes to produce lymphangiogenic mediators. PLoS Negl Trop Dis 2014;8:e2893. [PMID: 25010672 DOI: 10.1371/journal.pntd.0002893] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
121 Matsumoto T, Claesson-welsh L. VEGF Receptor Signal Transduction. Science Signaling 2001;2001:re21-re21. [DOI: 10.1126/stke.2001.112.re21] [Cited by in Crossref: 94] [Cited by in F6Publishing: 190] [Article Influence: 4.7] [Reference Citation Analysis]
122 Vale PR, Isner JM, Rosenfield K. Therapeutic angiogenesis in critical limb and myocardial ischemia. J Interv Cardiol. 2001;14:511-528. [PMID: 12053643 DOI: 10.1111/j.1540-8183.2001.tb00367.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]
123 Repovic P, Fears CY, Gladson CL, Benveniste EN. Oncostatin-M induction of vascular endothelial growth factor expression in astroglioma cells. Oncogene 2003;22:8117-24. [PMID: 14603252 DOI: 10.1038/sj.onc.1206922] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 2.4] [Reference Citation Analysis]
124 Mueller BU, Mulliken JB. The infant with a vascular tumor. Seminars in Perinatology 1999;23:332-40. [DOI: 10.1016/s0146-0005(99)80041-x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 4] [Article Influence: 2.4] [Reference Citation Analysis]
125 Kim SH, Jung YJ, Kang KP, Lee S, Park SK, Lee JH, Kim NH, Kim W. Decreased serum level and increased urinary excretion of vascular endothelial growth factor-C in patients with chronic kidney disease. Kidney Res Clin Pract 2013;32:66-71. [PMID: 26877915 DOI: 10.1016/j.krcp.2013.05.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
126 Mandriota SJ, Jussila L, Jeltsch M, Compagni A, Baetens D, Prevo R, Banerji S, Huarte J, Montesano R, Jackson DG. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J. 2001;20:672-682. [PMID: 11179212 DOI: 10.1093/emboj/20.4.672] [Cited by in Crossref: 646] [Cited by in F6Publishing: 588] [Article Influence: 32.3] [Reference Citation Analysis]
127 Royston D, Jackson DG. Mechanisms of lymphatic metastasis in human colorectal adenocarcinoma. J Pathol 2009;217:608-19. [PMID: 19253334 DOI: 10.1002/path.2517] [Cited by in Crossref: 68] [Cited by in F6Publishing: 66] [Article Influence: 5.7] [Reference Citation Analysis]
128 Sorensen EW, Gerber SA, Frelinger JG, Lord EM. IL-12 suppresses vascular endothelial growth factor receptor 3 expression on tumor vessels by two distinct IFN-gamma-dependent mechanisms. J Immunol 2010;184:1858-66. [PMID: 20061409 DOI: 10.4049/jimmunol.0903210] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
129 Cueni LN, Detmar M. New Insights into the Molecular Control of the Lymphatic Vascular System and its Role in Disease. Journal of Investigative Dermatology 2006;126:2167-77. [DOI: 10.1038/sj.jid.5700464] [Cited by in Crossref: 174] [Cited by in F6Publishing: 137] [Article Influence: 11.6] [Reference Citation Analysis]
130 Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K. Lymphangiogenesis and cancer metastasis. Nat Rev Cancer. 2002;2:573-583. [PMID: 12154350 DOI: 10.1038/nrc863] [Cited by in Crossref: 561] [Cited by in F6Publishing: 465] [Article Influence: 29.5] [Reference Citation Analysis]
131 Oliveira-Ferrer L, Milde-Langosch K, Eylmann K, Rossberg M, Müller V, Schmalfeldt B, Witzel I, Wellbrock J, Fiedler W. Mechanisms of Tumor-Lymphatic Interactions in Invasive Breast and Prostate Carcinoma. Int J Mol Sci 2020;21:E602. [PMID: 31963450 DOI: 10.3390/ijms21020602] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
132 Angeli V, Randolph GJ. Inflammation, lymphatic function, and dendritic cell migration. Lymphat Res Biol. 2006;4:217-228. [PMID: 17394405 DOI: 10.1089/lrb.2006.4406] [Cited by in Crossref: 86] [Cited by in F6Publishing: 73] [Article Influence: 6.1] [Reference Citation Analysis]
133 Blume C, Geiger MF, Müller M, Clusmann H, Mainz V, Kalder J, Brandenburg LO, Mueller CA. Decreased angiogenesis as a possible pathomechanism in cervical degenerative myelopathy. Sci Rep 2021;11:2497. [PMID: 33510227 DOI: 10.1038/s41598-021-81766-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
134 Kranich S, Hattermann K, Specht A, Lucius R, Mentlein R. VEGFR-3/Flt-4 mediates proliferation and chemotaxis in glial precursor cells. Neurochem Int 2009;55:747-53. [PMID: 19646499 DOI: 10.1016/j.neuint.2009.07.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
135 Mkonyi L, Bakken V, Søvik J, Mauland E, Fristad I, Barczyk M, Bletsa A, Berggreen E. Lymphangiogenesis Is Induced during Development of Periodontal Disease. J Dent Res 2012;91:71-7. [DOI: 10.1177/0022034511424747] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
136 Haiko P, Makinen T, Keskitalo S, Taipale J, Karkkainen MJ, Baldwin ME, Stacker SA, Achen MG, Alitalo K. Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse embryos. Mol Cell Biol 2008;28:4843-50. [PMID: 18519586 DOI: 10.1128/MCB.02214-07] [Cited by in Crossref: 141] [Cited by in F6Publishing: 70] [Article Influence: 10.8] [Reference Citation Analysis]
137 Dixon JB. Lymphatic lipid transport: sewer or subway? Trends Endocrinol Metab 2010;21:480-7. [PMID: 20541951 DOI: 10.1016/j.tem.2010.04.003] [Cited by in Crossref: 94] [Cited by in F6Publishing: 81] [Article Influence: 8.5] [Reference Citation Analysis]
138 Tammela T, Saaristo A, Holopainen T, Lyytikkä J, Kotronen A, Pitkonen M, Abo-ramadan U, Ylä-herttuala S, Petrova TV, Alitalo K. Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantation. Nat Med 2007;13:1458-66. [DOI: 10.1038/nm1689] [Cited by in Crossref: 246] [Cited by in F6Publishing: 216] [Article Influence: 17.6] [Reference Citation Analysis]
139 Detmar M. The role of VEGF and thrombospondins in skin angiogenesis. Journal of Dermatological Science 2000;24:S78-84. [DOI: 10.1016/s0923-1811(00)00145-6] [Cited by in Crossref: 112] [Cited by in F6Publishing: 25] [Article Influence: 5.3] [Reference Citation Analysis]
140 Christiansen A, Detmar M. Lymphangiogenesis and cancer. Genes Cancer 2011;2:1146-58. [PMID: 22866206 DOI: 10.1177/1947601911423028] [Cited by in Crossref: 114] [Cited by in F6Publishing: 90] [Article Influence: 12.7] [Reference Citation Analysis]
141 Karnezis T, Shayan R, Caesar C, Roufail S, Harris NC, Ardipradja K, Zhang YF, Williams SP, Farnsworth RH, Chai MG. VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium. Cancer Cell. 2012;21:181-195. [PMID: 22340592 DOI: 10.1016/j.ccr.2011.12.026] [Cited by in Crossref: 178] [Cited by in F6Publishing: 158] [Article Influence: 19.8] [Reference Citation Analysis]
142 Karkkainen MJ, Ferrell RE, Lawrence EC, Kimak MA, Levinson KL, Mctigue MA, Alitalo K, Finegold DN. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat Genet 2000;25:153-9. [DOI: 10.1038/75997] [Cited by in Crossref: 460] [Cited by in F6Publishing: 373] [Article Influence: 21.9] [Reference Citation Analysis]
143 Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407:249-257. [PMID: 11001068 DOI: 10.1038/35025220] [Cited by in Crossref: 5922] [Cited by in F6Publishing: 5082] [Article Influence: 282.0] [Reference Citation Analysis]
144 Wilting J, Papoutsi M, Schneider M, Christ B. The lymphatic endothelium of the avian wing is of somitic origin. Dev Dyn 2000;217:271-8. [PMID: 10741421 DOI: 10.1002/(SICI)1097-0177(200003)217:3<271::AID-DVDY5>3.0.CO;2-2] [Cited by in Crossref: 52] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
145 Fink DM, Connor AL, Kelley PM, Steele MM, Hollingsworth MA, Tempero RM. Nerve growth factor regulates neurolymphatic remodeling during corneal inflammation and resolution. PLoS One 2014;9:e112737. [PMID: 25383879 DOI: 10.1371/journal.pone.0112737] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
146 Fellmer PT, Sato K, Tanaka R, Okamoto T, Kato Y, Kobayashi M, Shibuya M, Obara T. Vascular endothelial growth factor-C gene expression in papillary and follicular thyroid carcinomas. Surgery. 1999;126:1056-1061; discussion 1061-1062. [PMID: 10598188 DOI: 10.1067/msy.2099.101432] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 2.5] [Reference Citation Analysis]
147 Chien MH, Liu YF, Hsin CH, Lin CH, Shih CH, Yang SF, Cheng CW, Lin CW. Impact of VEGF-C gene polymorphisms and environmental factors on oral cancer susceptibility in Taiwan. PLoS One 2013;8:e60283. [PMID: 23593187 DOI: 10.1371/journal.pone.0060283] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
148 Sipos B, Klapper W, Kruse ML, Kalthoff H, Kerjaschki D, Klöppel G. Expression of lymphangiogenic factors and evidence of intratumoral lymphangiogenesis in pancreatic endocrine tumors. Am J Pathol 2004;165:1187-97. [PMID: 15466385 DOI: 10.1016/S0002-9440(10)63379-2] [Cited by in Crossref: 51] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
149 Mould AW, Tonks ID, Cahill MM, Pettit AR, Thomas R, Hayward NK, Kay GF. Vegfb gene knockout mice display reduced pathology and synovial angiogenesis in both antigen-induced and collagen-induced models of arthritis. Arthritis Rheum. 2003;48:2660-2669. [PMID: 13130487 DOI: 10.1002/art.11232] [Cited by in Crossref: 91] [Cited by in F6Publishing: 88] [Article Influence: 5.1] [Reference Citation Analysis]
150 Breugem CC, van der Horst CMAM, Hennekam RCM. Progress toward Understanding Vascular Malformations: . Plastic and Reconstructive Surgery 2001;107:1509-23. [DOI: 10.1097/00006534-200105000-00033] [Cited by in Crossref: 45] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
151 Wang C, Xu S, Tian Y, Ju A, Hou Q, Liu J, Fu Y, Luo Y. Lysyl Oxidase-Like Protein 2 Promotes Tumor Lymphangiogenesis and Lymph Node Metastasis in Breast Cancer. Neoplasia 2019;21:413-27. [PMID: 30925417 DOI: 10.1016/j.neo.2019.03.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
152 North PE. Pediatric Vascular Tumors and Malformations. Surg Pathol Clin 2010;3:455-94. [PMID: 26839221 DOI: 10.1016/j.path.2010.07.002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
153 Francia G, Man S, Teicher B, Grasso L, Kerbel RS. Gene expression analysis of tumor spheroids reveals a role for suppressed DNA mismatch repair in multicellular resistance to alkylating agents. Mol Cell Biol 2004;24:6837-49. [PMID: 15254249 DOI: 10.1128/MCB.24.15.6837-6849.2004] [Cited by in Crossref: 44] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
154 Guillem EB, Sampse JW. Immune-Promoted Tumor Cell Invasion and Metastasis. In: Llombart-bosch A, Felipo V, editors. New Trends in Cancer for the 21stCentury. Boston: Springer US; 2003. pp. 153-73. [DOI: 10.1007/978-1-4615-0081-0_13] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
155 Furuya M, Nishiyama M, Kasuya Y, Kimura S, Ishikura H. Pathophysiology of tumor neovascularization. Vasc Health Risk Manag 2005;1:277-90. [PMID: 17315600 DOI: 10.2147/vhrm.2005.1.4.277] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
156 Pytowski B, Goldman J, Persaud K, Wu Y, Witte L, Hicklin DJ, Skobe M, Boardman KC, Swartz MA. Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody. J Natl Cancer Inst. 2005;97:14-21. [PMID: 15632376 DOI: 10.1093/jnci/dji003] [Cited by in Crossref: 182] [Cited by in F6Publishing: 163] [Article Influence: 11.4] [Reference Citation Analysis]
157 Papoutsi M, Tomarev SI, Eichmann A, Pröls F, Christ B, Wilting J. Endogenous origin of the lymphatics in the avian chorioallantoic membrane: Lymphangioblasts in the Avian Chorioallantoic Membrane. Dev Dyn 2001;222:238-51. [DOI: 10.1002/dvdy.1187] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 2.4] [Reference Citation Analysis]
158 Weston G, Rogers PA. Endometrial angiogenesis. Best Practice & Research Clinical Obstetrics & Gynaecology 2000;14:919-36. [DOI: 10.1053/beog.2000.0135] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
159 Yang Y, Oliver G. Development of the mammalian lymphatic vasculature. J Clin Invest 2014;124:888-97. [PMID: 24590273 DOI: 10.1172/JCI71609] [Cited by in Crossref: 134] [Cited by in F6Publishing: 60] [Article Influence: 19.1] [Reference Citation Analysis]
160 Wada H, Suzuki M, Matsuda M, Ajiro Y, Shinozaki T, Sakagami S, Yonezawa K, Shimizu M, Funada J, Takenaka T, Morita Y, Nakamura T, Fujimoto K, Matsubara H, Kato T, Unoki T, Takagi D, Ura S, Wada K, Iguchi M, Masunaga N, Ishii M, Yamakage H, Shimatsu A, Kotani K, Satoh-Asahara N, Abe M, Akao M, Hasegawa K; ANOX Study Investigators. VEGF-C and Mortality in Patients With Suspected or Known Coronary Artery Disease. J Am Heart Assoc 2018;7:e010355. [PMID: 30554564 DOI: 10.1161/JAHA.118.010355] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
161 Maby-El Hajjami H, Petrova TV. Developmental and pathological lymphangiogenesis: from models to human disease. Histochem Cell Biol. 2008;130:1063-1078. [PMID: 18946678 DOI: 10.1007/s00418-008-0525-5] [Cited by in Crossref: 67] [Cited by in F6Publishing: 57] [Article Influence: 5.2] [Reference Citation Analysis]
162 Hirakawa S, Detmar M. New insights into the biology and pathology of the cutaneous lymphatic system. Journal of Dermatological Science 2004;35:1-8. [DOI: 10.1016/j.jdermsci.2003.10.006] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
163 Fukunaga S, Maeda K, Noda E, Inoue T, Wada K, Hirakawa K. Association between expression of vascular endothelial growth factor C, chemokine receptor CXCR4 and lymph node metastasis in colorectal cancer. Oncology 2006;71:204-11. [PMID: 17641542 DOI: 10.1159/000106070] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
164 Kumagai K, Shimizu K, Yokoyama N, Aida S, Tanaka T, Yamagata K. Gastrointestinal cancer metastasis and lymphatic advancement. Surg Today. 2010;40:301-306. [PMID: 20339983 DOI: 10.1007/s00595-009-4142-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
165 Bush A. Update in pediatric lung disease 2006. Am J Respir Crit Care Med 2007;175:532-40. [PMID: 17341647 DOI: 10.1164/rccm.200701-018UP] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
166 Szuba A, Skobe M, Karkkainen MJ, Shin WS, Beynet DP, Rockson NB, Dakhil N, Spilman S, Goris ML, Strauss HW. Therapeutic lymphangiogenesis with human recombinant VEGF-C. FASEB J. 2002;16:1985-1987. [PMID: 12397087 DOI: 10.1096/fj.02-0401fje] [Cited by in Crossref: 178] [Cited by in F6Publishing: 155] [Article Influence: 9.4] [Reference Citation Analysis]
167 Nykänen AI, Sandelin H, Krebs R, Keränen MA, Tuuminen R, Kärpänen T, Wu Y, Pytowski B, Koskinen PK, Ylä-herttuala S, Alitalo K, Lemström KB. Targeting Lymphatic Vessel Activation and CCL21 Production by Vascular Endothelial Growth Factor Receptor-3 Inhibition Has Novel Immunomodulatory and Antiarteriosclerotic Effects in Cardiac Allografts. Circulation 2010;121:1413-22. [DOI: 10.1161/circulationaha.109.910703] [Cited by in Crossref: 99] [Cited by in F6Publishing: 50] [Article Influence: 9.0] [Reference Citation Analysis]
168 Fujimoto J, Toyoki H, Sato E, Sakaguchi H, Tamaya T. Clinical implication of expression of vascular endothelial growth factor-C in metastatic lymph nodes of uterine cervical cancers. Br J Cancer 2004;91:466-9. [PMID: 15226772 DOI: 10.1038/sj.bjc.6601963] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
169 Li X, Lee C, Tang Z, Zhang F, Arjunan P, Li Y, Hou X, Kumar A, Dong L. VEGF-B: a survival, or an angiogenic factor? Cell Adh Migr 2009;3:322-7. [PMID: 19684473 DOI: 10.4161/cam.3.4.9459] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 4.7] [Reference Citation Analysis]
170 Kinoshita J, Kitamura K, Kabashima A, Saeki H, Tanaka S, Sugimachi K. Clinical significance of vascular endothelial growth factor-C (VEGF-C) in breast cancer. Breast Cancer Res Treat. 2001;66:159-164. [PMID: 11437102 DOI: 10.1023/a:1010692132669] [Cited by in Crossref: 99] [Cited by in F6Publishing: 36] [Article Influence: 5.0] [Reference Citation Analysis]
171 Saaristo A, Veikkola T, Tammela T, Enholm B, Karkkainen MJ, Pajusola K, Bueler H, Ylä-Herttuala S, Alitalo K. Lymphangiogenic gene therapy with minimal blood vascular side effects. J Exp Med 2002;196:719-30. [PMID: 12235206 DOI: 10.1084/jem.20020587] [Cited by in Crossref: 110] [Cited by in F6Publishing: 97] [Article Influence: 5.8] [Reference Citation Analysis]
172 Bock F, Onderka J, Dietrich T, Bachmann B, Pytowski B, Cursiefen C. Blockade of VEGFR3-signalling specifically inhibits lymphangiogenesis in inflammatory corneal neovascularisation. Graefes Arch Clin Exp Ophthalmol 2008;246:115-9. [PMID: 17909835 DOI: 10.1007/s00417-007-0683-5] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 3.5] [Reference Citation Analysis]
173 Stacker SA, Achen MG. The Vascular Endothelial Growth Factor Family: Signalling for Vascular Development. Growth Factors 2009;17:1-11. [DOI: 10.3109/08977199909001058] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 4.1] [Reference Citation Analysis]
174 Witzenbichler B, Asahara T, Murohara T, Silver M, Spyridopoulos I, Magner M, Principe N, Kearney M, Hu JS, Isner JM. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. Am J Pathol 1998;153:381-94. [PMID: 9708799 DOI: 10.1016/S0002-9440(10)65582-4] [Cited by in Crossref: 242] [Cited by in F6Publishing: 49] [Article Influence: 10.5] [Reference Citation Analysis]
175 Newman B, Lose F, Kedda MA, Francois M, Ferguson K, Janda M, Yates P, Spurdle AB, Hayes SC. Possible genetic predisposition to lymphedema after breast cancer. Lymphat Res Biol. 2012;10:2-13. [PMID: 22404826 DOI: 10.1089/lrb.2011.0024] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 7.0] [Reference Citation Analysis]
176 Pinho DF, Subramaniam RM. PET–Computed Tomography and Precision Medicine in Pancreatic Adenocarcinoma and Pancreatic Neuroendocrine Tumors. PET Clinics 2017;12:407-21. [DOI: 10.1016/j.cpet.2017.05.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
177 Stearns ME, Wang M, Hu Y, Kim G, Garcia FU. Expression of a flt-4 (VEGFR3) splicing variant in primary human prostate tumors. VEGF D and flt-4tΔ773–1081 overexpression is diagnostic for sentinel lymph node metastasis. Lab Invest 2004;84:785-95. [DOI: 10.1038/labinvest.3700075] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
178 Henno A, Lapière C, Nusgens B, de la Brassinne M. Le système vasculaire lymphatique : états des connaissances et implications dermatologiques potentielles. Annales de Dermatologie et de Vénéréologie 2008;135:704-9. [DOI: 10.1016/j.annder.2008.04.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
179 Folpe AL, Veikkola T, Valtola R, Weiss SW. Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3): A Marker of Vascular Tumors with Presumed Lymphatic Differentiation, Including Kaposi's Sarcoma, Kaposiform and Dabska-Type Hemangioendotheliomas, and a Subset of Angiosarcomas. Mod Pathol 2000;13:180-5. [DOI: 10.1038/modpathol.3880033] [Cited by in Crossref: 146] [Cited by in F6Publishing: 99] [Article Influence: 7.0] [Reference Citation Analysis]
180 Belagodu AP, Fleming S, Galvez R. Neocortical developmental analysis of vasculature and their growth factors offer new insight into fragile X syndrome abnormalities. Devel Neurobio 2017;77:1321-33. [DOI: 10.1002/dneu.22514] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
181 Ebata N, Sawa Y, Nodasaka Y, Yamaoka Y, Yoshida S, Totsuka Y. Immunoelectron microscopic study of PECAM-1 expression on lymphatic endothelium of the human tongue. Tissue Cell 2001;33:211-8. [PMID: 11469534 DOI: 10.1054/tice.2000.0158] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
182 Jones, Fujiyama. Angiogenesis in urological malignancy: prognostic indicator and therapeutic target: ANGIOGENESIS IN UROLOGICAL MALIGNANCY. BJU International 1999;83:535-56. [DOI: 10.1046/j.1464-410x.1999.00018.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
183 Flamme I, Breier G. The Role of Vascular Endothelial Growth Factors and Their Receptors During Embryonic Vascular Development. In: Tomanek RJ, editor. Assembly of the Vasculature and Its Regulation. Boston: Birkhäuser; 2002. pp. 21-54. [DOI: 10.1007/978-1-4612-0109-0_2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
184 Johnson LA, Prevo R, Clasper S, Jackson DG. Inflammation-induced uptake and degradation of the lymphatic endothelial hyaluronan receptor LYVE-1. J Biol Chem. 2007;282:33671-33680. [PMID: 17884820 DOI: 10.1074/jbc.m702889200] [Cited by in Crossref: 105] [Cited by in F6Publishing: 48] [Article Influence: 7.5] [Reference Citation Analysis]
185 An A, Rockson SG. The Potential for Molecular Treatment Strategies in Lymphatic Disease. Lymphatic Research and Biology 2004;2:173-81. [DOI: 10.1089/lrb.2004.2.173] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
186 Kojima H, Shijubo N, Yamada G, Ichimiya S, Abe S, Satoh M, Sato N. Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma. Cancer 2005;104:1668-77. [DOI: 10.1002/cncr.21366] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 2.8] [Reference Citation Analysis]
187 Keskitalo S, Tammela T, Lyytikka J, Karpanen T, Jeltsch M, Markkanen J, Yla-Herttuala S, Alitalo K. Enhanced capillary formation stimulated by a chimeric vascular endothelial growth factor/vascular endothelial growth factor-C silk domain fusion protein. Circ Res 2007;100:1460-7. [PMID: 17478734 DOI: 10.1161/01.RES.0000269042.58594.f6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
188 Orpana A, Salven P. Angiogenic and Lymphangiogenic Molecules in Hematological Malignancies. Leukemia & Lymphoma 2009;43:219-24. [DOI: 10.1080/10428190290005964] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
189 Bando H, Brokelmann M, Toi M, Alitalo K, Sleeman JP, Sipos B, Gröne H, Weich HA. Immunodetection and quantification of vascular endothelial growth factor receptor-3 in human malignant tumor tissues: Endothelial Growth Factor Receptor-3 Assay. Int J Cancer 2004;111:184-91. [DOI: 10.1002/ijc.20211] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 1.9] [Reference Citation Analysis]
190 Chien MH, Ku CC, Johansson G, Chen MW, Hsiao M, Su JL, Inoue H, Hua KT, Wei LH, Kuo ML. Vascular endothelial growth factor-C (VEGF-C) promotes angiogenesis by induction of COX-2 in leukemic cells via the VEGF-R3/JNK/AP-1 pathway. Carcinogenesis 2009;30:2005-13. [PMID: 19825968 DOI: 10.1093/carcin/bgp244] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 4.7] [Reference Citation Analysis]
191 Zhao S, Yang X, Lu M, Sun G, Wang Y, Zhang Y, Pu Y, Tang E. Prognostic significance of VEGF immunohistochemical expression in oral cancer: a meta-analysis of the literature. Tumor Biol 2013;34:3165-71. [DOI: 10.1007/s13277-013-0886-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
192 Carmeliet P, Collen D. Vascular development and disorders: molecular analysis and pathogenic insights. Kidney Int. 1998;53:1519-1549. [PMID: 9607184 DOI: 10.1046/j.1523-1755.1998.00936.x] [Cited by in Crossref: 83] [Cited by in F6Publishing: 72] [Article Influence: 3.6] [Reference Citation Analysis]
193 Wang ZG, Puri TS, Quigg RJ. Characterization of novel VEGF (vascular endothelial growth factor)-C splicing isoforms from mouse. Biochem J 2010;428:347-54. [PMID: 20415667 DOI: 10.1042/BJ20100379] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
194 Saaristo A, Karkkainen MJ, Alitalo K. Insights into the molecular pathogenesis and targeted treatment of lymphedema. Ann N Y Acad Sci 2002;979:94-110. [PMID: 12543720 DOI: 10.1111/j.1749-6632.2002.tb04871.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
195 Swartz MA, Skobe M. Lymphatic function, lymphangiogenesis, and cancer metastasis. Microsc Res Tech 2001;55:92-9. [PMID: 11596154 DOI: 10.1002/jemt.1160] [Cited by in Crossref: 125] [Cited by in F6Publishing: 110] [Article Influence: 6.3] [Reference Citation Analysis]
196 Witte MH, Bernas MJ, Martin CP, Witte CL. Lymphangiogenesis and lymphangiodysplasia: From molecular to clinical lymphology. Microsc Res Tech 2001;55:122-45. [DOI: 10.1002/jemt.1163] [Cited by in Crossref: 138] [Cited by in F6Publishing: 121] [Article Influence: 6.9] [Reference Citation Analysis]
197 Kumasaka T, Seyama K, Mitani K, Sato T, Souma S, Kondo T, Hayashi S, Minami M, Uekusa T, Fukuchi Y, Suda K. Lymphangiogenesis in Lymphangioleiomyomatosis: Its Implication in the Progression of Lymphangioleiomyomatosis. American Journal of Surgical Pathology 2004;28:1007-16. [DOI: 10.1097/01.pas.0000126859.70814.6d] [Cited by in Crossref: 105] [Cited by in F6Publishing: 79] [Article Influence: 6.2] [Reference Citation Analysis]
198 Chen Y, Li J, Li Q, Wang T, Xing L, Xu H, Wang Y, Shi Q, Zhou Q, Liang Q. Du-Huo-Ji-Sheng-Tang Attenuates Inflammation of TNF-Tg Mice Related to Promoting Lymphatic Drainage Function. Evid Based Complement Alternat Med 2016;2016:7067691. [PMID: 27239212 DOI: 10.1155/2016/7067691] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
199 Kivelä R, Havas E, Vihko V. Localisation of lymphatic vessels and vascular endothelial growth factors-C and -D in human and mouse skeletal muscle with immunohistochemistry. Histochem Cell Biol 2007;127:31-40. [PMID: 16924525 DOI: 10.1007/s00418-006-0226-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
200 Song J, Chen W, Cui X, Huang Z, Wen D, Yang Y, Yu W, Cui L, Liu CY. CCBE1 promotes tumor lymphangiogenesis and is negatively regulated by TGFβ signaling in colorectal cancer. Theranostics 2020;10:2327-41. [PMID: 32089745 DOI: 10.7150/thno.39740] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
201 Ji R, Miura M, Qu P, Kato S. Expression of VEGFR-3 and 5?-Nase in regenerating lymphatic vessels of the cutaneous wound healing. Microsc Res Tech 2004;64:279-86. [DOI: 10.1002/jemt.20082] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
202 Adamis AP, Shima DT. The role of vascular endothelial growth factor in ocular health and disease. Retina 2005;25:111-8. [PMID: 15689799 DOI: 10.1097/00006982-200502000-00001] [Cited by in Crossref: 213] [Cited by in F6Publishing: 169] [Article Influence: 13.3] [Reference Citation Analysis]
203 Lee J, Parthiban P, Jin G, Knowles JC, Kim H. Materials roles for promoting angiogenesis in tissue regeneration. Progress in Materials Science 2021;117:100732. [DOI: 10.1016/j.pmatsci.2020.100732] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 14.0] [Reference Citation Analysis]
204 Gutierrez-Miranda L, Yaniv K. Cellular Origins of the Lymphatic Endothelium: Implications for Cancer Lymphangiogenesis. Front Physiol 2020;11:577584. [PMID: 33071831 DOI: 10.3389/fphys.2020.577584] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
205 Yesil S, Tanyildiz HG, Bozkurt C, Cakmakci E, Sahin G. Single-center experience with sirolimus therapy for vascular malformations. Pediatr Hematol Oncol 2016;33:219-25. [PMID: 27128161 DOI: 10.3109/08880018.2016.1160170] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 5.6] [Reference Citation Analysis]
206 Marsch WC. Lymphgef��system und Haut: Orthologie, Klinik und Pathologie. Hautarzt 2005;56:277-95. [DOI: 10.1007/s00105-005-0912-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
207 Marchiò S, Primo L, Pagano M, Palestro G, Albini A, Veikkola T, Cascone I, Alitalo K, Bussolino F. Vascular endothelial growth factor-C stimulates the migration and proliferation of Kaposi's sarcoma cells. J Biol Chem 1999;274:27617-22. [PMID: 10488101 DOI: 10.1074/jbc.274.39.27617] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 3.2] [Reference Citation Analysis]
208 Norrmén C, Tammela T, Petrova TV, Alitalo K. Biological Basis of Therapeutic Lymphangiogenesis. Circulation 2011;123:1335-51. [DOI: 10.1161/circulationaha.107.704098] [Cited by in Crossref: 99] [Cited by in F6Publishing: 47] [Article Influence: 9.9] [Reference Citation Analysis]
209 Karkkainen MJ, Alitalo K. Lymphatic endothelial regulation, lymphoedema, and lymph node metastasis. Seminars in Cell & Developmental Biology 2002;13:9-18. [DOI: 10.1006/scdb.2001.0286] [Cited by in Crossref: 55] [Cited by in F6Publishing: 36] [Article Influence: 2.9] [Reference Citation Analysis]
210 Hamaguchi I, Morisada T, Azuma M, Murakami K, Kuramitsu M, Mizukami T, Ohbo K, Yamaguchi K, Oike Y, Dumont DJ, Suda T. Loss of Tie2 receptor compromises embryonic stem cell-derived endothelial but not hematopoietic cell survival. Blood 2006;107:1207-13. [PMID: 16219799 DOI: 10.1182/blood-2005-05-1823] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
211 Nakao S, Maruyama K, Zandi S, Melhorn MI, Taher M, Noda K, Nusayr E, Doetschman T, Hafezi-Moghadam A. Lymphangiogenesis and angiogenesis: concurrence and/or dependence? Studies in inbred mouse strains. FASEB J 2010;24:504-13. [PMID: 19858096 DOI: 10.1096/fj.09-134056] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
212 Blesinger H, Kaulfuß S, Aung T, Schwoch S, Prantl L, Rößler J, Wilting J, Becker J. PIK3CA mutations are specifically localized to lymphatic endothelial cells of lymphatic malformations. PLoS One 2018;13:e0200343. [PMID: 29985963 DOI: 10.1371/journal.pone.0200343] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 9.7] [Reference Citation Analysis]
213 Schietroma C, Cianfarani F, Lacal PM, Odorisio T, Orecchia A, Kanitakis J, D'Atri S, Failla CM, Zambruno G. Vascular endothelial growth factor-C expression correlates with lymph node localization of human melanoma metastases. Cancer 2003;98:789-97. [PMID: 12910524 DOI: 10.1002/cncr.11583] [Cited by in Crossref: 72] [Cited by in F6Publishing: 55] [Article Influence: 4.0] [Reference Citation Analysis]
214 Ferrara N. Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int. 1999;56:794-814. [PMID: 10469350 DOI: 10.1046/j.1523-1755.1999.00610.x] [Cited by in Crossref: 513] [Cited by in F6Publishing: 447] [Article Influence: 23.3] [Reference Citation Analysis]
215 Olson TA, Mohanraj D, Roy S, Ramakrishnan S. Targeting the tumor vasculature: Inhibition of tumor growth by a vascular endothelial growth factor-toxin conjugate. Int J Cancer 1997;73:865-70. [DOI: 10.1002/(sici)1097-0215(19971210)73:6<865::aid-ijc17>3.0.co;2-3] [Cited by in Crossref: 54] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
216 Cursiefen C, Chen L, Borges LP, Jackson D, Cao J, Radziejewski C, D'Amore PA, Dana MR, Wiegand SJ, Streilein JW. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 2004;113:1040-50. [PMID: 15057311 DOI: 10.1172/JCI20465] [Cited by in Crossref: 590] [Cited by in F6Publishing: 343] [Article Influence: 34.7] [Reference Citation Analysis]
217 Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T, Alitalo K, Damsky C, Fisher SJ. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol. 2002;160:1405-1423. [PMID: 11943725 DOI: 10.1016/s0002-9440(10)62567-9] [Cited by in Crossref: 454] [Cited by in F6Publishing: 149] [Article Influence: 23.9] [Reference Citation Analysis]
218 Karkkainen MJ, Jussila L, Alitalo K, Ferrell RE, Finegold DN. Molecular regulation of lymphangiogenesis and targets for tissue oedema. Trends in Molecular Medicine 2001;7:18-22. [DOI: 10.1016/s1471-4914(00)01864-5] [Cited by in Crossref: 48] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
219 Palin NK, Savikko J, Koskinen PK. Sirolimus inhibits lymphangiogenesis in rat renal allografts, a novel mechanism to prevent chronic kidney allograft injury. Transpl Int 2013;26:195-205. [DOI: 10.1111/tri.12005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
220 Shimoda H, Bernas MJ, Witte MH. Dysmorphogenesis of lymph nodes in Foxc2 haploinsufficient mice. Histochem Cell Biol 2011;135:603-13. [PMID: 21614587 DOI: 10.1007/s00418-011-0819-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
221 Brown P. Lymphatic system: unlocking the drains. Nature. 2005;436:456-458. [PMID: 16049446 DOI: 10.1038/436456a] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 2.2] [Reference Citation Analysis]
222 Majesky MW. Development of coronary vessels. Curr Top Dev Biol 2004;62:225-59. [PMID: 15522744 DOI: 10.1016/S0070-2153(04)62008-4] [Cited by in Crossref: 47] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
223 Chang LK, Garcia-Cardeña G, Farnebo F, Fannon M, Chen EJ, Butterfield C, Moses MA, Mulligan RC, Folkman J, Kaipainen A. Dose-dependent response of FGF-2 for lymphangiogenesis. Proc Natl Acad Sci U S A 2004;101:11658-63. [PMID: 15289610 DOI: 10.1073/pnas.0404272101] [Cited by in Crossref: 196] [Cited by in F6Publishing: 179] [Article Influence: 11.5] [Reference Citation Analysis]
224 Kimura H, Mikami D, Kamiyama K, Sugimoto H, Kasuno K, Takahashi N, Yoshida H, Iwano M. Telmisartan, a possible PPAR-δ agonist, reduces TNF-α-stimulated VEGF-C production by inhibiting the p38MAPK/HSP27 pathway in human proximal renal tubular cells. Biochem Biophys Res Commun. 2014;454:320-327. [PMID: 25450396 DOI: 10.1016/j.bbrc.2014.10.077] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
225 Kärpänen T, Heckman CA, Keskitalo S, Jeltsch M, Ollila H, Neufeld G, Tamagnone L, Alitalo K. Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. FASEB J. 2006;20:1462-1472. [PMID: 16816121 DOI: 10.1096/fj.05-5646com] [Cited by in Crossref: 216] [Cited by in F6Publishing: 188] [Article Influence: 14.4] [Reference Citation Analysis]
226 Duxbury MS, Grikscheit TC, Gardner-Thorpe J, Rocha FG, Ito H, Perez A, Ashley SW, Vacanti JP, Whang EE. Lymphangiogenesis in tissue-engineered small intestine. Transplantation 2004;77:1162-6. [PMID: 15114078 DOI: 10.1097/01.tp.0000121506.34924.3c] [Cited by in Crossref: 34] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
227 Chilov D, Kukk E, Taira S, Jeltsch M, Kaukonen J, Palotie A, Joukov V, Alitalo K. Genomic Organization of Human and Mouse Genes for Vascular Endothelial Growth Factor C. Journal of Biological Chemistry 1997;272:25176-83. [DOI: 10.1074/jbc.272.40.25176] [Cited by in Crossref: 121] [Cited by in F6Publishing: 109] [Article Influence: 5.0] [Reference Citation Analysis]
228 Donoghue JF, Lederman FL, Susil BJ, Rogers PA. Lymphangiogenesis of normal endometrium and endometrial adenocarcinoma. Hum Reprod. 2007;22:1705-1713. [PMID: 17347164 DOI: 10.1093/humrep/dem037] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 3.3] [Reference Citation Analysis]
229 Agarwal B, Saxena R, Morimiya A, Mehrotra S, Badve S. Lymphangiogenesis does not occur in breast cancer. Am J Surg Pathol 2005;29:1449-55. [PMID: 16224211 DOI: 10.1097/01.pas.0000174269.99459.9d] [Cited by in Crossref: 59] [Cited by in F6Publishing: 45] [Article Influence: 3.9] [Reference Citation Analysis]
230 Bogliolo S, Cassani C, Gardella B, Musacchi V, Babilonti L, Venturini PL, Ferrero S, Spinillo A. Current opinion on bevacizumab on endometrial cancer treatment. Expert Opin Biol Ther 2015;15:299-307. [PMID: 25539414 DOI: 10.1517/14712598.2015.995624] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
231 Bautch VL, Caron KM. Blood and lymphatic vessel formation. Cold Spring Harb Perspect Biol 2015;7:a008268. [PMID: 25731762 DOI: 10.1101/cshperspect.a008268] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
232 Rinderknecht M, Detmar M. Tumor lymphangiogenesis and melanoma metastasis. J Cell Physiol. 2008;216:347-354. [PMID: 18481261 DOI: 10.1002/jcp.21494] [Cited by in Crossref: 114] [Cited by in F6Publishing: 97] [Article Influence: 8.8] [Reference Citation Analysis]
233 Villefranc JA, Nicoli S, Bentley K, Jeltsch M, Zarkada G, Moore JC, Gerhardt H, Alitalo K, Lawson ND. A truncation allele in vascular endothelial growth factor c reveals distinct modes of signaling during lymphatic and vascular development. Development 2013;140:1497-506. [PMID: 23462469 DOI: 10.1242/dev.084152] [Cited by in Crossref: 75] [Cited by in F6Publishing: 70] [Article Influence: 9.4] [Reference Citation Analysis]
234 Cueni LN, Detmar M. The lymphatic system in health and disease. Lymphat Res Biol 2008;6:109-22. [PMID: 19093783 DOI: 10.1089/lrb.2008.1008] [Cited by in Crossref: 164] [Cited by in F6Publishing: 137] [Article Influence: 13.7] [Reference Citation Analysis]
235 Kubo H, Cao R, Brakenhielm E, Mäkinen T, Cao Y, Alitalo K. Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea. Proc Natl Acad Sci USA. 2002;99:8868-8873. [PMID: 12070340 DOI: 10.1073/pnas.062040199] [Cited by in Crossref: 216] [Cited by in F6Publishing: 180] [Article Influence: 11.4] [Reference Citation Analysis]
236 Sato TN, Loughna S. Vasculogenesis and Angiogenesis. Mouse Development. Elsevier; 2002. pp. 211-33. [DOI: 10.1016/b978-012597951-1/50014-7] [Cited by in Crossref: 9] [Article Influence: 0.5] [Reference Citation Analysis]
237 Belkin DA, Mitsui H, Felsen D, Carucci JA. VEGF-C-producing macrophages in cutaneous squamous cell carcinoma. Expert Review of Dermatology 2014;6:643-51. [DOI: 10.1586/edm.11.66] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
238 Hosking B, Makinen T. Lymphatic vasculature: a molecular perspective. Bioessays 2007;29:1192-202. [PMID: 18008374 DOI: 10.1002/bies.20672] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
239 Swartz MA, Boardman KC Jr. The role of interstitial stress in lymphatic function and lymphangiogenesis. Ann N Y Acad Sci 2002;979:197-210; discussion 229-34. [PMID: 12543729 DOI: 10.1111/j.1749-6632.2002.tb04880.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
240 Farnebo F, Piehl F, Lagercrantz J. Restricted Expression Pattern ofvegf-din the Adult and Fetal Mouse: High Expression in the Embryonic Lung. Biochemical and Biophysical Research Communications 1999;257:891-4. [DOI: 10.1006/bbrc.1999.0562] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 1.4] [Reference Citation Analysis]
241 Olszewski WL. The Lymphatic System in Body Homeostasis: Physiological Conditions. Lymphatic Research and Biology 2003;1:11-24. [DOI: 10.1089/15396850360495655] [Cited by in Crossref: 81] [Cited by in F6Publishing: 57] [Article Influence: 4.5] [Reference Citation Analysis]
242 Lala PK, Nandi P, Majumder M. Roles of prostaglandins in tumor-associated lymphangiogenesis with special reference to breast cancer. Cancer Metastasis Rev 2018;37:369-84. [PMID: 29858743 DOI: 10.1007/s10555-018-9734-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 10.5] [Reference Citation Analysis]
243 Oliver G. Lymphatic vasculature development. Nat Rev Immunol 2004;4:35-45. [DOI: 10.1038/nri1258] [Cited by in Crossref: 295] [Cited by in F6Publishing: 255] [Article Influence: 17.4] [Reference Citation Analysis]
244 Robinson C, Stringer S. The splice variants of vascular endothelial growth factor (VEGF) and their receptors. Journal of Cell Science 2001;114:853-65. [DOI: 10.1242/jcs.114.5.853] [Cited by in Crossref: 263] [Cited by in F6Publishing: 179] [Article Influence: 13.2] [Reference Citation Analysis]
245 Chen YH, Pan SL, Wang JC, Kuo SH, Cheng JC, Teng CM. Radiation-induced VEGF-C expression and endothelial cell proliferation in lung cancer. Strahlenther Onkol 2014;190:1154-62. [PMID: 24989178 DOI: 10.1007/s00066-014-0708-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
246 Breslin JW, Gaudreault N, Watson KD, Reynoso R, Yuan SY, Wu MH. Vascular endothelial growth factor-C stimulates the lymphatic pump by a VEGF receptor-3-dependent mechanism. American Journal of Physiology-Heart and Circulatory Physiology 2007;293:H709-18. [DOI: 10.1152/ajpheart.00102.2007] [Cited by in Crossref: 66] [Cited by in F6Publishing: 61] [Article Influence: 4.7] [Reference Citation Analysis]
247 Schwager S, Detmar M. Inflammation and Lymphatic Function. Front Immunol 2019;10:308. [PMID: 30863410 DOI: 10.3389/fimmu.2019.00308] [Cited by in Crossref: 63] [Cited by in F6Publishing: 52] [Article Influence: 31.5] [Reference Citation Analysis]
248 Chakraborty S, Gurusamy M, Zawieja DC, Muthuchamy M. Lymphatic filariasis: perspectives on lymphatic remodeling and contractile dysfunction in filarial disease pathogenesis. Microcirculation 2013;20:349-64. [PMID: 23237232 DOI: 10.1111/micc.12031] [Cited by in Crossref: 35] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
249 Berisha B, Schilffarth S, Kenngott R, Sinowatz F, Meyer HH, Schams D. Expression of lymphangiogenic vascular endothelial growth factor family members in bovine corpus luteum. Anat Histol Embryol 2013;42:292-303. [PMID: 23126445 DOI: 10.1111/ahe.12016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
250 Yang W, Klos K, Yang Y, Smith TL, Shi D, Yu D. ErbB2 overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human breast carcinoma. Cancer 2002;94:2855-61. [PMID: 12115372 DOI: 10.1002/cncr.10553] [Cited by in Crossref: 84] [Cited by in F6Publishing: 67] [Article Influence: 4.4] [Reference Citation Analysis]
251 Milasan A, Dallaire F, Mayer G, Martel C. Effects of LDL Receptor Modulation on Lymphatic Function. Sci Rep 2016;6:27862. [PMID: 27279328 DOI: 10.1038/srep27862] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
252 Tu DG, Chang WW, Jan MS, Tu CW, Lu YC, Tai CK. Promotion of metastasis of thyroid cancer cells via NRP-2-mediated induction. Oncol Lett 2016;12:4224-30. [PMID: 27895796 DOI: 10.3892/ol.2016.5153] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
253 Sawada N, Ishiwata T, Naito Z, Maeda S, Sugisaki Y, Asano G. Immunohistochemical localization of endothelial cell markers in solitary fibrous tumor. Pathol Int 2002;52:769-76. [PMID: 12588446 DOI: 10.1046/j.1440-1827.2002.t01-1-01423.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
254 Shah PB, Losordo DW. Non‐Viral Vectors for Gene Therapy: Clinical Trials in Cardiovascular Disease. Non-Viral Vectors for Gene Therapy, Second Edition: Part 2. Elsevier; 2005. pp. 339-61. [DOI: 10.1016/s0065-2660(05)54014-8] [Cited by in Crossref: 42] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
255 Bui HM, Enis D, Robciuc MR, Nurmi HJ, Cohen J, Chen M, Yang Y, Dhillon V, Johnson K, Zhang H, Kirkpatrick R, Traxler E, Anisimov A, Alitalo K, Kahn ML. Proteolytic activation defines distinct lymphangiogenic mechanisms for VEGFC and VEGFD. J Clin Invest 2016;126:2167-80. [PMID: 27159393 DOI: 10.1172/JCI83967] [Cited by in Crossref: 59] [Cited by in F6Publishing: 38] [Article Influence: 11.8] [Reference Citation Analysis]
256 Janér J, Lassus P, Haglund C, Paavonen K, Alitalo K, Andersson S. Pulmonary Vascular Endothelial Growth Factor-C in Development and Lung Injury in Preterm Infants. Am J Respir Crit Care Med 2006;174:326-30. [DOI: 10.1164/rccm.200508-1291oc] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
257 Benest AV, Harper SJ, Herttuala SY, Alitalo K, Bates DO. VEGF-C induced angiogenesis preferentially occurs at a distance from lymphangiogenesis. Cardiovasc Res. 2008;78:315-323. [PMID: 18065770 DOI: 10.1093/cvr/cvm094] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 3.5] [Reference Citation Analysis]
258 Rutkowski JM, Davis KE, Scherer PE. Mechanisms of obesity and related pathologies: the macro- and microcirculation of adipose tissue. FEBS J. 2009;276:5738-5746. [PMID: 19754873 DOI: 10.1111/j.1742-4658.2009.07303.x] [Cited by in Crossref: 146] [Cited by in F6Publishing: 123] [Article Influence: 12.2] [Reference Citation Analysis]
259 Nathanson SD. Insights into the mechanisms of lymph node metastasis. Cancer. 2003;98:413-423. [PMID: 12872364 DOI: 10.1002/cncr.11464] [Cited by in Crossref: 272] [Cited by in F6Publishing: 231] [Article Influence: 16.0] [Reference Citation Analysis]
260 D’Alessio S, Correale C, Tacconi C, Gandelli A, Pietrogrande G, Vetrano S, Genua M, Arena V, Spinelli A, Peyrin-Biroulet L. VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease. J Clin Invest. 2014;124:3863-3878. [PMID: 25105363 DOI: 10.1172/jci72189] [Cited by in Crossref: 136] [Cited by in F6Publishing: 79] [Article Influence: 19.4] [Reference Citation Analysis]
261 Humbert M, Hugues S, Dubrot J. Shaping of Peripheral T Cell Responses by Lymphatic Endothelial Cells. Front Immunol 2016;7:684. [PMID: 28127298 DOI: 10.3389/fimmu.2016.00684] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
262 Yoshimatsu Y, Miyazaki H, Watabe T. Roles of signaling and transcriptional networks in pathological lymphangiogenesis. Adv Drug Deliv Rev 2016;99:161-71. [PMID: 26850127 DOI: 10.1016/j.addr.2016.01.020] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
263 Gong T, Xue Z, Tang S, Zheng X, Xu G, Gao L, Zhao G, Hong L, Tang G, Zhang H, Wang R, Jiang Y, Fan D. Nuclear expression of Twist promotes lymphatic metastasis in esophageal squamous cell carcinoma. Cancer Biol Ther 2012;13:606-13. [PMID: 22441818 DOI: 10.4161/cbt.19851] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
264 Stacker SA, Achen MG. From Anti-Angiogenesis to Anti-Lymphangiogenesis: Emerging Trends in Cancer Therapy. Lymphatic Research and Biology 2008;6:165-72. [DOI: 10.1089/lrb.2008.1015] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
265 Fukumoto S, Morifuji M, Katakura Y, Ohishi M, Nakamura S. Endostatin inhibits lymph node metastasis by a down-regulation of the vascular endothelial growth factor C expression in tumor cells. Clin Exp Metastasis 2005;22:31-8. [DOI: 10.1007/s10585-005-3973-5] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.4] [Reference Citation Analysis]
266 Red-Horse K, Rivera J, Schanz A, Zhou Y, Winn V, Kapidzic M, Maltepe E, Okazaki K, Kochman R, Vo KC, Giudice L, Erlebacher A, McCune JM, Stoddart CA, Fisher SJ. Cytotrophoblast induction of arterial apoptosis and lymphangiogenesis in an in vivo model of human placentation. J Clin Invest 2006;116:2643-52. [PMID: 16998586 DOI: 10.1172/JCI27306] [Cited by in Crossref: 9] [Cited by in F6Publishing: 50] [Article Influence: 0.6] [Reference Citation Analysis]
267 Yamashita M, Mouri T, Niisato M, Kowada K, Kobayashi H, Chiba R, Satoh T, Sugai T, Sawai T, Takahashi T, Yamauchi K. Heterogeneous Characteristics of Lymphatic Microvasculatures Associated with Pulmonary Sarcoid Granulomas. Annals ATS 2013;10:90-7. [DOI: 10.1513/annalsats.201209-078oc] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
268 Urner S, Planas-Paz L, Hilger LS, Henning C, Branopolski A, Kelly-Goss M, Stanczuk L, Pitter B, Montanez E, Peirce SM, Mäkinen T, Lammert E. Identification of ILK as a critical regulator of VEGFR3 signalling and lymphatic vascular growth. EMBO J 2019;38:e99322. [PMID: 30518533 DOI: 10.15252/embj.201899322] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
269 Yamashita M, Mouri T, Niisato M, Nitanai H, Kobayashi H, Ogasawara M, Endo R, Konishi K, Sugai T, Sawai T, Yamauchi K. Lymphangiogenic factors are associated with the severity of hypersensitivity pneumonitis. BMJ Open Respir Res 2015;2:e000085. [PMID: 26448865 DOI: 10.1136/bmjresp-2015-000085] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
270 Chen CC, Mo FE, Lau LF. The angiogenic factor Cyr61 activates a genetic program for wound healing in human skin fibroblasts. J Biol Chem. 2001;276:47329-47337. [PMID: 11584015 DOI: 10.1074/jbc.m107666200] [Cited by in Crossref: 196] [Cited by in F6Publishing: 82] [Article Influence: 9.8] [Reference Citation Analysis]
271 Carmeliet P, Collen D. Molecular basis of angiogenesis. Role of VEGF and VE-cadherin. Ann N Y Acad Sci 2000;902:249-62; discussion 262-4. [PMID: 10865845 DOI: 10.1111/j.1749-6632.2000.tb06320.x] [Cited by in Crossref: 175] [Cited by in F6Publishing: 158] [Article Influence: 8.3] [Reference Citation Analysis]
272 Ferrara N, Gerber HP. Vascular Endothelial Growth Factor Molecular and Biological Aspects. Coronary Angiogenesis. Elsevier; 1999. pp. 25-57. [DOI: 10.1016/s1569-2590(08)60162-7] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
273 Rivard A, Isner JM. Angiogenesis and Vasculogenesis in Treatment of Cardiovascular Disease. Mol Med 1998;4:429-40. [DOI: 10.1007/bf03401749] [Cited by in Crossref: 47] [Article Influence: 2.0] [Reference Citation Analysis]
274 Zachary I. Vascular endothelial growth factor. The International Journal of Biochemistry & Cell Biology 1998;30:1169-74. [DOI: 10.1016/s1357-2725(98)00082-x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
275 Harvey NL, Oliver G. Choose your fate: artery, vein or lymphatic vessel? Curr Opin Genet Dev 2004;14:499-505. [PMID: 15380240 DOI: 10.1016/j.gde.2004.07.005] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
276 Ongstad EL, Bouta EM, Roberts JE, Uzarski JS, Gibbs SE, Sabel MS, Cimmino VM, Roberts MA, Goldman J. Lymphangiogenesis-independent resolution of experimental edema. Am J Physiol Heart Circ Physiol 2010;299:H46-54. [PMID: 20207821 DOI: 10.1152/ajpheart.00008.2010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
277 Baldwin ME, Catimel B, Nice EC, Roufail S, Hall NE, Stenvers KL, Karkkainen MJ, Alitalo K, Stacker SA, Achen MG. The specificity of receptor binding by vascular endothelial growth factor-d is different in mouse and man. J Biol Chem 2001;276:19166-71. [PMID: 11279005 DOI: 10.1074/jbc.M100097200] [Cited by in Crossref: 124] [Cited by in F6Publishing: 44] [Article Influence: 6.2] [Reference Citation Analysis]
278 Kutryk MJ, Stewart DJ. Angiogenesis of the heart. Microsc Res Tech 2003;60:138-58. [DOI: 10.1002/jemt.10252] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 1.8] [Reference Citation Analysis]
279 Leppänen P, Kholová I, Mähönen AJ, Airenne K, Koota S, Mansukoski H, Närväinen J, Wirzenius M, Alhonen L, Jänne J, Alitalo K, Ylä-Herttuala S. Short and long-term effects of hVEGF-A(165) in Cre-activated transgenic mice. PLoS One 2006;1:e13. [PMID: 17183639 DOI: 10.1371/journal.pone.0000013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
280 Kurahara H, Takao S, Maemura K, Mataki Y, Kuwahata T, Maeda K, Sakoda M, Iino S, Ishigami S, Ueno S, Shinchi H, Natsugoe S. M2-polarized tumor-associated macrophage infiltration of regional lymph nodes is associated with nodal lymphangiogenesis and occult nodal involvement in pN0 pancreatic cancer. Pancreas. 2013;42:155-159. [PMID: 22699204 DOI: 10.1097/mpa.0b013e318254f2d1] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 6.3] [Reference Citation Analysis]
281 Becker J, Covelo-Fernandez A, von Bonin F, Kube D, Wilting J. Specific tumor-stroma interactions of EBV-positive Burkitt's lymphoma cells in the chick chorioallantoic membrane. Vasc Cell 2012;4:3. [PMID: 22404859 DOI: 10.1186/2045-824X-4-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
282 Jones N, Iljin K, Dumont DJ, Alitalo K. Tie receptors: new modulators of angiogenic and lymphangiogenic responses. Nat Rev Mol Cell Biol 2001;2:257-67. [DOI: 10.1038/35067005] [Cited by in Crossref: 280] [Cited by in F6Publishing: 250] [Article Influence: 14.0] [Reference Citation Analysis]
283 Xiang Z, Zeng Z, Tang Z, Fan J, Sun H, Wu W, Tan Y. Increased expression of vascular endothelial growth factor-C and nuclear CXCR4 in hepatocellular carcinoma is correlated with lymph node metastasis and poor outcome. Cancer J 2009;15:519-25. [PMID: 20010172 DOI: 10.1097/PPO.0b013e3181c6aa6b] [Cited by in Crossref: 36] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
284 He Y, Kozaki K, Karpanen T, Koshikawa K, Yla-herttuala S, Takahashi T, Alitalo K. Suppression of Tumor Lymphangiogenesis and Lymph Node Metastasis by Blocking Vascular Endothelial Growth Factor Receptor 3 Signaling. JNCI Journal of the National Cancer Institute 2002;94:819-25. [DOI: 10.1093/jnci/94.11.819] [Cited by in Crossref: 364] [Cited by in F6Publishing: 306] [Article Influence: 19.2] [Reference Citation Analysis]
285 Bauer SM, Bauer RJ, Liu Z, Chen H, Goldstein L, Velazquez OC. Vascular endothelial growth factor-C promotes vasculogenesis, angiogenesis, and collagen constriction in three-dimensional collagen gels. Journal of Vascular Surgery 2005;41:699-707. [DOI: 10.1016/j.jvs.2005.01.015] [Cited by in Crossref: 72] [Cited by in F6Publishing: 61] [Article Influence: 4.5] [Reference Citation Analysis]
286 Bunone G, Vigneri P, Mariani L, Butó S, Collini P, Pilotti S, Pierotti MA, Bongarzone I. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features. Am J Pathol 1999;155:1967-76. [PMID: 10595926 DOI: 10.1016/S0002-9440(10)65515-0] [Cited by in Crossref: 264] [Cited by in F6Publishing: 100] [Article Influence: 12.0] [Reference Citation Analysis]
287 Gerwins P, Sköldenberg E, Claesson-Welsh L. Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis. Crit Rev Oncol Hematol. 2000;34:185-194. [PMID: 10838264 DOI: 10.1016/s1040-8428(00)00062-7] [Cited by in Crossref: 196] [Cited by in F6Publishing: 54] [Article Influence: 9.3] [Reference Citation Analysis]
288 Bhattacharjee S, Lee Y, Zhu B, Wu H, Chen Y, Chen H. Epsins in vascular development, function and disease. Cell Mol Life Sci 2021;78:833-42. [PMID: 32930806 DOI: 10.1007/s00018-020-03642-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
289 Homer J, Greenman J, Stafford N. The expression of vascular endothelial growth factor (VEGF) and VEGF-C in early laryngeal cancer: relationship with radioresistance. Clin Otolaryngol 2001;26:498-504. [DOI: 10.1046/j.1365-2273.2001.00512.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
290 Blei F. Congenital Lymphatic Malformations. Annals of the New York Academy of Sciences 2008;1131:185-94. [DOI: 10.1196/annals.1413.016] [Cited by in Crossref: 30] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
291 Hong YK, Shin JW, Detmar M. Development of the lymphatic vascular system: a mystery unravels. Dev Dyn. 2004;231:462-473. [PMID: 15376314 DOI: 10.1002/dvdy.20179] [Cited by in Crossref: 69] [Cited by in F6Publishing: 57] [Article Influence: 4.3] [Reference Citation Analysis]
292 Taniguchi K, Iida T, Hori T, Yagi S, Imai H, Shiraishi T, Uemoto S. Impact of lymph node micrometastasis in hilar bile duct carcinoma patients. World J Gastroenterol. 2006;12:2549-2555. [PMID: 16688800 DOI: 10.3748/wjg.v12.i16.2549] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
293 Kobayashi H, Kawamoto S, Choyke PL, Sato N, Knopp MV, Star RA, Waldmann TA, Tagaya Y, Brechbiel MW. Comparison of dendrimer-based macromolecular contrast agents for dynamic micro-magnetic resonance lymphangiography. Magn Reson Med 2003;50:758-66. [PMID: 14523962 DOI: 10.1002/mrm.10583] [Cited by in Crossref: 88] [Cited by in F6Publishing: 69] [Article Influence: 5.2] [Reference Citation Analysis]
294 Jian M, Qingfu Z, Yanduo J, Guocheng J, Xueshan Q. Anti-lymphangiogenesis effects of a specific anti-interleukin 7 receptor antibody in lung cancer model in vivo. Mol Carcinog. 2015;54:148-155. [PMID: 24115038 DOI: 10.1002/mc.22082] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
295 Foskett AM, Ezekiel UR, Trzeciakowski JP, Zawieja DC, Muthuchamy M. Hypoxia and extracellular matrix proteins influence angiogenesis and lymphangiogenesis in mouse embryoid bodies. Front Physiol 2011;2:103. [PMID: 22194726 DOI: 10.3389/fphys.2011.00103] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
296 Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol. 2005;23:1011-1027. [PMID: 15585754 DOI: 10.1200/jco.2005.06.081] [Cited by in Crossref: 1878] [Cited by in F6Publishing: 748] [Article Influence: 110.5] [Reference Citation Analysis]
297 Veikkola T, Alitalo K. VEGFs, receptors and angiogenesis. Semin Cancer Biol. 1999;9:211-220. [PMID: 10343072 DOI: 10.1006/scbi.1998.0091] [Cited by in Crossref: 337] [Cited by in F6Publishing: 309] [Article Influence: 15.3] [Reference Citation Analysis]
298 Alderfer L, Wei A, Hanjaya-Putra D. Lymphatic Tissue Engineering and Regeneration. J Biol Eng 2018;12:32. [PMID: 30564284 DOI: 10.1186/s13036-018-0122-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
299 Moehler M, Frings C, Mueller A, Gockel I, Schimanski CC, Biesterfeld S, Galle PR, Holtmann MH. VEGF-D expression correlates with colorectal cancer aggressiveness and is downregulated by cetuximab. World J Gastroenterol. 2008;14:4156-4167. [PMID: 18636661 DOI: 10.3748/wjg.14.4156] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
300 Au AC, Hernandez PA, Lieber E, Nadroo AM, Shen YM, Kelley KA, Gelb BD, Diaz GA. Protein tyrosine phosphatase PTPN14 is a regulator of lymphatic function and choanal development in humans. Am J Hum Genet 2010;87:436-44. [PMID: 20826270 DOI: 10.1016/j.ajhg.2010.08.008] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 5.2] [Reference Citation Analysis]
301 Karpanen T, Alitalo K. Lymphatic vessels as targets of tumor therapy? J Exp Med 2001;194:F37-42. [PMID: 11561002 DOI: 10.1084/jem.194.6.f37] [Cited by in Crossref: 88] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
302 Jain RK, Martin JD, Stylianopoulos T. The role of mechanical forces in tumor growth and therapy. Annu Rev Biomed Eng 2014;16:321-46. [PMID: 25014786 DOI: 10.1146/annurev-bioeng-071813-105259] [Cited by in Crossref: 461] [Cited by in F6Publishing: 356] [Article Influence: 76.8] [Reference Citation Analysis]
303 Kajiya K, Detmar M. An Important Role of Lymphatic Vessels in the Control of UVB-Induced Edema Formation and Inflammation. Journal of Investigative Dermatology 2006;126:920-2. [DOI: 10.1038/sj.jid.5700126] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 3.4] [Reference Citation Analysis]
304 Paydas S, Ergin M, Seydaoglu G, Erdogan S, Yavuz S. Pronostic significance of angiogenic/lymphangiogenic, anti-apoptotic, inflammatory and viral factors in 88 cases with diffuse large B cell lymphoma and review of the literature. Leukemia Research 2009;33:1627-35. [DOI: 10.1016/j.leukres.2009.02.015] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
305 Jerafi-Vider A, Bassi I, Moshe N, Tevet Y, Hen G, Splittstoesser D, Shin M, Lawson ND, Yaniv K. VEGFC/FLT4-induced cell-cycle arrest mediates sprouting and differentiation of venous and lymphatic endothelial cells. Cell Rep 2021;35:109255. [PMID: 34133928 DOI: 10.1016/j.celrep.2021.109255] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
306 Sleeman JP, Thiele W. Tumor metastasis and the lymphatic vasculature. Int J Cancer 2009;125:2747-56. [DOI: 10.1002/ijc.24702] [Cited by in Crossref: 156] [Cited by in F6Publishing: 137] [Article Influence: 13.0] [Reference Citation Analysis]
307 Kim JD, Jin SW. A tale of two models: mouse and zebrafish as complementary models for lymphatic studies. Mol Cells 2014;37:503-10. [PMID: 24854860 DOI: 10.14348/molcells.2014.0108] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
308 Riccardi C, Napolitano E, Platella C, Musumeci D, Melone MAB, Montesarchio D. Anti-VEGF DNA-based aptamers in cancer therapeutics and diagnostics. Med Res Rev 2021;41:464-506. [PMID: 33038031 DOI: 10.1002/med.21737] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
309 Koop EA, Voest EE. TUMOR VASCULATURE AS A TARGET. Anticancer Drug Development. Elsevier; 2002. pp. 123-cp2. [DOI: 10.1016/b978-012072651-6/50008-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
310 Kubo H, Fujiwara T, Jussila L, Hashi H, Ogawa M, Shimizu K, Awane M, Sakai Y, Takabayashi A, Alitalo K, Yamaoka Y, Nishikawa S. Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis. Blood 2000;96:546-53. [DOI: 10.1182/blood.v96.2.546] [Cited by in Crossref: 153] [Article Influence: 7.3] [Reference Citation Analysis]
311 McColl BK, Baldwin ME, Roufail S, Freeman C, Moritz RL, Simpson RJ, Alitalo K, Stacker SA, Achen MG. Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D. J Exp Med. 2003;198:863-868. [PMID: 12963694 DOI: 10.1084/jem.20030361] [Cited by in Crossref: 140] [Cited by in F6Publishing: 127] [Article Influence: 7.8] [Reference Citation Analysis]
312 Mccoll BK, Stacker SA, Achen MG. Molecular regulation of the VEGF family – inducers of angiogenesis and lymphangiogenesis: MOLECULAR REGULATION OF THE VEGFS. APMIS 2004;112:463-80. [DOI: 10.1111/j.1600-0463.2004.apm11207-0807.x] [Cited by in Crossref: 91] [Cited by in F6Publishing: 85] [Article Influence: 5.4] [Reference Citation Analysis]
313 Luo J, Guo P, Matsuda K, Truong N, Lee A, Chun C, Cheng SY, Korc M. Pancreatic cancer cell-derived vascular endothelial growth factor is biologically active in vitro and enhances tumorigenicity in vivo. Int J Cancer. 2001;92:361-369. [PMID: 11291072 DOI: 10.1002/ijc.1202] [Cited by in Crossref: 65] [Cited by in F6Publishing: 54] [Article Influence: 3.3] [Reference Citation Analysis]
314 Goldman J, Le TX, Skobe M, Swartz MA. Overexpression of VEGF-C Causes Transient Lymphatic Hyperplasia but Not Increased Lymphangiogenesis in Regenerating Skin. Circulation Research 2005;96:1193-9. [DOI: 10.1161/01.res.0000168918.27576.78] [Cited by in Crossref: 84] [Cited by in F6Publishing: 37] [Article Influence: 5.3] [Reference Citation Analysis]
315 Pollina EA, Legesse-Miller A, Haley EM, Goodpaster T, Randolph-Habecker J, Coller HA. Regulating the angiogenic balance in tissues. Cell Cycle 2008;7:2056-70. [PMID: 18642446 DOI: 10.4161/cc.7.13.6240] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 3.4] [Reference Citation Analysis]
316 Korpelainen EI, Karkkainen MJ, Tenhunen A, Lakso M, Rauvala H, Vierula M, Parvinen M, Alitalo K. Overexpression of VEGF in testis and epididymis causes infertility in transgenic mice: evidence for nonendothelial targets for VEGF. J Cell Biol 1998;143:1705-12. [PMID: 9852161 DOI: 10.1083/jcb.143.6.1705] [Cited by in Crossref: 72] [Cited by in F6Publishing: 61] [Article Influence: 3.3] [Reference Citation Analysis]
317 Dixon DN, Izon DJ, Dagger S, Callow MJ, Taplin RH, Kees UR, Greene WK. TLX1/HOX11 transcription factor inhibits differentiation and promotes a non-haemopoietic phenotype in murine bone marrow cells. Br J Haematol 2007;138:54-67. [PMID: 17555447 DOI: 10.1111/j.1365-2141.2007.06626.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
318 Ochi N, Matsuo Y, Sawai H, Yasuda A, Takahashi H, Sato M, Funahashi H, Okada Y, Manabe T. Vascular Endothelial Growth Factor-C Secreted by Pancreatic Cancer Cell Line Promotes Lymphatic Endothelial Cell Migration in an In Vitro Model of Tumor Lymphangiogenesis. Pancreas 2007;34:444-51. [DOI: 10.1097/mpa.0b13e31803dd307] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
319 Schito L. Hypoxia-Dependent Angiogenesis and Lymphangiogenesis in Cancer. Adv Exp Med Biol 2019;1136:71-85. [PMID: 31201717 DOI: 10.1007/978-3-030-12734-3_5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
320 Hamrah P, Zhang Q, Dana MR. Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) in the conjunctiva--a potential link between lymphangiogenesis and leukocyte trafficking on the ocular surface. Adv Exp Med Biol 2002;506:851-60. [PMID: 12614002 DOI: 10.1007/978-1-4615-0717-8_120] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
321 Scavelli C, Weber E, Aglianò M, Cirulli T, Nico B, Vacca A, Ribatti D. Lymphatics at the crossroads of angiogenesis and lymphangiogenesis. J Anat 2004;204:433-49. [PMID: 15198686 DOI: 10.1111/j.0021-8782.2004.00293.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 62] [Article Influence: 3.8] [Reference Citation Analysis]
322 Freedman SB, Isner JM. Therapeutic Angiogenesis for Ischemic Cardiovascular Disease. Journal of Molecular and Cellular Cardiology 2001;33:379-93. [DOI: 10.1006/jmcc.2000.1329] [Cited by in Crossref: 122] [Cited by in F6Publishing: 106] [Article Influence: 6.1] [Reference Citation Analysis]
323 Sivakumar R, Sharma-Walia N, Raghu H, Veettil MV, Sadagopan S, Bottero V, Varga L, Levine R, Chandran B. Kaposi's sarcoma-associated herpesvirus induces sustained levels of vascular endothelial growth factors A and C early during in vitro infection of human microvascular dermal endothelial cells: biological implications. J Virol 2008;82:1759-76. [PMID: 18057235 DOI: 10.1128/JVI.00873-07] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 3.6] [Reference Citation Analysis]
324 Zhan P, Ji YN, Yu LK. VEGF is associated with the poor survival of patients with prostate cancer: a meta-analysis. Transl Androl Urol 2013;2:99-105. [PMID: 26816732 DOI: 10.3978/j.issn.2223-4683.2013.06.03] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
325 Nipper ME, Dixon JB. Engineering the Lymphatic System. Cardiovasc Eng Technol 2011;2:296-308. [PMID: 23408477 DOI: 10.1007/s13239-011-0054-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
326 Nibbs RJ, Kriehuber E, Ponath PD, Parent D, Qin S, Campbell JD, Henderson A, Kerjaschki D, Maurer D, Graham GJ, Rot A. The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. Am J Pathol 2001;158:867-77. [PMID: 11238036 DOI: 10.1016/s0002-9440(10)64035-7] [Cited by in Crossref: 202] [Cited by in F6Publishing: 78] [Article Influence: 10.1] [Reference Citation Analysis]
327 Guo B, Zhang Y, Luo G, Li L, Zhang J. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma. Anat Rec (Hoboken) 2009;292:633-9. [PMID: 19382240 DOI: 10.1002/ar.20893] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
328 van IJzendoorn M, van den Born J, Hijmans R, Bodde R, Buter H, Dam W, Kingma P, Maes G, van der Veen T, Zijlstra W, Dijkstra B, Navis G, Boerma C. An observational study on intracutaneous sodium storage in intensive care patients and controls. PLoS One 2019;14:e0223100. [PMID: 31581250 DOI: 10.1371/journal.pone.0223100] [Reference Citation Analysis]
329 Karkkainen MJ, Saaristo A, Jussila L, Karila KA, Lawrence EC, Pajusola K, Bueler H, Eichmann A, Kauppinen R, Kettunen MI. A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci U S A. 2001;98:12677-12682. [PMID: 11592985 DOI: 10.1073/pnas.221449198] [Cited by in Crossref: 415] [Cited by in F6Publishing: 364] [Article Influence: 20.8] [Reference Citation Analysis]
330 Koltowska K, Betterman KL, Harvey NL, Hogan BM. Getting out and about: the emergence and morphogenesis of the vertebrate lymphatic vasculature. Development 2013;140:1857-70. [DOI: 10.1242/dev.089565] [Cited by in Crossref: 99] [Cited by in F6Publishing: 82] [Article Influence: 12.4] [Reference Citation Analysis]
331 Jain R. Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function. Journal of Controlled Release 2001;74:7-25. [DOI: 10.1016/s0168-3659(01)00306-6] [Cited by in Crossref: 198] [Cited by in F6Publishing: 54] [Article Influence: 9.9] [Reference Citation Analysis]
332 Enholm B, Karpanen T, Jeltsch M, Kubo H, Stenback F, Prevo R, Jackson DG, Yla-Herttuala S, Alitalo K. Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin. Circ Res. 2001;88:623-629. [PMID: 11282897 DOI: 10.1161/01.res.88.6.623] [Cited by in Crossref: 164] [Cited by in F6Publishing: 52] [Article Influence: 8.2] [Reference Citation Analysis]
333 Wigle JT, Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell 1999;98:769-78. [PMID: 10499794 DOI: 10.1016/s0092-8674(00)81511-1] [Cited by in Crossref: 1045] [Cited by in F6Publishing: 451] [Article Influence: 47.5] [Reference Citation Analysis]
334 Veikkola T, Jussila L, Makinen T, Karpanen T, Jeltsch M, Petrova TV, Kubo H, Thurston G, McDonald DM, Achen MG. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J. 2001;20:1223-1231. [PMID: 11250889 DOI: 10.1093/emboj/20.6.1223] [Cited by in Crossref: 465] [Cited by in F6Publishing: 403] [Article Influence: 23.3] [Reference Citation Analysis]
335 Takahashi H, Shibuya M. The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clin Sci (Lond). 2005;109:227-241. [PMID: 16104843 DOI: 10.1042/cs20040370] [Cited by in Crossref: 543] [Cited by in F6Publishing: 213] [Article Influence: 33.9] [Reference Citation Analysis]
336 Kurahara H, Shinchi H, Mataki Y, Maemura K, Noma H, Kubo F, Sakoda M, Ueno S, Natsugoe S, Takao S. Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. J Surg Res. 2011;167:e211-e219. [PMID: 19765725 DOI: 10.1016/j.jss.2009.05.026] [Cited by in Crossref: 336] [Cited by in F6Publishing: 327] [Article Influence: 28.0] [Reference Citation Analysis]
337 Shibuya M. Vascular Endothelial Growth Factor Receptor Family Genes: When Did the Three Genes Phylogenetically Segregate? Biological Chemistry 2002;383:1573-9. [DOI: 10.1515/bc.2002.177] [Cited by in Crossref: 30] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
338 Gorenflo M, Herpel E, Ullmann MV, Röhlig K, Demirakca S, Klimpel H, Hagl S, Gebhard MM, Schnabel PA. Pulmonary vascular changes in piglets with increased pulmonary blood flow and pressure. Virchows Arch 2007;450:643-52. [PMID: 17450378 DOI: 10.1007/s00428-007-0414-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
339 Kubo H, Fujiwara T, Jussila L, Hashi H, Ogawa M, Shimizu K, Awane M, Sakai Y, Takabayashi A, Alitalo K, Yamaoka Y, Nishikawa S. Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis. Blood 2000;96:546-53. [DOI: 10.1182/blood.v96.2.546.014k12_546_553] [Cited by in Crossref: 10] [Article Influence: 0.5] [Reference Citation Analysis]
340 Achen MG, Jeltsch M, Kukk E, Mäkinen T, Vitali A, Wilks AF, Alitalo K, Stacker SA. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci U S A. 1998;95:548-553. [PMID: 9435229 DOI: 10.1073/pnas.95.2.548] [Cited by in Crossref: 837] [Cited by in F6Publishing: 737] [Article Influence: 36.4] [Reference Citation Analysis]
341 Salven P, Lymboussaki A, Heikkilä P, Jääskela-Saari H, Enholm B, Aase K, von Euler G, Eriksson U, Alitalo K, Joensuu H. Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. Am J Pathol. 1998;153:103-108. [PMID: 9665470 DOI: 10.1016/s0002-9440(10)65550-2] [Cited by in Crossref: 225] [Cited by in F6Publishing: 57] [Article Influence: 9.8] [Reference Citation Analysis]
342 He Y, Karpanen T, Alitalo K. Role of lymphangiogenic factors in tumor metastasis. Biochim Biophys Acta 2004;1654:3-12. [PMID: 14984763 DOI: 10.1016/j.bbcan.2003.07.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 49] [Article Influence: 0.7] [Reference Citation Analysis]
343 Jubb AM, Miller KD, Rugo HS, Harris AL, Chen D, Reimann JD, Cobleigh MA, Schmidt M, Langmuir VK, Hillan KJ, Chen DS, Koeppen H. Impact of exploratory biomarkers on the treatment effect of bevacizumab in metastatic breast cancer. Clin Cancer Res 2011;17:372-81. [PMID: 21224365 DOI: 10.1158/1078-0432.CCR-10-1791] [Cited by in Crossref: 77] [Cited by in F6Publishing: 42] [Article Influence: 7.7] [Reference Citation Analysis]
344 Jussila L, Alitalo K. Vascular growth factors and lymphangiogenesis. Physiol Rev. 2002;82:673-700. [PMID: 12087132 DOI: 10.1152/physrev.00005.2002] [Cited by in Crossref: 269] [Cited by in F6Publishing: 228] [Article Influence: 14.2] [Reference Citation Analysis]
345 Ohta Y, Shridhar V, Bright RK, Kalemkerian GP, Du W, Carbone M, Watanabe Y, Pass HI. VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours. Br J Cancer. 1999;81:54-61. [PMID: 10487612 DOI: 10.1038/sj.bjc.6690650] [Cited by in Crossref: 248] [Cited by in F6Publishing: 233] [Article Influence: 11.3] [Reference Citation Analysis]
346 Lee JY, Hong SH, Shin M, Heo HR, Jang IH. Blockade of FLT4 suppresses metastasis of melanoma cells by impaired lymphatic vessels. Biochem Biophys Res Commun 2016;478:733-8. [PMID: 27507214 DOI: 10.1016/j.bbrc.2016.08.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
347 Yoon SY, Dieterich LC, Karaman S, Proulx ST, Bachmann SB, Sciaroni C, Detmar M. An important role of cutaneous lymphatic vessels in coordinating and promoting anagen hair follicle growth. PLoS One 2019;14:e0220341. [PMID: 31344105 DOI: 10.1371/journal.pone.0220341] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
348 Kurebayashi J, Otsuki T, Kunisue H, Mikami Y, Tanaka K, Yamamoto S, Sonoo H. Expression of vascular endothelial growth factor (VEGF) family members in breast cancer. Jpn J Cancer Res. 1999;90:977-981. [PMID: 10551327 DOI: 10.1111/j.1349-7006.1999.tb00844.x] [Cited by in Crossref: 106] [Cited by in F6Publishing: 92] [Article Influence: 4.8] [Reference Citation Analysis]
349 Ji RC, Eshita Y, Kato S. Investigation of intratumoural and peritumoural lymphatics expressed by podoplanin and LYVE-1 in the hybridoma-induced tumours. Int J Exp Pathol 2007;88:257-70. [PMID: 17696907 DOI: 10.1111/j.1365-2613.2007.00532.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
350 Arinaga M, Noguchi T, Takeno S, Chujo M, Miura T, Uchida Y. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma. Cancer. 2003;97:457-464. [PMID: 12518370 DOI: 10.1002/cncr.11073] [Cited by in Crossref: 115] [Cited by in F6Publishing: 100] [Article Influence: 6.4] [Reference Citation Analysis]
351 Tsurusaki T, Kanda S, Sakai H, Kanetake H, Saito Y, Alitalo K, Koji T. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis. Br J Cancer. 1999;80:309-313. [PMID: 10390013 DOI: 10.1038/sj.bjc.6690356] [Cited by in Crossref: 195] [Cited by in F6Publishing: 202] [Article Influence: 8.9] [Reference Citation Analysis]
352 Takahashi M, Yoshimoto T, Kubo H. Molecular mechanisms of lymphangiogenesis. Int J Hematol 2004;80:29-34. [PMID: 15293565 DOI: 10.1532/ijh97.04042] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
353 Deng J, Liang H, Sun D, Pan Y, Wang B, Guo Y. Vascular endothelial growth factor-D is correlated with hepatic metastasis from gastric cancer after radical gastrectomy. Surgery. 2009;146:896-905. [PMID: 19744460 DOI: 10.1016/j.surg.2009.04.025] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
354 Lymboussaki A, Partanen TA, Olofsson B, Thomas-Crusells J, Fletcher CD, de Waal RM, Kaipainen A, Alitalo K. Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors. Am J Pathol 1998;153:395-403. [PMID: 9708800 DOI: 10.1016/S0002-9440(10)65583-6] [Cited by in Crossref: 151] [Cited by in F6Publishing: 33] [Article Influence: 6.6] [Reference Citation Analysis]
355 Polomska AK, Proulx ST. Imaging technology of the lymphatic system. Adv Drug Deliv Rev 2021;170:294-311. [PMID: 32891679 DOI: 10.1016/j.addr.2020.08.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
356 Alitalo K, Tammela T, Petrova TV. Lymphangiogenesis in development and human disease. Nature. 2005;438:946-953. [PMID: 16355212 DOI: 10.1038/nature04480] [Cited by in Crossref: 849] [Cited by in F6Publishing: 719] [Article Influence: 56.6] [Reference Citation Analysis]
357 Mäkinen T, Adams RH, Bailey J, Lu Q, Ziemiecki A, Alitalo K, Klein R, Wilkinson GA. PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev 2005;19:397-410. [PMID: 15687262 DOI: 10.1101/gad.330105] [Cited by in Crossref: 320] [Cited by in F6Publishing: 291] [Article Influence: 20.0] [Reference Citation Analysis]
358 Li ZW, Dalton WS. Tumor microenvironment and drug resistance in hematologic malignancies. Blood Rev 2006;20:333-42. [PMID: 16920238 DOI: 10.1016/j.blre.2005.08.003] [Cited by in Crossref: 99] [Cited by in F6Publishing: 84] [Article Influence: 6.6] [Reference Citation Analysis]
359 Kerjaschki D. The crucial role of macrophages in lymphangiogenesis. J Clin Invest. 2005;115:2316-2319. [PMID: 16138185 DOI: 10.1172/jci26354] [Cited by in Crossref: 153] [Cited by in F6Publishing: 90] [Article Influence: 9.6] [Reference Citation Analysis]
360 Jacquemier J, Mathoulin-portier M, Valtola R, Charafe-jauffret E, Geneix J, Houvenaeghel G, Puig B, Bardou V, Hassoun J, Viens P, Birnbaum D. Prognosis of breast-carcinoma lymphagenesis evaluated by immunohistochemical investigation of vascular-endothelial-growth-factor receptor 3. Int J Cancer 2000;89:69-73. [DOI: 10.1002/(sici)1097-0215(20000120)89:1<69::aid-ijc11>3.0.co;2-m] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
361 Kajiya K, Sawane M, Huggenberger R, Detmar M. Activation of the VEGFR-3 Pathway by VEGF-C Attenuates UVB-Induced Edema Formation and Skin Inflammation by Promoting Lymphangiogenesis. Journal of Investigative Dermatology 2009;129:1292-8. [DOI: 10.1038/jid.2008.351] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 6.0] [Reference Citation Analysis]
362 Park BK, Paik YH, Park JY, Park KH, Bang S, Park SW, Chung JB, Park YN, Song SY. The clinicopathologic significance of the expression of vascular endothelial growth factor-C in intrahepatic cholangiocarcinoma. Am J Clin Oncol. 2006;29:138-142. [PMID: 16601431 DOI: 10.1097/01.coc.0000204402.29830.08] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 3.7] [Reference Citation Analysis]
363 Valtola R, Salven P, Heikkila P, Taipale J, Joensuu H, Rehn M, Pihlajaniemi T, Weich H, deWaal R, Alitalo K. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J Pathol. 1999;154:1381-1390. [PMID: 10329591 DOI: 10.1016/s0002-9440(10)65392-8] [Cited by in Crossref: 382] [Cited by in F6Publishing: 122] [Article Influence: 17.4] [Reference Citation Analysis]
364 Bouta EM, McCarthy CW, Keim A, Wang HB, Gilbert RJ, Goldman J. Biomaterial guides for lymphatic endothelial cell alignment and migration. Acta Biomater 2011;7:1104-13. [PMID: 20974299 DOI: 10.1016/j.actbio.2010.10.016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
365 Mounzer RH, Svendsen OS, Baluk P, Bergman CM, Padera TP, Wiig H, Jain RK, McDonald DM, Ruddle NH. Lymphotoxin-alpha contributes to lymphangiogenesis. Blood 2010;116:2173-82. [PMID: 20566898 DOI: 10.1182/blood-2009-12-256065] [Cited by in Crossref: 59] [Cited by in F6Publishing: 60] [Article Influence: 5.4] [Reference Citation Analysis]
366 Bruyère F, Noël A. Lymphangiogenesis: in vitro and in vivo models. FASEB j 2009;24:8-21. [DOI: 10.1096/fj.09-132852] [Cited by in Crossref: 71] [Cited by in F6Publishing: 56] [Article Influence: 5.9] [Reference Citation Analysis]
367 Zachary I. Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor. Am J Physiol Cell Physiol 2001;280:C1375-86. [PMID: 11350732 DOI: 10.1152/ajpcell.2001.280.6.C1375] [Cited by in Crossref: 211] [Cited by in F6Publishing: 56] [Article Influence: 10.6] [Reference Citation Analysis]
368 Goldman J, Conley KA, Raehl A, Bondy DM, Pytowski B, Swartz MA, Rutkowski JM, Jaroch DB, Ongstad EL. Regulation of lymphatic capillary regeneration by interstitial flow in skin. Am J Physiol Heart Circ Physiol 2007;292:H2176-83. [PMID: 17189348 DOI: 10.1152/ajpheart.01011.2006] [Cited by in Crossref: 62] [Cited by in F6Publishing: 53] [Article Influence: 4.1] [Reference Citation Analysis]
369 Detmar M, Brown LF, Schön MP, Elicker BM, Velasco P, Richard L, Fukumura D, Monsky W, Claffey KP, Jain RK. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol 1998;111:1-6. [PMID: 9665379 DOI: 10.1046/j.1523-1747.1998.00262.x] [Cited by in Crossref: 396] [Cited by in F6Publishing: 367] [Article Influence: 17.2] [Reference Citation Analysis]
370 Mäkinen T, Veikkola T, Mustjoki S, Karpanen T, Catimel B, Nice EC, Wise L, Mercer A, Kowalski H, Kerjaschki D, Stacker SA, Achen MG, Alitalo K. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J 2001;20:4762-73. [PMID: 11532940 DOI: 10.1093/emboj/20.17.4762] [Cited by in Crossref: 560] [Cited by in F6Publishing: 501] [Article Influence: 28.0] [Reference Citation Analysis]
371 Tsai PW, Shiah SG, Lin MT, Wu CW, Kuo ML. Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway. J Biol Chem 2003;278:5750-9. [PMID: 12471041 DOI: 10.1074/jbc.M204863200] [Cited by in Crossref: 110] [Cited by in F6Publishing: 37] [Article Influence: 5.8] [Reference Citation Analysis]
372 Ikeda Y, Yonemitsu Y, Onimaru M, Nakano T, Miyazaki M, Kohno R, Nakagawa K, Ueno A, Sueishi K, Ishibashi T. The regulation of vascular endothelial growth factors (VEGF-A, -C, and -D) expression in the retinal pigment epithelium. Experimental Eye Research 2006;83:1031-40. [DOI: 10.1016/j.exer.2006.05.007] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
373 Wang C, Liu Q, Huang M, Zhou Q, Zhang X, Zhang J, Xie R, Yu Y, Chen S, Fan J, Chen X. Loss of GATA6 expression promotes lymphatic metastasis in bladder cancer. FASEB J 2020;34:5754-66. [PMID: 32103545 DOI: 10.1096/fj.201903176R] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
374 Singh N, Tiem M, Watkins R, Cho YK, Wang Y, Olsen T, Uehara H, Mamalis C, Luo L, Oakey Z, Ambati BK. Soluble vascular endothelial growth factor receptor 3 is essential for corneal alymphaticity. Blood 2013;121:4242-9. [PMID: 23476047 DOI: 10.1182/blood-2012-08-453043] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 6.8] [Reference Citation Analysis]
375 Kinnunen K, Ylä-Herttuala S. Vascular endothelial growth factors in retinal and choroidal neovascular diseases. Ann Med 2012;44:1-17. [PMID: 21284527 DOI: 10.3109/07853890.2010.532150] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
376 Jubb AM, Sa SM, Ratti N, Strickland LA, Schmidt M, Callahan CA, Koeppen H. Neuropilin-2 expression in cancer. Histopathology 2012;61:340-9. [PMID: 22384800 DOI: 10.1111/j.1365-2559.2012.04224.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
377 Sundlisaeter E, Dicko A, Sakariassen PØ, Sondenaa K, Enger PØ, Bjerkvig R. Lymphangiogenesis in colorectal cancer--prognostic and therapeutic aspects. Int J Cancer. 2007;121:1401-1409. [PMID: 17640040 DOI: 10.1002/ijc.22996] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
378 Edel M, Robbins P, D'Antuono M, Harvey J, Papadimitrion J, Mitchell C, Dawkins H. Assessment of endothelial cell proliferation in primary breast carcinoma and its association with axillary lymph node status. Breast 2000;9:28-34. [PMID: 14731581 DOI: 10.1054/brst.1999.0082] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
379 Gambino TJ, Williams SP, Caesar C, Resnick D, Nowell CJ, Farnsworth RH, Achen MG, Stacker SA, Karnezis T. A Three-Dimensional Lymphatic Endothelial Cell Tube Formation Assay to Identify Novel Kinases Involved in Lymphatic Vessel Remodeling. ASSAY and Drug Development Technologies 2017;15:30-43. [DOI: 10.1089/adt.2016.764] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
380 Liu Y, Fang Y, Dong P, Gao J, Liu R, Tian H, Ding Z, Bi Y, Liu Z. Effect of vascular endothelial growth factor C (VEGF-C) gene transfer in rat model of secondary lymphedema. Vascular Pharmacology 2008;49:44-50. [DOI: 10.1016/j.vph.2008.05.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
381 Kilarski WW. Physiological Perspective on Therapies of Lymphatic Vessels. Adv Wound Care (New Rochelle) 2018;7:189-208. [PMID: 29984111 DOI: 10.1089/wound.2017.0768] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
382 Dvorak HF, Nagy JA, Feng D, Brown LF, Dvorak AM. Vascular Permeability Factor/Vascular Endothelial Growth Factor and the Significance of Microvascular Hyperpermeability in Angiogenesis. In: Claesson-welsh L, editor. Vascular Growth Factors and Angiogenesis. Berlin: Springer Berlin Heidelberg; 1999. pp. 97-132. [DOI: 10.1007/978-3-642-59953-8_6] [Cited by in Crossref: 134] [Cited by in F6Publishing: 227] [Article Influence: 6.1] [Reference Citation Analysis]
383 Hoon DS, Kitago M, Kim J, Mori T, Piris A, Szyfelbein K, Mihm MC Jr, Nathanson SD, Padera TP, Chambers AF, Vantyghem SA, MacDonald IC, Shivers SC, Alsarraj M, Reintgen DS, Passlick B, Sienel W, Pantel K. Molecular mechanisms of metastasis. Cancer Metastasis Rev 2006;25:203-20. [PMID: 16770533 DOI: 10.1007/s10555-006-8500-x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 42] [Article Influence: 3.5] [Reference Citation Analysis]
384 Puujalka E, Heinz M, Hoesel B, Friedl P, Schweighofer B, Wenzina J, Pirker C, Schmid JA, Loewe R, Wagner EF, Berger W, Petzelbauer P. Opposing Roles of JNK and p38 in Lymphangiogenesis in Melanoma. J Invest Dermatol 2016;136:967-77. [PMID: 26829032 DOI: 10.1016/j.jid.2016.01.020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
385 Detmar M. Tumor angiogenesis. J Investig Dermatol Symp Proc. 2000;5:20-23. [PMID: 11147670 DOI: 10.1046/j.1087-0024.2000.00003.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 2.5] [Reference Citation Analysis]
386 Tanaka M, Iwakiri Y. The Hepatic Lymphatic Vascular System: Structure, Function, Markers, and Lymphangiogenesis. Cell Mol Gastroenterol Hepatol. 2016;2:733-749. [PMID: 28105461 DOI: 10.1016/j.jcmgh.2016.09.002] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 8.6] [Reference Citation Analysis]
387 Zhu Z, Witte L. Inhibition of tumor growth and metastasis by targeting tumor-associated angiogenesis with antagonists to the receptors of vascular endothelial growth factor. Invest New Drugs 1999;17:195-212. [PMID: 10665474 DOI: 10.1023/a:1006314501634] [Cited by in Crossref: 68] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
388 Hirai M, Nakagawara A, Oosaki T, Hayashi Y, Hirono M, Yoshihara T. Expression of Vascular Endothelial Growth Factors (VEGF-A/VEGF-1 and VEGF-C/VEGF-2) in Postmenopausal Uterine Endometrial Carcinoma. Gynecologic Oncology 2001;80:181-8. [DOI: 10.1006/gyno.2000.6056] [Cited by in Crossref: 71] [Cited by in F6Publishing: 90] [Article Influence: 3.6] [Reference Citation Analysis]
389 Lohela M, Bry M, Tammela T, Alitalo K. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Current Opinion in Cell Biology 2009;21:154-65. [DOI: 10.1016/j.ceb.2008.12.012] [Cited by in Crossref: 474] [Cited by in F6Publishing: 420] [Article Influence: 39.5] [Reference Citation Analysis]
390 Simpson DA, Murphy GM, Bhaduri T, Gardiner TA, Archer DB, Stitt AW. Expression of the VEGF Gene Family during Retinal Vaso-Obliteration and Hypoxia. Biochemical and Biophysical Research Communications 1999;262:333-40. [DOI: 10.1006/bbrc.1999.1201] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 1.8] [Reference Citation Analysis]
391 Brown HM, Robker RL, Russell DL. Development and Hormonal Regulation of the Ovarian Lymphatic Vasculature. Endocrinology 2010;151:5446-55. [DOI: 10.1210/en.2010-0629] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
392 Zachary I, Mathur A, Yla-herttuala S, Martin J. Vascular Protection: A Novel Nonangiogenic Cardiovascular Role for Vascular Endothelial Growth Factor. ATVB 2000;20:1512-20. [DOI: 10.1161/01.atv.20.6.1512] [Cited by in Crossref: 85] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
393 Tang X, Sun J, Du L, Du H, Wang L, Mai J, Zhang F, Liu P. Neuropilin-2 contributes to LPS-induced corneal inflammatory lymphangiogenesis. Exp Eye Res 2016;143:110-9. [PMID: 26500194 DOI: 10.1016/j.exer.2015.10.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
394 Huber H, Eggert A, Janss AJ, Wiewrodt R, Zhao H, Sutton LN, Rorke LB, Phillips PC, Grotzer MA. Angiogenic profile of childhood primitive neuroectodermal brain tumours/medulloblastomas. Eur J Cancer 2001;37:2064-72. [PMID: 11597385 DOI: 10.1016/s0959-8049(01)00225-8] [Cited by in Crossref: 50] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
395 Shida A, Fujioka S, Kobayashi K, Ishibashi Y, Nimura H, Mitsumori N, Yanaga K. Expression of vascular endothelial growth factor (VEGF)-C and -D in gastric carcinoma. Int J Clin Oncol. 2006;11:38-43. [PMID: 16508727 DOI: 10.1007/s10147-005-0528-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
396 Albuquerque RJ, Hayashi T, Cho WG, Kleinman ME, Dridi S, Takeda A, Baffi JZ, Yamada K, Kaneko H, Green MG, Chappell J, Wilting J, Weich HA, Yamagami S, Amano S, Mizuki N, Alexander JS, Peterson ML, Brekken RA, Hirashima M, Capoor S, Usui T, Ambati BK, Ambati J. Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth. Nat Med 2009;15:1023-30. [PMID: 19668192 DOI: 10.1038/nm.2018] [Cited by in Crossref: 238] [Cited by in F6Publishing: 223] [Article Influence: 19.8] [Reference Citation Analysis]
397 Kurahara H, Takao S, Shinchi H, Maemura K, Mataki Y, Sakoda M, Hayashi T, Kuwahata T, Minami K, Ueno S, Natsugoe S. Significance of lymphangiogenesis in primary tumor and draining lymph nodes during lymphatic metastasis of pancreatic head cancer: Lymphangiogenesis in Pancreatic Cancer. J Surg Oncol 2010;102:809-15. [DOI: 10.1002/jso.21744] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
398 Jiang X, Nicolls MR, Tian W, Rockson SG. Lymphatic Dysfunction, Leukotrienes, and Lymphedema. Annu Rev Physiol. 2018;80:49-70. [PMID: 29029593 DOI: 10.1146/annurev-physiol-022516-034008] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 11.0] [Reference Citation Analysis]
399 Takeda K, Sowa Y, Nishino K, Itoh K, Fushiki S. Adipose-derived stem cells promote proliferation, migration, and tube formation of lymphatic endothelial cells in vitro by secreting lymphangiogenic factors. Ann Plast Surg. 2015;74:728-736. [PMID: 24401810 DOI: 10.1097/sap.0000000000000084] [Cited by in Crossref: 38] [Cited by in F6Publishing: 14] [Article Influence: 7.6] [Reference Citation Analysis]
400 Kirkin V, Mazitschek R, Krishnan J, Steffen A, Waltenberger J, Pepper MS, Giannis A, Sleeman JP. Characterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2. Eur J Biochem. 2001;268:5530-5540. [PMID: 11683876 DOI: 10.1046/j.1432-1033.2001.02476.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 3.6] [Reference Citation Analysis]
401 Larrieu-Lahargue F, Welm AL, Thomas KR, Li DY. Netrin-4 induces lymphangiogenesis in vivo. Blood. 2010;115:5418-5426. [PMID: 20407033 DOI: 10.1182/blood-2009-11-252338] [Cited by in Crossref: 61] [Cited by in F6Publishing: 50] [Article Influence: 5.5] [Reference Citation Analysis]
402 Van Trappen PO, Pepper MS. Lymphangiogenesis in human gynaecological cancers. Angiogenesis 2005;8:137-45. [PMID: 16211357 DOI: 10.1007/s10456-005-9008-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
403 Marti HH. Vascular endothelial growth factor. Adv Exp Med Biol 2002;513:375-94. [PMID: 12575829 DOI: 10.1007/978-1-4615-0123-7_14] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
404 Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol 2006;7:359-71. [PMID: 16633338 DOI: 10.1038/nrm1911] [Cited by in Crossref: 2043] [Cited by in F6Publishing: 1815] [Article Influence: 136.2] [Reference Citation Analysis]
405 Nash AD, Baca M, Wright C, Scotney PD. The biology of vascular endothelial growth factor-B (VEGF-B). Pulmonary Pharmacology & Therapeutics 2006;19:61-9. [DOI: 10.1016/j.pupt.2005.02.007] [Cited by in Crossref: 58] [Cited by in F6Publishing: 46] [Article Influence: 3.9] [Reference Citation Analysis]
406 Baldwin ME, Stacker SA, Achen MG. Molecular control of lymphangiogenesis. Bioessays 2002;24:1030-40. [DOI: 10.1002/bies.10173] [Cited by in Crossref: 71] [Cited by in F6Publishing: 56] [Article Influence: 3.7] [Reference Citation Analysis]
407 Silha JV, Krsek M, Sucharda P, Murphy LJ. Angiogenic factors are elevated in overweight and obese individuals. Int J Obes (Lond) 2005;29:1308-14. [PMID: 15953938 DOI: 10.1038/sj.ijo.0802987] [Cited by in Crossref: 216] [Cited by in F6Publishing: 180] [Article Influence: 14.4] [Reference Citation Analysis]
408 Coulon S, Heindryckx F, Geerts A, Van Steenkiste C, Colle I, Van Vlierberghe H. Angiogenesis in chronic liver disease and its complications: Angiogenesis in CLD. Liver International 2011;31:146-62. [DOI: 10.1111/j.1478-3231.2010.02369.x] [Cited by in Crossref: 159] [Cited by in F6Publishing: 149] [Article Influence: 14.5] [Reference Citation Analysis]
409 Burton JB, Priceman SJ, Sung JL, Brakenhielm E, An DS, Pytowski B, Alitalo K, Wu L. Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis. Cancer Res 2008;68:7828-37. [PMID: 18829538 DOI: 10.1158/0008-5472.CAN-08-1488] [Cited by in Crossref: 119] [Cited by in F6Publishing: 68] [Article Influence: 9.2] [Reference Citation Analysis]
410 Ishii H, Yazawa T, Sato H, Suzuki T, Ikeda M, Hayashi Y, Takanashi Y, Kitamura H. Enhancement of pleural dissemination and lymph node metastasis of intrathoracic lung cancer cells by vascular endothelial growth factors (VEGFs). Lung Cancer 2004;45:325-37. [DOI: 10.1016/j.lungcan.2004.02.021] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.0] [Reference Citation Analysis]
411 [DOI: 10.1101/2020.06.17.155028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
412 Huggenberger R, Siddiqui SS, Brander D, Ullmann S, Zimmermann K, Antsiferova M, Werner S, Alitalo K, Detmar M. An important role of lymphatic vessel activation in limiting acute inflammation. Blood 2011;117:4667-78. [PMID: 21364190 DOI: 10.1182/blood-2010-10-316356] [Cited by in Crossref: 162] [Cited by in F6Publishing: 148] [Article Influence: 16.2] [Reference Citation Analysis]
413 Nikolinakos P, Heymach JV. The Tyrosine Kinase Inhibitor Cediranib for Non-small Cell Lung Cancer and Other Thoracic Malignancies. Journal of Thoracic Oncology 2008;3:S131-4. [DOI: 10.1097/jto.0b013e318174e910] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
414 Gale NW, Thurston G, Hackett SF, Renard R, Wang Q, Mcclain J, Martin C, Witte C, Witte MH, Jackson D, Suri C, Campochiaro PA, Wiegand SJ, Yancopoulos GD. Angiopoietin-2 Is Required for Postnatal Angiogenesis and Lymphatic Patterning, and Only the Latter Role Is Rescued by Angiopoietin-1. Developmental Cell 2002;3:411-23. [DOI: 10.1016/s1534-5807(02)00217-4] [Cited by in Crossref: 699] [Cited by in F6Publishing: 285] [Article Influence: 36.8] [Reference Citation Analysis]
415 Ganjoo KN, Moore AM, Orazi A, Sen JA, Johnson CS, An CS. The importance of angiogenesis markers in the outcome of patients with diffuse large B cell lymphoma: a retrospective study of 97 patients. J Cancer Res Clin Oncol 2008;134:381-7. [PMID: 17694324 DOI: 10.1007/s00432-007-0294-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
416 Partanen TA, Arola J, Saaristo A, Jussila L, Ora A, Miettinen M, Stacker SA, Achen MG, Alitalo K. VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues. FASEB J. 2000;14:2087-2096. [PMID: 11023993 DOI: 10.1096/fj.99-1049com] [Cited by in Crossref: 226] [Cited by in F6Publishing: 203] [Article Influence: 10.8] [Reference Citation Analysis]
417 Hamrah P, Chen L, Zhang Q, Dana MR. Novel expression of vascular endothelial growth factor receptor (VEGFR)-3 and VEGF-C on corneal dendritic cells. Am J Pathol. 2003;163:57-68. [PMID: 12819011 DOI: 10.1016/s0002-9440(10)63630-9] [Cited by in Crossref: 97] [Cited by in F6Publishing: 40] [Article Influence: 5.4] [Reference Citation Analysis]
418 Leiter U, Meier F, Schittek B, Garbe C. The natural course of cutaneous melanoma. J Surg Oncol. 2004;86:172-178. [PMID: 15221923 DOI: 10.1002/jso.20079] [Cited by in Crossref: 164] [Cited by in F6Publishing: 123] [Article Influence: 9.6] [Reference Citation Analysis]
419 Le CP, Nowell CJ, Kim-Fuchs C, Botteri E, Hiller JG, Ismail H, Pimentel MA, Chai MG, Karnezis T, Rotmensz N, Renne G, Gandini S, Pouton CW, Ferrari D, Möller A, Stacker SA, Sloan EK. Chronic stress in mice remodels lymph vasculature to promote tumour cell dissemination. Nat Commun 2016;7:10634. [PMID: 26925549 DOI: 10.1038/ncomms10634] [Cited by in Crossref: 127] [Cited by in F6Publishing: 119] [Article Influence: 25.4] [Reference Citation Analysis]
420 Stefater JA 3rd, Ren S, Lang RA, Duffield JS. Metchnikoff's policemen: macrophages in development, homeostasis and regeneration. Trends Mol Med 2011;17:743-52. [PMID: 21890411 DOI: 10.1016/j.molmed.2011.07.009] [Cited by in Crossref: 103] [Cited by in F6Publishing: 97] [Article Influence: 10.3] [Reference Citation Analysis]
421 Aharinejad S, Schäfer R, Hofbauer R, Abraham D, Blumer R, Miksovsky A, Traxler H, Pullirsch D, Alexandrowicz R, Taghavi S, Kocher A, Laufer G. IMPACT OF CARDIAC TRANSPLANTATION ON MOLECULAR PATHOLOGY OF ET-1, VEGF-C, AND MITOCHONDRIAL METABOLISM AND MORPHOLOGY IN DILATED VERSUS ISCHEMIC CARDIOMYOPATHIC PATIENTS1: . Transplantation 2001;72:1043-9. [DOI: 10.1097/00007890-200109270-00011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
422 Tammela T, Petrova TV, Alitalo K. Molecular lymphangiogenesis: new players. Trends Cell Biol 2005;15:434-41. [PMID: 16005628 DOI: 10.1016/j.tcb.2005.06.004] [Cited by in Crossref: 96] [Cited by in F6Publishing: 75] [Article Influence: 6.0] [Reference Citation Analysis]
423 Brambilla D, Proulx ST, Marschalkova P, Detmar M, Leroux J. Microneedles for the Noninvasive Structural and Functional Assessment of Dermal Lymphatic Vessels. Small 2016;12:1053-61. [DOI: 10.1002/smll.201503093] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.6] [Reference Citation Analysis]
424 Witte MH, Dellinger MT, McDonald DM, Nathanson SD, Boccardo FM, Campisi CC, Sleeman JP, Gershenwald JE. Lymphangiogenesis and hemangiogenesis: potential targets for therapy. J Surg Oncol. 2011;103:489-500. [PMID: 21480241 DOI: 10.1002/jso.21714] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
425 Shin WS, Szuba A, Rockson SG. Animal Models for the Study of Lymphatic Insufficiency. Lymphatic Research and Biology 2003;1:159-69. [DOI: 10.1089/153968503321642642] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
426 Hirakawa S, Brown LF, Kodama S, Paavonen K, Alitalo K, Detmar M. VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood. 2007;109:1010-1017. [PMID: 17032920 DOI: 10.1182/blood-2006-05-021758] [Cited by in Crossref: 349] [Cited by in F6Publishing: 310] [Article Influence: 23.3] [Reference Citation Analysis]
427 Ueda M, Terai Y, Kanda K, Kanemura M, Takehara M, Futakuchi H, Yamaguchi H, Yasuda M, Nishkama K, Ueki M. Tumor Angiogenesis and Molecular Target Therapy in Ovarian Carcinomas. Human Cell 2005;18:1-16. [DOI: 10.1111/j.1749-0774.2005.tb00052.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
428 Holmes DI, Zachary I. The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease. Genome Biol. 2005;6:209. [PMID: 15693956 DOI: 10.1186/gb-2005-6-2-209] [Cited by in Crossref: 302] [Cited by in F6Publishing: 266] [Article Influence: 18.9] [Reference Citation Analysis]
429 Le Bras B, Barallobre MJ, Homman-Ludiye J, Ny A, Wyns S, Tammela T, Haiko P, Karkkainen MJ, Yuan L, Muriel MP, Chatzopoulou E, Bréant C, Zalc B, Carmeliet P, Alitalo K, Eichmann A, Thomas JL. VEGF-C is a trophic factor for neural progenitors in the vertebrate embryonic brain. Nat Neurosci 2006;9:340-8. [PMID: 16462734 DOI: 10.1038/nn1646] [Cited by in Crossref: 132] [Cited by in F6Publishing: 120] [Article Influence: 8.8] [Reference Citation Analysis]
430 Ober EA, Olofsson B, Mäkinen T, Jin SW, Shoji W, Koh GY, Alitalo K, Stainier DY. Vegfc is required for vascular development and endoderm morphogenesis in zebrafish. EMBO Rep 2004;5:78-84. [PMID: 14710191 DOI: 10.1038/sj.embor.7400047] [Cited by in Crossref: 81] [Cited by in F6Publishing: 75] [Article Influence: 4.8] [Reference Citation Analysis]
431 Chen C, Li M, Chai H, Yang H, Fisher WE, Yao Q. Roles of neuropilins in neuronal development, angiogenesis, and cancers. World J Surg 2005;29:271-5. [PMID: 15696396 DOI: 10.1007/s00268-004-7818-1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.0] [Reference Citation Analysis]
432 Eriksson U, Alitalo K. Structure, expression and receptor-binding properties of novel vascular endothelial growth factors. Curr Top Microbiol Immunol. 1999;237:41-57. [PMID: 9893345 DOI: 10.1007/978-3-642-59953-8_3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 76] [Article Influence: 1.5] [Reference Citation Analysis]
433 Narko K, Enholm B, Mäkinen T, Ristimäki A. Effect of inflammatory cytokines on the expression of the vascular endothelial growth factor-C. Int J Exp Pathol 1999;80:109-12. [PMID: 10469266 DOI: 10.1046/j.1365-2613.1999.00115.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
434 Zawieja DC, von der Weid P, Gashev AA. Microlymphatic Biology. Microcirculation. Elsevier; 2008. pp. 125-58. [DOI: 10.1016/b978-0-12-374530-9.00005-x] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
435 Romereim SM, Cupp AS. Mesonephric Cell Migration into the Gonads and Vascularization Are Processes Crucial for Testis Development. In: Piprek RP, editor. Molecular Mechanisms of Cell Differentiation in Gonad Development. Cham: Springer International Publishing; 2016. pp. 67-100. [DOI: 10.1007/978-3-319-31973-5_4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
436 Breslin JW, Yang Y, Scallan JP, Sweat RS, Adderley SP, Murfee WL. Lymphatic Vessel Network Structure and Physiology. Compr Physiol 2018;9:207-99. [PMID: 30549020 DOI: 10.1002/cphy.c180015] [Cited by in Crossref: 62] [Cited by in F6Publishing: 51] [Article Influence: 20.7] [Reference Citation Analysis]
437 Shin WS, Rockson SG. Animal models for the molecular and mechanistic study of lymphatic biology and disease. Ann N Y Acad Sci 2008;1131:50-74. [PMID: 18519959 DOI: 10.1196/annals.1413.005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
438 Liang X, Zhou H, Liu X, He Y, Tang Y, Zhu G, Zheng M, Yang J. Effect of local hyperthermia on lymphangiogenic factors VEGF-C and -D in a nude mouse xenograft model of tongue squamous cell carcinoma. Oral Oncol 2010;46:111-5. [PMID: 20036606 DOI: 10.1016/j.oraloncology.2009.12.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
439 Bader-Meunier B, Husseini K, Nouyrigat V, Pariente D. Partial splenic embolization in lymphangiomatosis. J Pediatr. 2001;138:613-614. [PMID: 11295746 DOI: 10.1067/mpd.2001.113784] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
440 Kim H, Dumont DJ. Molecular mechanisms in lymphangiogenesis: model systems and implications in human disease. Clin Genet 2003;64:282-92. [PMID: 12974730 DOI: 10.1034/j.1399-0004.2003.00152.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
441 Ribatti D. Transgenic mouse models of angiogenesis and lymphangiogenesis. Int Rev Cell Mol Biol 2008;266:1-35. [PMID: 18544491 DOI: 10.1016/S1937-6448(07)66001-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
442 Yaniv K, Isogai S, Castranova D, Dye L, Hitomi J, Weinstein BM. Live imaging of lymphatic development in the zebrafish. Nat Med. 2006;12:711-716. [PMID: 16732279 DOI: 10.1038/nm1427] [Cited by in Crossref: 337] [Cited by in F6Publishing: 283] [Article Influence: 22.5] [Reference Citation Analysis]
443 Dupin N, Fisher C, Kellam P, Ariad S, Tulliez M, Franck N, van Marck E, Salmon D, Gorin I, Escande JP, Weiss RA, Alitalo K, Boshoff C. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci U S A 1999;96:4546-51. [PMID: 10200299 DOI: 10.1073/pnas.96.8.4546] [Cited by in Crossref: 511] [Cited by in F6Publishing: 452] [Article Influence: 23.2] [Reference Citation Analysis]
444 Perrault DP, Lee GK, Park SY, Lee S, Choi D, Jung E, Seong YJ, Park EK, Sung C, Yu R, Bouz A, Pourmoussa A, Kim SJ, Hong YK, Wong AK. Small Peptide Modulation of Fibroblast Growth Factor Receptor 3-Dependent Postnatal Lymphangiogenesis. Lymphat Res Biol 2019;17:19-29. [PMID: 30648916 DOI: 10.1089/lrb.2018.0035] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
445 Shin JW, Huggenberger R, Detmar M. Transcriptional profiling of VEGF-A and VEGF-C target genes in lymphatic endothelium reveals endothelial-specific molecule-1 as a novel mediator of lymphangiogenesis. Blood. 2008;112:2318-2326. [PMID: 18614759 DOI: 10.1182/blood-2008-05-156331] [Cited by in Crossref: 92] [Cited by in F6Publishing: 84] [Article Influence: 7.1] [Reference Citation Analysis]
446 Cunnick GH, Jiang WG, Douglas-Jones T, Watkins G, Gomez KF, Morgan MJ, Subramanian A, Mokbel K, Mansel RE. Lymphangiogenesis and lymph node metastasis in breast cancer. Mol Cancer 2008;7:23. [PMID: 18325094 DOI: 10.1186/1476-4598-7-23] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
447 Jain RK, Munn LL, Fukumura D. Transparent Window Models and Intravital Microscopy: Imaging Gene Expression, Physiological Function and Therapeutic Effects in Tumors. In: Teicher BA, editor. Tumor Models in Cancer Research. Totowa: Humana Press; 2011. pp. 641-79. [DOI: 10.1007/978-1-60761-968-0_26] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
448 Jones A, Zhang H, Harris AL. Emerging therapeutic targets in angiogenesis. Emerging Therapeutic Targets 2005;2:213-29. [DOI: 10.1517/14728222.2.2.213] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
449 Ishikawa M, Kitayama J, Kazama S, Nagawa H. Expression of vascular endothelial growth factor C and D (VEGF-C and -D) is an important risk factor for lymphatic metastasis in undifferentiated early gastric carcinoma. Jpn J Clin Oncol. 2003;33:21-27. [PMID: 12604720 DOI: 10.1093/jjco/hyg008] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 2.4] [Reference Citation Analysis]
450 Becker J, Pavlakovic H, Ludewig F, Wilting F, Weich HA, Albuquerque R, Ambati J, Wilting J. Neuroblastoma progression correlates with downregulation of the lymphangiogenesis inhibitor sVEGFR-2. Clin Cancer Res 2010;16:1431-41. [PMID: 20179233 DOI: 10.1158/1078-0432.CCR-09-1936] [Cited by in Crossref: 45] [Cited by in F6Publishing: 20] [Article Influence: 4.1] [Reference Citation Analysis]
451 Sáinz-Jaspeado M, Claesson-Welsh L. Cytokines regulating lymphangiogenesis. Curr Opin Immunol 2018;53:58-63. [PMID: 29680577 DOI: 10.1016/j.coi.2018.04.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
452 Korpelainen EI, Kärkkäinen M, Gunji Y, Vikkula M, Alitalo K. Endothelial receptor tyrosine kinases activate the STAT signaling pathway: mutant Tie-2 causing venous malformations signals a distinct STAT activation response. Oncogene 1999;18:1-8. [DOI: 10.1038/sj.onc.1202288] [Cited by in Crossref: 94] [Cited by in F6Publishing: 81] [Article Influence: 4.3] [Reference Citation Analysis]
453 Ferrara N. Role of Vascular Endothelial Growth Factor in Regulation of Angiogenesis. In: Teicher BA, editor. Antiangiogenic Agents in Cancer Therapy. Totowa: Humana Press; 1999. pp. 119-41. [DOI: 10.1007/978-1-59259-453-5_8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
454 Tobler NE, Detmar M. Tumor and lymph node lymphangiogenesis-impact on cancer metastasis. Journal of Leukocyte Biology 2006;80:691-6. [DOI: 10.1189/jlb.1105653] [Cited by in Crossref: 155] [Cited by in F6Publishing: 125] [Article Influence: 10.3] [Reference Citation Analysis]
455 Watabe T. Roles of transcriptional network during the formation of lymphatic vessels. J Biochem 2012;152:213-20. [PMID: 22825883 DOI: 10.1093/jb/mvs081] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
456 Al-Rawi MA, Mansel RE, Jiang WG. Molecular and cellular mechanisms of lymphangiogenesis. Eur J Surg Oncol 2005;31:117-21. [PMID: 15698725 DOI: 10.1016/j.ejso.2004.08.015] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 2.6] [Reference Citation Analysis]
457 Debrah LB, Albers A, Debrah AY, Brockschmidt FF, Becker T, Herold C, Hofmann A, Osei-Mensah J, Mubarik Y, Fröhlich H, Hoerauf A, Pfarr K. Single nucleotide polymorphisms in the angiogenic and lymphangiogenic pathways are associated with lymphedema caused by Wuchereria bancrofti. Hum Genomics 2017;11:26. [PMID: 29122006 DOI: 10.1186/s40246-017-0121-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
458 Shintani S, Li C, Ishikawa T, Mihara M, Nakashiro K, Hamakawa H. Expression of vascular endothelial growth factor A, B, C, and D in oral squamous cell carcinoma. Oral Oncol. 2004;40:13-20. [PMID: 14662410 DOI: 10.1016/s1368-8375(03)00127-1] [Cited by in Crossref: 89] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
459 Foster RR, Slater SC, Seckley J, Kerjaschki D, Bates DO, Mathieson PW, Satchell SC. Vascular endothelial growth factor-C, a potential paracrine regulator of glomerular permeability, increases glomerular endothelial cell monolayer integrity and intracellular calcium. Am J Pathol 2008;173:938-48. [PMID: 18772335 DOI: 10.2353/ajpath.2008.070416] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
460 Black LM, Winfree S, Khochare SD, Kamocka MM, Traylor AM, Esman SK, Khan S, Zarjou A, Agarwal A, El-Achkar TM. Quantitative 3-dimensional imaging and tissue cytometry reveals lymphatic expansion in acute kidney injury. Lab Invest 2021;101:1186-96. [PMID: 34017058 DOI: 10.1038/s41374-021-00609-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
461 Lymboussaki A, Achen MG, Stacker SA, Alitalo K. Growth factors regulating lymphatic vessels. Curr Top Microbiol Immunol 2000;251:75-82. [PMID: 11036761 DOI: 10.1007/978-3-642-57276-0_10] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.1] [Reference Citation Analysis]
462 Proulx ST, Ma Q, Andina D, Leroux JC, Detmar M. Quantitative measurement of lymphatic function in mice by noninvasive near-infrared imaging of a peripheral vein. JCI Insight 2017;2:e90861. [PMID: 28097238 DOI: 10.1172/jci.insight.90861] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
463 Azzali G. Tumor cell transendothelial passage in the absorbing lymphatic vessel of transgenic adenocarcinoma mouse prostate. Am J Pathol 2007;170:334-46. [PMID: 17200205 DOI: 10.2353/ajpath.2007.060447] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
464 Shawber CJ, Funahashi Y, Francisco E, Vorontchikhina M, Kitamura Y, Stowell SA, Borisenko V, Feirt N, Podgrabinska S, Shiraishi K, Chawengsaksophak K, Rossant J, Accili D, Skobe M, Kitajewski J. Notch alters VEGF responsiveness in human and murine endothelial cells by direct regulation of VEGFR-3 expression. J Clin Invest 2007;117:3369-82. [PMID: 17948123 DOI: 10.1172/JCI24311] [Cited by in Crossref: 111] [Cited by in F6Publishing: 62] [Article Influence: 8.5] [Reference Citation Analysis]
465 Ruohola JK, Valve EM, Karkkainen MJ, Joukov V, Alitalo K, Härkönen PL. Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells. Mol Cell Endocrinol 1999;149:29-40. [PMID: 10375015 DOI: 10.1016/s0303-7207(99)00003-9] [Cited by in Crossref: 147] [Cited by in F6Publishing: 46] [Article Influence: 6.7] [Reference Citation Analysis]
466 Okamoto M, Nishimine M, Kishi M, Kirita T, Sugimura M, Nakamura M, Konishi N. Prediction of delayed neck metastasis in patients with stage I/II squamous cell carcinoma of the tongue: Prediction of delayed neck metastasis. Journal of Oral Pathology & Medicine 2002;31:227-33. [DOI: 10.1034/j.1600-0714.2002.310406.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 71] [Article Influence: 4.4] [Reference Citation Analysis]
467 Sawa Y, Shibata K, Braithwaite MW, Suzuki M, Yoshida S. Expression of immunoglobulin superfamily members on the lymphatic endothelium of inflamed human small intestine. Microvasc Res 1999;57:100-6. [PMID: 10049658 DOI: 10.1006/mvre.1998.2132] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.0] [Reference Citation Analysis]
468 Yu M, Berk R, Kosir MA. CXCL7-Mediated Stimulation of Lymphangiogenic Factors VEGF-C, VEGF-D in Human Breast Cancer Cells. J Oncol 2010;2010:939407. [PMID: 20652010 DOI: 10.1155/2010/939407] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
469 Reilly JP, Grise MA, Fortuin FD, Vale PR, Schaer GL, Lopez J, Van Camp JR, Henry T, Richenbacher WE, Losordo DW, Schatz RA, Isner JM. Long‐Term (2‐Year) Clinical Events Following Transthoracic Intramyocardial Gene Transfer of VEGF‐2 in No‐Option Patients. Journal of Interventional Cardiology 2005;18:27-31. [DOI: 10.1111/j.1540-8183.2005.04026.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 40] [Article Influence: 3.3] [Reference Citation Analysis]
470 Amioka T, Kitadai Y, Tanaka S, Haruma K, Yoshihara M, Yasui W, Chayama K. Vascular endothelial growth factor-C expression predicts lymph node metastasis of human gastric carcinomas invading the submucosa. European Journal of Cancer 2002;38:1413-9. [DOI: 10.1016/s0959-8049(02)00106-5] [Cited by in Crossref: 90] [Cited by in F6Publishing: 39] [Article Influence: 4.7] [Reference Citation Analysis]
471 Ito Y, Shibata MA, Eid N, Morimoto J, Otsuki Y. Lymphangiogenesis and Axillary Lymph Node Metastases Correlated with VEGF-C Expression in Two Immunocompetent Mouse Mammary Carcinoma Models. Int J Breast Cancer 2011;2011:867152. [PMID: 22295235 DOI: 10.4061/2011/867152] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
472 Kim IG, Lee JY, Lee DS, Kwon JY, Hwang JH. Extracorporeal Shock Wave Therapy Combined with Vascular Endothelial Growth Factor-C Hydrogel for Lymphangiogenesis. J Vasc Res 2013;50:124-33. [DOI: 10.1159/000343699] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
473 Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000;6:389-95. [DOI: 10.1038/74651] [Cited by in Crossref: 2745] [Cited by in F6Publishing: 2404] [Article Influence: 130.7] [Reference Citation Analysis]
474 Suzuki H, Onimaru M, Yonemitsu Y, Maehara Y, Nakamura S, Sueishi K. Podoplanin in cancer cells is experimentally able to attenuate prolymphangiogenic and lymphogenous metastatic potentials of lung squamoid cancer cells. Mol Cancer 2010;9:287. [PMID: 21034514 DOI: 10.1186/1476-4598-9-287] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
475 Alitalo K, Carmeliet P. Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 2002;1:219-27. [DOI: 10.1016/s1535-6108(02)00051-x] [Cited by in Crossref: 469] [Cited by in F6Publishing: 162] [Article Influence: 24.7] [Reference Citation Analysis]
476 Siegfried G, Basak A, Cromlish JA, Benjannet S, Marcinkiewicz J, Chrétien M, Seidah NG, Khatib AM. The secretory proprotein convertases furin, PC5, and PC7 activate VEGF-C to induce tumorigenesis. J Clin Invest 2003;111:1723-32. [PMID: 12782675 DOI: 10.1172/JCI17220] [Cited by in Crossref: 11] [Cited by in F6Publishing: 68] [Article Influence: 0.6] [Reference Citation Analysis]
477 Güç E, Briquez PS, Foretay D, Fankhauser MA, Hubbell JA, Kilarski WW, Swartz MA. Local induction of lymphangiogenesis with engineered fibrin-binding VEGF-C promotes wound healing by increasing immune cell trafficking and matrix remodeling. Biomaterials 2017;131:160-75. [DOI: 10.1016/j.biomaterials.2017.03.033] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 13.0] [Reference Citation Analysis]
478 Scallan J, Huxley VH, Korthuis RJ. Capillary Fluid Exchange: Regulation, Functions, and Pathology. Colloquium Series on Integrated Systems Physiology: From Molecule to Function 2010;2:1-94. [DOI: 10.4199/c00006ed1v01y201002isp003] [Cited by in Crossref: 43] [Cited by in F6Publishing: 1] [Article Influence: 3.9] [Reference Citation Analysis]
479 Pronto-Laborinho AC, Pinto S, de Carvalho M. Roles of vascular endothelial growth factor in amyotrophic lateral sclerosis. Biomed Res Int 2014;2014:947513. [PMID: 24987705 DOI: 10.1155/2014/947513] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
480 Wilting J. New perspectives in lymphangiogenesis research. Microsc Res Tech 2001;55:59-60. [DOI: 10.1002/jemt.1156] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
481 Huggenberger R, Ullmann S, Proulx ST, Pytowski B, Alitalo K, Detmar M. Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation. J Exp Med 2010;207:2255-69. [PMID: 20837699 DOI: 10.1084/jem.20100559] [Cited by in Crossref: 167] [Cited by in F6Publishing: 154] [Article Influence: 15.2] [Reference Citation Analysis]
482 Blum KS, Karaman S, Proulx ST, Ochsenbein AM, Luciani P, Leroux JC, Wolfrum C, Detmar M. Chronic high-fat diet impairs collecting lymphatic vessel function in mice. PLoS One 2014;9:e94713. [PMID: 24714646 DOI: 10.1371/journal.pone.0094713] [Cited by in Crossref: 73] [Cited by in F6Publishing: 60] [Article Influence: 10.4] [Reference Citation Analysis]
483 Zhan P, Qian Q, Yu LK. Serum VEGF level is associated with the outcome of patients with hepatocellular carcinoma: a meta-analysis. Hepatobiliary Surg Nutr. 2013;2:209-215. [PMID: 24570945 DOI: 10.3978/j.issn.2304-3881.2013.06.07] [Cited by in F6Publishing: 23] [Reference Citation Analysis]
484 Hendriksen EM, Span PN, Schuuring J, Peters JP, Sweep FC, van der Kogel AJ, Bussink J. Angiogenesis, hypoxia and VEGF expression during tumour growth in a human xenograft tumour model. Microvasc Res. 2009;77:96-103. [PMID: 19118564 DOI: 10.1016/j.mvr.2008.11.002] [Cited by in Crossref: 68] [Cited by in F6Publishing: 55] [Article Influence: 5.2] [Reference Citation Analysis]
485 Marziano C, Genet G, Hirschi KK. Vascular endothelial cell specification in health and disease. Angiogenesis 2021;24:213-36. [PMID: 33844116 DOI: 10.1007/s10456-021-09785-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
486 Lohela M, Heloterä H, Haiko P, Dumont DJ, Alitalo K. Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues. Am J Pathol 2008;173:1891-901. [PMID: 18988807 DOI: 10.2353/ajpath.2008.080378] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 4.7] [Reference Citation Analysis]
487 Nakamura K, Rockson SG. Molecular targets for therapeutic lymphangiogenesis in lymphatic dysfunction and disease. Lymphat Res Biol 2008;6:181-9. [PMID: 19093791 DOI: 10.1089/lrb.2008.63404] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
488 Munir H, Mazzaglia C, Shields JD. Stromal regulation of tumor-associated lymphatics. Adv Drug Deliv Rev 2020;161-162:75-89. [PMID: 32783989 DOI: 10.1016/j.addr.2020.08.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
489 Marconcini L, Marchio S, Morbidelli L, Cartocci E, Albini A, Ziche M, Bussolino F, Oliviero S. c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro. Proc Natl Acad Sci USA. 1999;96:9671-9676. [PMID: 10449752 DOI: 10.1073/pnas.96.17.9671] [Cited by in Crossref: 175] [Cited by in F6Publishing: 163] [Article Influence: 8.0] [Reference Citation Analysis]
490 Tian X, Cong M, Zhou W, Zhu J, Liu Q. Relationship between protein expression of VEGF-C, MMP-2 and lymph node metastasis in papillary thyroid cancer. J Int Med Res 2008;36:699-703. [PMID: 18652765 DOI: 10.1177/147323000803600411] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
491 Olofsson B, Jeltsch M, Eriksson U, Alitalo K. Current biology of VEGF-B and VEGF-C. Current Opinion in Biotechnology 1999;10:528-38. [DOI: 10.1016/s0958-1669(99)00024-5] [Cited by in Crossref: 113] [Cited by in F6Publishing: 27] [Article Influence: 5.1] [Reference Citation Analysis]
492 Zwaans BM, Bielenberg DR. Potential therapeutic strategies for lymphatic metastasis. Microvasc Res 2007;74:145-58. [PMID: 17950368 DOI: 10.1016/j.mvr.2007.08.006] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
493 Schwager S, Renner S, Hemmerle T, Karaman S, Proulx ST, Fetz R, Golding-Ochsenbein AM, Probst P, Halin C, Neri D, Detmar M. Antibody-mediated delivery of VEGF-C potently reduces chronic skin inflammation. JCI Insight 2018;3:124850. [PMID: 30518687 DOI: 10.1172/jci.insight.124850] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
494 Molema G, Griffioen AW. Rocking the foundations of solid tumor growth by attacking the tumor's blood supply. Immunology Today 1998;19:392-4. [DOI: 10.1016/s0167-5699(98)01314-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
495 Guo Z, Mo Z. Regulation of endothelial cell differentiation in embryonic vascular development and its therapeutic potential in cardiovascular diseases. Life Sci 2021;276:119406. [PMID: 33785330 DOI: 10.1016/j.lfs.2021.119406] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
496 Nicosia RF. What is the role of vascular endothelial growth factor-related molecules in tumor angiogenesis? Am J Pathol 1998;153:11-6. [PMID: 9665459 DOI: 10.1016/S0002-9440(10)65539-3] [Cited by in Crossref: 102] [Cited by in F6Publishing: 13] [Article Influence: 4.4] [Reference Citation Analysis]
497 Red-Horse K. Lymphatic vessel dynamics in the uterine wall. Placenta 2008;29 Suppl A:S55-9. [PMID: 18155143 DOI: 10.1016/j.placenta.2007.11.011] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
498 Omoto I, Matsumoto M, Okumura H, Uchikado Y, Setoyama T, Kita Y, Owaki T, Kijima Y, Shinchi H, Ishigami S, Ueno S, Natsugoe S. Expression of vascular endothelial growth factor-C and vascular endothelial growth factor receptor-3 in esophageal squamous cell carcinoma. Oncol Lett 2014;7:1027-32. [PMID: 24944663 DOI: 10.3892/ol.2014.1823] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
499 Yucel Y, Gupta N. Lymphatic drainage from the eye: A new target for therapy. Prog Brain Res 2015;220:185-98. [PMID: 26497791 DOI: 10.1016/bs.pbr.2015.07.028] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
500 Daniels CB, Lewis BC, Tsopelas C, Munns SL, Orgeig S, Baldwin ME, Stacker SA, Achen MG, Chatterton BE, Cooter RD. Regenerating lizard tails: a new model for investigating lymphangiogenesis. FASEB J 2003;17:479-81. [PMID: 12514111 DOI: 10.1096/fj.02-0579fje] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
501 Ueda M, Terai Y, Kumagai K, Ueki K, Yamaguchi H, Akise D, Ueki M. Vascular endothelial growth factor C gene expression is closely related to invasion phenotype in gynecological tumor cells. Gynecol Oncol. 2001;82:162-166. [PMID: 11426979 DOI: 10.1006/gyno.2001.6229] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 1.6] [Reference Citation Analysis]
502 Breiteneder-Geleff S, Soleiman A, Kowalski H, Horvat R, Amann G, Kriehuber E, Diem K, Wen-inger W, Tschachler E, Alitalo K. An-giosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol. 1999;154:385-394. [PMID: 10027397 DOI: 10.1016/S0002-9440(10)65285-] [Reference Citation Analysis]
503 Vale PR, Losordo DW, Symes JF, Isner JM. Factores de crecimiento para la angiogénesis terapéutica en las enfermedades cardiovasculares. Revista Española de Cardiología 2001;54:1210-24. [DOI: 10.1016/s0300-8932(01)76480-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
504 Garzon MC, Huang JT, Enjolras O, Frieden IJ. Vascular malformations: Part I. J Am Acad Dermatol. 2007;56:353-370; quiz 371-374. [PMID: 17317485 DOI: 10.1016/j.jaad.2006.05.069] [Cited by in Crossref: 239] [Cited by in F6Publishing: 114] [Article Influence: 17.1] [Reference Citation Analysis]
505 Dashkevich A, Hagl C, Beyersdorf F, Nykänen AI, Lemström KB. VEGF Pathways in the Lymphatics of Healthy and Diseased Heart. Microcirculation 2016;23:5-14. [PMID: 26190445 DOI: 10.1111/micc.12220] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
506 Yonemura Y, Endo Y, Tabata K, Kawamura T, Yun HY, Bandou E, Sasaki T, Miura M. Role of VEGF-C and VEGF-D in lymphangiogenesis in gastric cancer. Int J Clin Oncol 2005;10:318-27. [PMID: 16247658 DOI: 10.1007/s10147-005-0508-7] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 2.7] [Reference Citation Analysis]
507 Li X, Shou Y, Tay A. Hydrogels for Engineering the Immune System. Adv NanoBio Res 2021;1:2000073. [DOI: 10.1002/anbr.202000073] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
508 Dunworth WP, Cardona-Costa J, Bozkulak EC, Kim JD, Meadows S, Fischer JC, Wang Y, Cleaver O, Qyang Y, Ober EA, Jin SW. Bone morphogenetic protein 2 signaling negatively modulates lymphatic development in vertebrate embryos. Circ Res 2014;114:56-66. [PMID: 24122719 DOI: 10.1161/CIRCRESAHA.114.302452] [Cited by in Crossref: 67] [Cited by in F6Publishing: 36] [Article Influence: 8.4] [Reference Citation Analysis]
509 Carmeliet P, Collen D. Genetic Analysis of Blood Vessel Formation. Trends in Cardiovascular Medicine 1997;7:271-81. [DOI: 10.1016/s1050-1738(97)00093-5] [Cited by in Crossref: 29] [Article Influence: 1.2] [Reference Citation Analysis]
510 Bae ON, Noh M, Chun YJ, Jeong TC. Keratinocytic vascular endothelial growth factor as a novel biomarker for pathological skin condition. Biomol Ther (Seoul) 2015;23:12-8. [PMID: 25593638 DOI: 10.4062/biomolther.2014.102] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
511 Boone B, Blokx W, De Bacquer D, Lambert J, Ruiter D, Brochez L. The role of VEGF-C staining in predicting regional metastasis in melanoma. Virchows Arch 2008;453:257-65. [PMID: 18679715 DOI: 10.1007/s00428-008-0641-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
512 Babu S, Nutman TB. Immunopathogenesis of lymphatic filarial disease. Semin Immunopathol 2012;34:847-61. [PMID: 23053393 DOI: 10.1007/s00281-012-0346-4] [Cited by in Crossref: 82] [Cited by in F6Publishing: 55] [Article Influence: 9.1] [Reference Citation Analysis]
513 Paydas S, Seydaoglu G, Ergin M, Erdogan S, Yavuz S. The prognostic significance of VEGF-C and VEGF-A in non-Hodgkin lymphomas. Leuk Lymphoma 2009;50:366-73. [PMID: 19347725 DOI: 10.1080/10428190802706665] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
514 Vass DG, Hughes J, Marson LP. Restorative and rejection-associated lymphangiogenesis after renal transplantation: friend or foe? Transplantation 2009;88:1237-9. [PMID: 19996921 DOI: 10.1097/TP.0b013e3181c1afa7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
515 Ling S, Lin H, Liang L, Xu J, Xu C, Zhao W, Liu Z. Development of new lymphatic vessels in alkali-burned corneas. Acta Ophthalmologica 2009;87:315-22. [DOI: 10.1111/j.1755-3768.2008.01349.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
516 Kitadai Y, Amioka T, Haruma K, Tanaka S, Yoshihara M, Sumii K, Matsutani N, Yasui W, Chayama K. Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas. Int J Cancer. 2001;93:662-666. [PMID: 11477575 DOI: 10.1002/ijc.1379] [Cited by in Crossref: 130] [Cited by in F6Publishing: 144] [Article Influence: 6.5] [Reference Citation Analysis]
517 Roth L, Prahst C, Ruckdeschel T, Savant S, Weström S, Fantin A, Riedel M, Héroult M, Ruhrberg C, Augustin HG. Neuropilin-1 mediates vascular permeability independently of vascular endothelial growth factor receptor-2 activation. Sci Signal 2016;9:ra42. [PMID: 27117252 DOI: 10.1126/scisignal.aad3812] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
518 Zhao B, Ma A, Cai J, Boulton M. VEGF-A regulates the expression of VEGF-C in human retinal pigment epithelial cells. Br J Ophthalmol 2006;90:1052-9. [PMID: 16687456 DOI: 10.1136/bjo.2006.091215] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
519 Navarro C, Ruiz V, Gaxiola M, Carrillo G, Selman M. Angiogenesis in hypersensitivity pneumonitis. Arch Physiol Biochem 2003;111:365-8. [PMID: 15764076 DOI: 10.3109/13813450312331337612] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
520 Wilting J, Tomarev SI, Christ B, Schweigerer L. Lymphangioblasts in Embryonic Lymphangiogenesis. Lymphatic Research and Biology 2003;1:33-40. [DOI: 10.1089/15396850360495673] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
521 Alabi AA, Suppiah A, Madden LA, Monson JR, Greenman J. Preoperative serum levels of serum VEGF-C is associated with distant metastasis in colorectal cancer patients. Int J Colorectal Dis 2009;24:269-74. [DOI: 10.1007/s00384-008-0622-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
522 Nash A, Kurek J, Hilton D. Cytokines: From the laboratory to the clinic. Drug Dev Res 1999;46:197-205. [DOI: 10.1002/(sici)1098-2299(199903/04)46:3/4<197::aid-ddr5>3.0.co;2-z] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
523 Nagano T, Tachihara M, Nishimura Y. Molecular Mechanisms and Targeted Therapies Including Immunotherapy for Non-Small Cell Lung Cancer. Curr Cancer Drug Targets 2019;19:595-630. [PMID: 30526458 DOI: 10.2174/1568009619666181210114559] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
524 Kubo H, Hosono K, Suzuki T, Ogawa Y, Kato H, Kamata H, Ito Y, Amano H, Kato T, Sakagami H, Hayashi I, Sugimoto Y, Narumiya S, Watanabe M, Majima M. Host prostaglandin EP3 receptor signaling relevant to tumor-associated lymphangiogenesis. Biomed Pharmacother 2010;64:101-6. [PMID: 20034758 DOI: 10.1016/j.biopha.2009.04.039] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
525 Udan RS, Culver JC, Dickinson ME. Understanding vascular development. Wiley Interdiscip Rev Dev Biol 2013;2:327-46. [PMID: 23799579 DOI: 10.1002/wdev.91] [Cited by in Crossref: 64] [Cited by in F6Publishing: 55] [Article Influence: 7.1] [Reference Citation Analysis]
526 Damsky WE, Rosenbaum LE, Bosenberg M. Decoding melanoma metastasis. Cancers (Basel) 2010;3:126-63. [PMID: 24212610 DOI: 10.3390/cancers3010126] [Cited by in Crossref: 70] [Cited by in F6Publishing: 49] [Article Influence: 6.4] [Reference Citation Analysis]
527 Jennbacken K, Vallbo C, Wang W, Damber J. Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis. Prostate 2005;65:110-6. [DOI: 10.1002/pros.20276] [Cited by in Crossref: 95] [Cited by in F6Publishing: 82] [Article Influence: 5.9] [Reference Citation Analysis]
528 Tourani SS, Taylor GI, Ashton MW. Vascularized Lymph Node Transfer: A Review of the Current Evidence. Plast Reconstr Surg 2016;137:985-93. [PMID: 26809038 DOI: 10.1097/01.prs.0000475827.94283.56] [Cited by in Crossref: 35] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
529 Papoutsi M, Sleeman JP, Wilting J. Interaction of rat tumor cells with blood vessels and lymphatics of the avian chorioallantoic membrane. Microsc Res Tech 2001;55:100-7. [DOI: 10.1002/jemt.1161] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
530 Goldman J, Rutkowski JM, Shields JD, Pasquier MC, Cui Y, Schmökel HG, Willey S, Hicklin DJ, Pytowski B, Swartz MA. Cooperative and redundant roles of VEGFR-2 and VEGFR-3 signaling in adult lymphangiogenesis. FASEB J 2007;21:1003-12. [PMID: 17210781 DOI: 10.1096/fj.06-6656com] [Cited by in Crossref: 108] [Cited by in F6Publishing: 99] [Article Influence: 7.7] [Reference Citation Analysis]
531 Kataru RP, Baik JE, Park HJ, Ly CL, Shin J, Schwartz N, Lu TT, Ortega S, Mehrara BJ. Lymphatic-specific intracellular modulation of receptor tyrosine kinase signaling improves lymphatic growth and function. Sci Signal 2021;14:eabc0836. [PMID: 34376570 DOI: 10.1126/scisignal.abc0836] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
532 Thiele W, Sleeman JP. Tumor-induced lymphangiogenesis: a target for cancer therapy? J Biotechnol. 2006;124:224-241. [PMID: 16497404 DOI: 10.1016/j.jbiotec.2006.01.007] [Cited by in Crossref: 67] [Cited by in F6Publishing: 56] [Article Influence: 4.5] [Reference Citation Analysis]
533 Huang H, Ho C, Huang P, Hsu S. Co-Expression of VEGF-C and Its Receptors, VEGFR-2 and VEGFR-3, in Endothelial Cells of Lymphangioma. Implication in Autocrine or Paracrine Regulation of Lymphangioma. Lab Invest 2001;81:1729-34. [DOI: 10.1038/labinvest.3780386] [Cited by in Crossref: 53] [Cited by in F6Publishing: 40] [Article Influence: 2.7] [Reference Citation Analysis]
534 Cao W, Fan R, Yang W, Wu Y. VEGF-C expression is associated with the poor survival in gastric cancer tissue. Tumor Biol 2014;35:3377-83. [DOI: 10.1007/s13277-013-1445-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
535 Duff SE, Li C, Jeziorska M, Kumar S, Saunders MP, Sherlock D, O'Dwyer ST, Jayson GC. Vascular endothelial growth factors C and D and lymphangiogenesis in gastrointestinal tract malignancy. Br J Cancer. 2003;89:426-430. [PMID: 12888807 DOI: 10.1038/sj.bjc.6601145] [Cited by in Crossref: 72] [Cited by in F6Publishing: 62] [Article Influence: 4.0] [Reference Citation Analysis]
536 Mitchell JC, Parangi S. Angiogenesis in Benign and Malignant Thyroid Disease. Thyroid 2005;15:494-510. [DOI: 10.1089/thy.2005.15.494] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
537 Pang C, Evans N, Jethwa P, Papadopoulou A, Khalifa M, Tsui J, Hamilton G, Lim CS, Brookes J. Single Center Experience of Sirolimus Therapy in Head and Neck Low-flow Vascular Malformations. Vasc Endovascular Surg 2021;55:482-90. [PMID: 33878964 DOI: 10.1177/15385744211010378] [Reference Citation Analysis]
538 Rogers P, Donoghue J, Girling J. Endometrial Lymphangiogensis. Placenta 2008;29:48-54. [DOI: 10.1016/j.placenta.2007.09.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
539 Karpanen T, Wirzenius M, Mäkinen T, Veikkola T, Haisma HJ, Achen MG, Stacker SA, Pytowski B, Ylä-Herttuala S, Alitalo K. Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation. Am J Pathol 2006;169:708-18. [PMID: 16877368 DOI: 10.2353/ajpath.2006.051200] [Cited by in Crossref: 107] [Cited by in F6Publishing: 89] [Article Influence: 7.1] [Reference Citation Analysis]
540 Joukov V, Sorsa T, Kumar V, Jeltsch M, Claesson-Welsh L, Cao Y, Saksela O, Kalkkinen N, Alitalo K. Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J. 1997;16:3898-3911. [PMID: 9233800 DOI: 10.1093/emboj/16.13.3898] [Cited by in Crossref: 527] [Cited by in F6Publishing: 483] [Article Influence: 22.0] [Reference Citation Analysis]
541 Kartopawiro J, Bower NI, Karnezis T, Kazenwadel J, Betterman KL, Lesieur E, Koltowska K, Astin J, Crosier P, Vermeren S, Achen MG, Stacker SA, Smith KA, Harvey NL, François M, Hogan BM. Arap3 is dysregulated in a mouse model of hypotrichosis–lymphedema–telangiectasia and regulates lymphatic vascular development. Human Molecular Genetics 2014;23:1286-97. [DOI: 10.1093/hmg/ddt518] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
542 Yanagawa T, Shinozaki T, Watanabe H, Saito K, Raz A, Takagishi K. Vascular endothelial growth factor-D is a key molecule that enhances lymphatic metastasis of soft tissue sarcomas. Exp Cell Res. 2012;318:800-808. [PMID: 22326461 DOI: 10.1016/j.yexcr.2012.01.024] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
543 Hadler-Olsen E, Wetting HL, Rikardsen O, Steigen SE, Kanapathippillai P, Grénman R, Winberg JO, Svineng G, Uhlin-Hansen L. Stromal impact on tumor growth and lymphangiogenesis in human carcinoma xenografts. Virchows Arch 2010;457:677-92. [PMID: 20890764 DOI: 10.1007/s00428-010-0980-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
544 Gonzalez de Torre I, Alonso M, Rodriguez-Cabello JC. Elastin-Based Materials: Promising Candidates for Cardiac Tissue Regeneration. Front Bioeng Biotechnol 2020;8:657. [PMID: 32695756 DOI: 10.3389/fbioe.2020.00657] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
545 Otani A, Takagi H, Oh H, Koyama S, Ogura Y, Matumura M, Honda Y. Vascular endothelial growth factor family and receptor expression in human choroidal neovascular membranes. Microvasc Res 2002;64:162-9. [PMID: 12074642 DOI: 10.1006/mvre.2002.2407] [Cited by in Crossref: 77] [Cited by in F6Publishing: 67] [Article Influence: 4.1] [Reference Citation Analysis]
546 Lee S, Choi I, Hong YK. Heterogeneity and plasticity of lymphatic endothelial cells. Semin Thromb Hemost 2010;36:352-61. [PMID: 20490985 DOI: 10.1055/s-0030-1253457] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
547 Duong T, Koopman P, Francois M. Tumor lymphangiogenesis as a potential therapeutic target. J Oncol. 2012;2012:204946. [PMID: 22481918 DOI: 10.1155/2012/204946] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 5.7] [Reference Citation Analysis]
548 Otto B, Koenig AM, Tolstonog GV, Jeschke A, Klaetschke K, Vashist YK, Wicklein D, Wagener C, Izbicki JR, Streichert T. Molecular changes in pre-metastatic lymph nodes of esophageal cancer patients. PLoS One. 2014;9:e102552. [PMID: 25048826 DOI: 10.1371/journal.pone.0102552] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
549 Sleeman JP, Krishnan J, Kirkin V, Baumann P. Markers for the lymphatic endothelium: in search of the holy grail? Microsc Res Tech 2001;55:61-9. [PMID: 11596151 DOI: 10.1002/jemt.1157] [Cited by in Crossref: 127] [Cited by in F6Publishing: 111] [Article Influence: 6.4] [Reference Citation Analysis]
550 Zhao B, Smith G, Cai J, Ma A, Boulton M. Vascular endothelial growth factor C promotes survival of retinal vascular endothelial cells via vascular endothelial growth factor receptor-2. Br J Ophthalmol 2007;91:538-45. [PMID: 16943230 DOI: 10.1136/bjo.2006.101543] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
551 Sleeman J, Schmid A, Thiele W. Tumor lymphatics. Semin Cancer Biol 2009;19:285-97. [PMID: 19482087 DOI: 10.1016/j.semcancer.2009.05.005] [Cited by in Crossref: 59] [Cited by in F6Publishing: 47] [Article Influence: 4.9] [Reference Citation Analysis]
552 Nakamura K, Rockson SG. The role of the lymphatic circulation in the natural history and expression of cardiovascular disease. Int J Cardiol 2008;129:309-17. [PMID: 18559287 DOI: 10.1016/j.ijcard.2008.02.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
553 Cho HJ, Kim IK, Park SM, Baek KE, Nam IK, Park SH, Ryu KJ, Choi J, Ryu J, Hong SC. VEGF-C mediates RhoGDI2-induced gastric cancer cell metastasis and cisplatin resistance. Int J Cancer. 2014;135:1553-1563. [PMID: 24585459 DOI: 10.1002/ijc.28801] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
554 Ma Q, Dieterich LC, Ikenberg K, Bachmann SB, Mangana J, Proulx ST, Amann VC, Levesque MP, Dummer R, Baluk P, McDonald DM, Detmar M. Unexpected contribution of lymphatic vessels to promotion of distant metastatic tumor spread. Sci Adv 2018;4:eaat4758. [PMID: 30101193 DOI: 10.1126/sciadv.aat4758] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 11.3] [Reference Citation Analysis]
555 Skobe M, Detmar M, Brown LF, Tognazzi K, Ganju RK, Dezube BJ, Alitalo K. Vascular Endothelial Growth Factor-C (VEGF-C) and its Receptors KDR and flt-4 are Expressed in AIDS-Associated Kaposi’s Sarcoma. Journal of Investigative Dermatology 1999;113:1047-53. [DOI: 10.1046/j.1523-1747.1999.00798.x] [Cited by in Crossref: 87] [Cited by in F6Publishing: 77] [Article Influence: 4.0] [Reference Citation Analysis]
556 Camp RL, Rimm EB, Rimm DL. A high number of tumor free axillary lymph nodes from patients with lymph node negative breast carcinoma is associated with poor outcome. Cancer 2000;88:108-13. [DOI: 10.1002/(sici)1097-0142(20000101)88:1<108::aid-cncr15>3.0.co;2-b] [Cited by in Crossref: 50] [Article Influence: 2.4] [Reference Citation Analysis]
557 Hiltunen MO, Laitinen M, Turunen MP, Jeltsch M, Hartikainen J, Rissanen TT, Laukkanen J, Niemi M, Kossila M, Häkkinen TP, Kivelä A, Enholm B, Mansukoski H, Turunen A, Alitalo K, Ylä-herttuala S. Intravascular Adenovirus-Mediated VEGF-C Gene Transfer Reduces Neointima Formation in Balloon-Denuded Rabbit Aorta. Circulation 2000;102:2262-8. [DOI: 10.1161/01.cir.102.18.2262] [Cited by in Crossref: 88] [Cited by in F6Publishing: 15] [Article Influence: 4.2] [Reference Citation Analysis]
558 Edwards PD, Rahbar R, Ferraro NF, Burrows PE, Mulliken JB. Lymphatic Malformation of the Lingual Base and Oral Floor: . Plastic and Reconstructive Surgery 2005;115:1906-15. [DOI: 10.1097/01.prs.0000165071.48422.a4] [Cited by in Crossref: 46] [Article Influence: 2.9] [Reference Citation Analysis]
559 Mulliken JB, Fishman SJ, Burrows PE. Vascular anomalies. Current Problems in Surgery 2000;37:517-84. [DOI: 10.1016/s0011-3840(00)80013-1] [Cited by in Crossref: 381] [Cited by in F6Publishing: 62] [Article Influence: 18.1] [Reference Citation Analysis]
560 Fukumura D, Duda DG, Munn LL, Jain RK. Tumor microvasculature and microenvironment: novel insights through intravital imaging in pre-clinical models. Microcirculation. 2010;17:206-225. [PMID: 20374484 DOI: 10.1111/j.1549-8719.2010.00029.x] [Cited by in Crossref: 267] [Cited by in F6Publishing: 231] [Article Influence: 24.3] [Reference Citation Analysis]
561 Sedlacek H. Pharmacological aspects of targeting cancer gene therapy to endothelial cells. Critical Reviews in Oncology/Hematology 2001;37:169-215. [DOI: 10.1016/s1040-8428(00)00113-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
562 Joukov V, Kumar V, Sorsa T, Arighi E, Weich H, Saksela O, Alitalo K. A Recombinant Mutant Vascular Endothelial Growth Factor-C that Has Lost Vascular Endothelial Growth Factor Receptor-2 Binding, Activation, and Vascular Permeability Activities. Journal of Biological Chemistry 1998;273:6599-602. [DOI: 10.1074/jbc.273.12.6599] [Cited by in Crossref: 168] [Cited by in F6Publishing: 161] [Article Influence: 7.3] [Reference Citation Analysis]
563 Byrne AM, Bouchier-Hayes DJ, Harmey JH. Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J Cell Mol Med 2005;9:777-94. [PMID: 16364190 DOI: 10.1111/j.1582-4934.2005.tb00379.x] [Cited by in Crossref: 443] [Cited by in F6Publishing: 413] [Article Influence: 29.5] [Reference Citation Analysis]
564 Akita S, Mitsukawa N, Kuriyama M, Kubota Y, Hasegawa M, Tokumoto H, Ishigaki T, Togawa T, Kuyama J, Satoh K. Comparison of Vascularized Supraclavicular Lymph Node Transfer and Lymphaticovenular Anastomosis for Advanced Stage Lower Extremity Lymphedema. Annals of Plastic Surgery 2015;74:573-9. [DOI: 10.1097/sap.0000000000000513] [Cited by in Crossref: 38] [Cited by in F6Publishing: 8] [Article Influence: 6.3] [Reference Citation Analysis]
565 Uzarski J, Drelles MB, Gibbs SE, Ongstad EL, Goral JC, Mckeown KK, Raehl AM, Roberts MA, Pytowski B, Smith MR, Goldman J. The resolution of lymphedema by interstitial flow in the mouse tail skin. American Journal of Physiology-Heart and Circulatory Physiology 2008;294:H1326-34. [DOI: 10.1152/ajpheart.00900.2007] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
566 Ji YN, Wang Q, Li Y, Wang Z. Prognostic value of vascular endothelial growth factor A expression in gastric cancer: a meta-analysis. Tumour Biol. 2014;35:2787-2793. [PMID: 24234334 DOI: 10.1007/s13277-013-1371-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
567 Halin C, Detmar M. Chapter 1 Inflammation, Angiogenesis, and Lymphangiogenesis. Angiogenesis: In Vivo Systems, Part B. Elsevier; 2008. pp. 1-25. [DOI: 10.1016/s0076-6879(08)03001-2] [Cited by in Crossref: 47] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
568 Rissanen TT, Rutanen J, Ylä-herttuala S. Gene Transfer for Therapeutic Vascular Growth in Myocardial and Peripheral Ischemia. Elsevier; 2004. pp. 117-64. [DOI: 10.1016/s0065-2660(04)52004-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
569 van Impel A, Schulte-merker S. A Fisheye View on Lymphangiogenesis. In: Kiefer F, Schulte-merker S, editors. Developmental Aspects of the Lymphatic Vascular System. Vienna: Springer; 2014. pp. 153-65. [DOI: 10.1007/978-3-7091-1646-3_12] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
570 Nakamura K, Rockson SG. Biomarkers of Lymphatic Function and Disease: State of the Art and Future Directions. Mol Diag Ther 2007;11:227-38. [DOI: 10.1007/bf03256244] [Cited by in Crossref: 19] [Cited by in F6Publishing: 3] [Article Influence: 2.1] [Reference Citation Analysis]
571 Saharinen P, Petrova TV. Molecular regulation of lymphangiogenesis. Ann N Y Acad Sci 2004;1014:76-87. [PMID: 15153422 DOI: 10.1196/annals.1294.008] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
572 Sestito LF, Thomas SN. Biomaterials for Modulating Lymphatic Function in Immunoengineering. ACS Pharmacol Transl Sci 2019;2:293-310. [PMID: 32259064 DOI: 10.1021/acsptsci.9b00047] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
573 Liu Y, Fang Y, Dong P, Gao J, Liu R, Hhahbaz M., Bi Y, Ding Z, Tian H, Liu Z. Effect of vascular endothelial growth factor C (VEGF-C) gene transfer in rat model of secondary lymphedema. Vascular Pharmacology 2008;48:150-6. [DOI: 10.1016/j.vph.2008.01.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
574 Kerjaschki D. How to control lymphangiogenesis: a novel role for rapamycin. Kidney Int 2007;71:717-9. [PMID: 17429417 DOI: 10.1038/sj.ki.5002184] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
575 Urner S, Kelly-Goss M, Peirce SM, Lammert E. Mechanotransduction in Blood and Lymphatic Vascular Development and Disease. Adv Pharmacol 2018;81:155-208. [PMID: 29310798 DOI: 10.1016/bs.apha.2017.08.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
576 Xu LB, Liu C, Gao GQ, Yu XH, Zhang R, Wang J. Nerve growth factor-beta expression is associated with lymph node metastasis and nerve infiltration in human hilar cholangiocarcinoma. World J Surg. 2010;34:1039-1045. [PMID: 20119692 DOI: 10.1007/s00268-010-0417-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
577 Haibe Y, Kreidieh M, El Hajj H, Khalifeh I, Mukherji D, Temraz S, Shamseddine A. Resistance Mechanisms to Anti-angiogenic Therapies in Cancer. Front Oncol 2020;10:221. [PMID: 32175278 DOI: 10.3389/fonc.2020.00221] [Cited by in Crossref: 57] [Cited by in F6Publishing: 46] [Article Influence: 57.0] [Reference Citation Analysis]
578 Abraham D, Hofbauer R, Schäfer R, Blumer R, Paulus P, Miksovsky A, Traxler H, Kocher A, Aharinejad S. Selective Downregulation of VEGF-A 165 , VEGF-R 1 , and Decreased Capillary Density in Patients With Dilative but Not Ischemic Cardiomyopathy. Circulation Research 2000;87:644-7. [DOI: 10.1161/01.res.87.8.644] [Cited by in Crossref: 99] [Cited by in F6Publishing: 41] [Article Influence: 4.7] [Reference Citation Analysis]
579 Wen J, Fu AF, Chen LJ, Xie XJ, Yang GL, Chen XC, Wang YS, Li J, Chen P, Tang MH. Liposomal honokiol inhibits VEGF-D-induced lymphangiogenesis and metastasis in xenograft tumor model. Int J Cancer. 2009;124:2709-2718. [PMID: 19219913 DOI: 10.1002/ijc.24244] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 3.7] [Reference Citation Analysis]
580 Suri C, Yancopoulos GD. Growth Factors in Vascular Morphogenesis: Insights from Gene Knockout Studies in Mice. In: Little CD, Mironov V, Sage EH, editors. Vascular Morphogenesis: In Vivo, In Vitro, In Mente. Boston: Birkhäuser; 1996. pp. 65-71. [DOI: 10.1007/978-1-4612-4156-0_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
581 Oh SJ, Jeltsch MM, Birkenhäger R, McCarthy JE, Weich HA, Christ B, Alitalo K, Wilting J. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol. 1997;188:96-109. [PMID: 9245515 DOI: 10.1006/dbio.1997.8639] [Cited by in Crossref: 332] [Cited by in F6Publishing: 294] [Article Influence: 13.8] [Reference Citation Analysis]
582 Schneider M, Othman-hassan K, Christ B, Wilting J. Lymphangioblasts in the avian wing bud. Dev Dyn 1999;216:311-9. [DOI: 10.1002/(sici)1097-0177(199912)216:4/5<311::aid-dvdy1>3.0.co;2-m] [Cited by in Crossref: 78] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
583 Tien J. Tissue Engineering of the Microvasculature. Compr Physiol 2019;9:1155-212. [PMID: 31187896 DOI: 10.1002/cphy.c180037] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
584 Liersch R, Biermann C, Mesters RM, Berdel WE. Lymphangiogenesis in cancer: current perspectives. Recent Results Cancer Res 2010;180:115-35. [PMID: 20033381 DOI: 10.1007/978-3-540-78281-0_8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
585 Weich HA, Bando H, Brokelmann M, Baumann P, Toi M, Barleon B, Alitalo K, Sipos B, Sleeman J. Quantification of vascular endothelial growth factor-C (VEGF-C) by a novel ELISA. J Immunol Methods 2004;285:145-55. [PMID: 14980429 DOI: 10.1016/j.jim.2003.10.015] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
586 Parker MW, Linkugel AD, Goel HL, Wu T, Mercurio AM, Vander Kooi CW. Structural basis for VEGF-C binding to neuropilin-2 and sequestration by a soluble splice form. Structure 2015;23:677-87. [PMID: 25752543 DOI: 10.1016/j.str.2015.01.018] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
587 Rockson SG. Preclinical Models of Lymphatic Disease. Annals of the New York Academy of Sciences 2002;979:64-75. [DOI: 10.1111/j.1749-6632.2002.tb04868.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
588 Wirzenius M, Tammela T, Uutela M, He Y, Odorisio T, Zambruno G, Nagy JA, Dvorak HF, Ylä-Herttuala S, Shibuya M, Alitalo K. Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting. J Exp Med 2007;204:1431-40. [PMID: 17535974 DOI: 10.1084/jem.20062642] [Cited by in Crossref: 120] [Cited by in F6Publishing: 112] [Article Influence: 8.6] [Reference Citation Analysis]
589 Kubis N, Levy BI. Vasculogenesis and angiogenesis: molecular and cellular controls. Part 1: growth factors. Interv Neuroradiol 2003;9:227-37. [PMID: 20591248 DOI: 10.1177/159101990300900301] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
590 Wu H, Rahman HNA, Dong Y, Liu X, Lee Y, Wen A, To KH, Xiao L, Birsner AE, Bazinet L, Wong S, Song K, Brophy ML, Mahamud MR, Chang B, Cai X, Pasula S, Kwak S, Yang W, Bischoff J, Xu J, Bielenberg DR, Dixon JB, D'Amato RJ, Srinivasan RS, Chen H. Epsin deficiency promotes lymphangiogenesis through regulation of VEGFR3 degradation in diabetes. J Clin Invest 2018;128:4025-43. [PMID: 30102256 DOI: 10.1172/JCI96063] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 10.3] [Reference Citation Analysis]
591 Bates DO. An interstitial hypothesis for breast cancer related lymphoedema. Pathophysiology 2010;17:289-94. [PMID: 19963358 DOI: 10.1016/j.pathophys.2009.10.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
592 Azzarello J, Kropp BP, Fung K, Lin H. Age-dependent vascular endothelial growth factor expression and angiogenic capability of bladder smooth muscle cells: implications for cell-seeded technology in bladder tissue engineering. J Tissue Eng Regen Med 2009;3:579-89. [DOI: 10.1002/term.199] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
593 Le CP, Karnezis T, Achen MG, Stacker SA, Sloan EK. Lymphovascular and neural regulation of metastasis: shared tumour signalling pathways and novel therapeutic approaches. Best Pract Res Clin Anaesthesiol 2013;27:409-25. [PMID: 24267548 DOI: 10.1016/j.bpa.2013.10.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
594 Götte M, Kersting C, Radke I, Kiesel L, Wülfing P. An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situ. Breast Cancer Res. 2007;9:R8. [PMID: 17244359 DOI: 10.1186/bcr1641] [Cited by in Crossref: 76] [Cited by in F6Publishing: 72] [Article Influence: 5.4] [Reference Citation Analysis]
595 Lammoglia GM, Van Zandt CE, Galvan DX, Orozco JL, Dellinger MT, Rutkowski JM. Hyperplasia, de novo lymphangiogenesis, and lymphatic regression in mice with tissue-specific, inducible overexpression of murine VEGF-D. Am J Physiol Heart Circ Physiol 2016;311:H384-94. [PMID: 27342876 DOI: 10.1152/ajpheart.00208.2016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
596 Saban MR, Towner R, Smith N, Abbott A, Neeman M, Davis CA, Simpson C, Maier J, Mémet S, Wu XR, Saban R. Lymphatic vessel density and function in experimental bladder cancer. BMC Cancer 2007;7:219. [PMID: 18047671 DOI: 10.1186/1471-2407-7-219] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
597 Parsons-wingerter P, Mckay TL, Leontiev D, Vickerman MB, Condrich TK, Dicorleto PE. Lymphangiogenesis by blind-ended vessel sprouting is concurrent with hemangiogenesis by vascular splitting. Anat Rec 2006;288A:233-47. [DOI: 10.1002/ar.a.20309] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
598 Lagercrantz J, Farnebo F, Larsson C, Tvrdik T, Weber G, Piehl F. A comparative study of the expression patterns for vegf, vegf-b/vrf and vegf-c in the developing and adult mouse. Biochim Biophys Acta 1998;1398:157-63. [PMID: 9689915 DOI: 10.1016/s0167-4781(98)00040-2] [Cited by in Crossref: 65] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
599 Li Y, Kaneko M, Amatya VJ, Takeshima Y, Arihiro K, Inai K. Expression of vascular endothelial growth factor-C and its receptor in invasive micropapillary carcinoma of the breast. Pathol Int 2006;56:256-61. [DOI: 10.1111/j.1440-1827.2006.01961.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
600 Zachary I. Signal transduction in angiogenesis. EXS 2005;:267-300. [PMID: 15617484 DOI: 10.1007/3-7643-7311-3_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
601 Jin D, Harada K, Ohnishi S, Yamahara K, Kangawa K, Nagaya N. Adrenomedullin induces lymphangiogenesis and ameliorates secondary lymphoedema. Cardiovasc Res 2008;80:339-45. [PMID: 18708640 DOI: 10.1093/cvr/cvn228] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 3.3] [Reference Citation Analysis]
602 Nassiri N, Rootman J, Rootman DB, Goldberg RA. Orbital lymphaticovenous malformations: Current and future treatments. Survey of Ophthalmology 2015;60:383-405. [DOI: 10.1016/j.survophthal.2015.03.001] [Cited by in Crossref: 39] [Cited by in F6Publishing: 18] [Article Influence: 6.5] [Reference Citation Analysis]
603 Ran S, Volk-Draper L. Lymphatic Endothelial Cell Progenitors in the Tumor Microenvironment. Adv Exp Med Biol 2020;1234:87-105. [PMID: 32040857 DOI: 10.1007/978-3-030-37184-5_7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
604 Christiansen AJ, Dieterich LC, Ohs I, Bachmann SB, Bianchi R, Proulx ST, Hollmén M, Aebischer D, Detmar M. Lymphatic endothelial cells attenuate inflammation via suppression of dendritic cell maturation. Oncotarget 2016;7:39421-35. [PMID: 27270646 DOI: 10.18632/oncotarget.9820] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 10.7] [Reference Citation Analysis]
605 Peng L, Zhan P, Zhou Y, Fang W, Zhao P, Zheng Y, Xu N. Prognostic significance of vascular endothelial growth factor immunohistochemical expression in gastric cancer: a meta-analysis. Mol Biol Rep. 2012;39:9473-9484. [PMID: 22729879 DOI: 10.1007/s11033-012-1812-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
606 Laitinen M, Ristimäki A, Honkasalo M, Narko K, Paavonen K, Ritvos O. Differential Hormonal Regulation of Vascular Endothelial Growth Factors VEGF, VEGF-B, and VEGF-C Messenger Ribonucleic Acid Levels in Cultured Human Granulosa-Luteal Cells*. Endocrinology 1997;138:4748-56. [DOI: 10.1210/endo.138.11.5500] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 2.3] [Reference Citation Analysis]
607 Nowak-Sliwinska P, Alitalo K, Allen E, Anisimov A, Aplin AC, Auerbach R, Augustin HG, Bates DO, van Beijnum JR, Bender RHF, Bergers G, Bikfalvi A, Bischoff J, Böck BC, Brooks PC, Bussolino F, Cakir B, Carmeliet P, Castranova D, Cimpean AM, Cleaver O, Coukos G, Davis GE, De Palma M, Dimberg A, Dings RPM, Djonov V, Dudley AC, Dufton NP, Fendt SM, Ferrara N, Fruttiger M, Fukumura D, Ghesquière B, Gong Y, Griffin RJ, Harris AL, Hughes CCW, Hultgren NW, Iruela-Arispe ML, Irving M, Jain RK, Kalluri R, Kalucka J, Kerbel RS, Kitajewski J, Klaassen I, Kleinmann HK, Koolwijk P, Kuczynski E, Kwak BR, Marien K, Melero-Martin JM, Munn LL, Nicosia RF, Noel A, Nurro J, Olsson AK, Petrova TV, Pietras K, Pili R, Pollard JW, Post MJ, Quax PHA, Rabinovich GA, Raica M, Randi AM, Ribatti D, Ruegg C, Schlingemann RO, Schulte-Merker S, Smith LEH, Song JW, Stacker SA, Stalin J, Stratman AN, Van de Velde M, van Hinsbergh VWM, Vermeulen PB, Waltenberger J, Weinstein BM, Xin H, Yetkin-Arik B, Yla-Herttuala S, Yoder MC, Griffioen AW. Consensus guidelines for the use and interpretation of angiogenesis assays. Angiogenesis 2018;21:425-532. [PMID: 29766399 DOI: 10.1007/s10456-018-9613-x] [Cited by in Crossref: 206] [Cited by in F6Publishing: 201] [Article Influence: 103.0] [Reference Citation Analysis]
608 Michels WM, Zweers MM, Smit W, Korevaar J, Struijk DG, van Westrhenen R, Krediet RT. Does Lymphatic Absorption Change with the Duration of Peritoneal Dialysis? Perit Dial Int 2004;24:347-52. [DOI: 10.1177/089686080402400409] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 25.0] [Reference Citation Analysis]
609 Xu H, Zhang T, Man GC, May KE, Becker CM, Davis TN, Kung AL, Birsner AE, D'Amato RJ, Wong AW, Wang CC. Vascular endothelial growth factor C is increased in endometrium and promotes endothelial functions, vascular permeability and angiogenesis and growth of endometriosis. Angiogenesis 2013;16:541-51. [PMID: 23334337 DOI: 10.1007/s10456-013-9333-1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
610 Petrova TV, Mäkinen T, Mäkelä TP, Saarela J, Virtanen I, Ferrell RE, Finegold DN, Kerjaschki D, Ylä-Herttuala S, Alitalo K. Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J. 2002;21:4593-4599. [PMID: 12198161 DOI: 10.1093/emboj/cdf470] [Cited by in Crossref: 426] [Cited by in F6Publishing: 393] [Article Influence: 22.4] [Reference Citation Analysis]
611 Suzuki K, Morita T, Tokue A. Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder. Int J Urol. 2005;12:152-158. [PMID: 15733109 DOI: 10.1111/j.1442-2042.2005.01010.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
612 Achen MG, Stacker SA. Tumor lymphangiogenesis and metastatic spread-new players begin to emerge. Int J Cancer 2006;119:1755-60. [PMID: 16557570 DOI: 10.1002/ijc.21899] [Cited by in Crossref: 98] [Cited by in F6Publishing: 73] [Article Influence: 6.5] [Reference Citation Analysis]
613 Akagi K, Ikeda Y, Miyazaki M, Abe T, Kinoshita J, Maehara Y, Sugimachi K. Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues. Br J Cancer 2000;83:887-91. [PMID: 10970690 DOI: 10.1054/bjoc.2000.1396] [Cited by in Crossref: 155] [Cited by in F6Publishing: 168] [Article Influence: 7.4] [Reference Citation Analysis]
614 Blei F. Vascular anomalies: From bedside to bench and back again. Current Problems in Pediatric and Adolescent Health Care 2002;32:72-93. [DOI: 10.1067/mps.2002.125533] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
615 O-charoenrat P, Rhys-evans P, Eccles SA. Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis. Cancer 2001;92:556-68. [DOI: 10.1002/1097-0142(20010801)92:3<556::aid-cncr1355>3.0.co;2-q] [Cited by in Crossref: 154] [Cited by in F6Publishing: 38] [Article Influence: 7.7] [Reference Citation Analysis]
616 Hess-Stumpp H, Haberey M, Thierauch KH. PTK 787/ZK 222584, a tyrosine kinase inhibitor of all known VEGF receptors, represses tumor growth with high efficacy. Chembiochem. 2005;6:550-557. [PMID: 15742376 DOI: 10.1002/cbic.200400305] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 3.0] [Reference Citation Analysis]
617 Hagendoorn J, Padera TP, Fukumura D, Jain RK. Molecular Regulation of Microlymphatic Formation and Function: Role of Nitric Oxide. Trends in Cardiovascular Medicine 2005;15:169-73. [DOI: 10.1016/j.tcm.2005.06.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
618 Schoppmann SF, Birner P, Stöckl J, Kalt R, Ullrich R, Caucig C, Kriehuber E, Nagy K, Alitalo K, Kerjaschki D. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol. 2002;161:947-956. [PMID: 12213723 DOI: 10.1016/s0002-9440(10)64255-1] [Cited by in Crossref: 534] [Cited by in F6Publishing: 237] [Article Influence: 28.1] [Reference Citation Analysis]
619 Saaristo A, Karpanen T, Alitalo K. Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis. Oncogene 2000;19:6122-9. [DOI: 10.1038/sj.onc.1203969] [Cited by in Crossref: 169] [Cited by in F6Publishing: 144] [Article Influence: 8.0] [Reference Citation Analysis]
620 Shoji MK, Shishido S, Freitag SK. The Use of Sirolimus for Treatment of Orbital Lymphatic Malformations: A Systematic Review. Ophthalmic Plast Reconstr Surg 2020;36:215-21. [PMID: 31990892 DOI: 10.1097/IOP.0000000000001518] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
621 Tang RF, Itakura J, Aikawa T, Matsuda K, Fujii H, Korc M, Matsumoto Y. Overexpression of Lymphangiogenic Growth Factor VEGF-C in Human Pancreatic Cancer: . Pancreas 2001;22:285-92. [DOI: 10.1097/00006676-200104000-00010] [Cited by in Crossref: 55] [Cited by in F6Publishing: 81] [Article Influence: 2.8] [Reference Citation Analysis]
622 Mühlner U, Möhle-steinlein U, Wizigmann-voos S, Christofori G, Risau W, Wagner EF. Formation of transformed endothelial cells in the absence of VEGFR-2/Flk-1 by Polyoma middle T oncogene. Oncogene 1999;18:4200-10. [DOI: 10.1038/sj.onc.1203014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
623 van Impel A, Zhao Z, Hermkens DM, Roukens MG, Fischer JC, Peterson-Maduro J, Duckers H, Ober EA, Ingham PW, Schulte-Merker S. Divergence of zebrafish and mouse lymphatic cell fate specification pathways. Development 2014;141:1228-38. [PMID: 24523456 DOI: 10.1242/dev.105031] [Cited by in Crossref: 102] [Cited by in F6Publishing: 88] [Article Influence: 14.6] [Reference Citation Analysis]
624 Uchida Y, James JM, Suto F, Mukouyama YS. Class 3 semaphorins negatively regulate dermal lymphatic network formation. Biol Open 2015;4:1194-205. [PMID: 26319580 DOI: 10.1242/bio.012302] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
625 Zheng X, Liu Q, Yi M, Qin S, Wu K. The regulation of cytokine signaling by retinal determination gene network pathway in cancer. Onco Targets Ther 2018;11:6479-87. [PMID: 30323623 DOI: 10.2147/OTT.S176113] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
626 Karlsen TV, Reikvam T, Tofteberg A, Nikpey E, Skogstrand T, Wagner M, Tenstad O, Wiig H. Lymphangiogenesis Facilitates Initial Lymph Formation and Enhances the Dendritic Cell Mobilizing Chemokine CCL21 Without Affecting Migration. ATVB 2017;37:2128-35. [DOI: 10.1161/atvbaha.117.309883] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
627 Hagura A, Asai J, Maruyama K, Takenaka H, Kinoshita S, Katoh N. The VEGF-C/VEGFR3 signaling pathway contributes to resolving chronic skin inflammation by activating lymphatic vessel function. Journal of Dermatological Science 2014;73:135-41. [DOI: 10.1016/j.jdermsci.2013.10.006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
628 Lv XH, Liu BQ, Li XM, Wang XC, Li XL, Ahmed N, Zhang YF. Integrin α4 Induces Lymphangiogenesis and Metastasis via Upregulation of VEGF-C in Human Colon Cancer. Anat Rec (Hoboken) 2016;299:741-7. [PMID: 26917449 DOI: 10.1002/ar.23338] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
629 Witmer AN, van Blijswijk BC, Dai J, Hofman P, Partanen TA, Vrensen GF, Schlingemann RO. VEGFR-3 in adult angiogenesis. J Pathol. 2001;195:490-497. [PMID: 11745682 DOI: 10.1002/path.969] [Cited by in Crossref: 107] [Cited by in F6Publishing: 100] [Article Influence: 5.6] [Reference Citation Analysis]
630 Ohno F, Nakanishi H, Abe A, Seki Y, Kinoshita A, Hasegawa Y, Tatematsu M, Kurita K. Regional difference in intratumoral lymphangiogenesis of oral squamous cell carcinomas evaluated by immunohistochemistry using D2-40 and podoplanin antibody: an analysis in comparison with angiogenesis. J Oral Pathol Med 2007;36:281-9. [PMID: 17448138 DOI: 10.1111/j.1600-0714.2007.00529.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
631 Arenberg DA, Strieter RM. Angiogenesis. In: Serhan CN, Ward PA, editors. Molecular and Cellular Basis of Inflammation. Totowa: Humana Press; 1999. pp. 29-49. [DOI: 10.1007/978-1-59259-253-1_2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
632 Stacker SA, Baldwin ME, Achen MG. The role of tumor lymphangiogenesis in metastatic spread. FASEB J. 2002;16:922-934. [PMID: 12087053 DOI: 10.1096/fj.01-0945rev] [Cited by in Crossref: 208] [Cited by in F6Publishing: 180] [Article Influence: 10.9] [Reference Citation Analysis]
633 Ristimäki A, Narko K, Enholm B, Joukov V, Alitalo K. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J Biol Chem 1998;273:8413-8. [PMID: 9525952 DOI: 10.1074/jbc.273.14.8413] [Cited by in Crossref: 276] [Cited by in F6Publishing: 249] [Article Influence: 12.0] [Reference Citation Analysis]
634 Kaipainen A, Chen E, Chang L, Zhao B, Shin H, Stahl A, Fishman SJ, Mulliken JB, Folkman J, Huang S, Fannon M. Characterization of lymphatic malformations using primary cells and tissue transcriptomes. Scand J Immunol 2019;90. [DOI: 10.1111/sji.12800] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
635 Szél E, Kemény L, Groma G, Szolnoky G. Pathophysiological dilemmas of lipedema. Medical Hypotheses 2014;83:599-606. [DOI: 10.1016/j.mehy.2014.08.011] [Cited by in Crossref: 47] [Cited by in F6Publishing: 30] [Article Influence: 6.7] [Reference Citation Analysis]
636 Xuan M, Fang Y, Wato M, Hata S, Tanaka A. Immunohistochemical co-localization of lymphatics and blood vessels in oral squamous cell carcinomas. J Oral Pathol Med 2005;34:334-9. [DOI: 10.1111/j.1600-0714.2005.00316.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
637 Zhu XR, Zhu ML, Wang Q, Xue WJ, Wang YW, Wang RF, Chen SY, Zheng LZ. A case report of targeted therapy with apatinib in a patient with advanced gastric cancer and high serum level of alpha-fetoprotein. Medicine (Baltimore). 2016;95:e4610. [PMID: 27631210 DOI: 10.1097/md.0000000000004610] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
638 Kadowaki I, Ichinohasama R, Harigae H, Ishizawa K, Okitsu Y, Kameoka J, Sasaki T. Accelerated lymphangiogenesis in malignant lymphoma: possible role of VEGF-A and VEGF-C. Br J Haematol 2005;130:869-77. [PMID: 16156857 DOI: 10.1111/j.1365-2141.2005.05695.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
639 Kirkin V, Thiele W, Baumann P, Mazitschek R, Rohde K, Fellbrich G, Weich H, Waltenberger J, Giannis A, Sleeman JP. MAZ51, an indolinone that inhibits endothelial cell and tumor cell growthin vitro, suppresses tumor growthin vivo. Int J Cancer 2004;112:986-93. [DOI: 10.1002/ijc.20509] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
640 Yuan L, Moyon D, Pardanaud L, Bréant C, Karkkainen MJ, Alitalo K, Eichmann A. Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development 2002;129:4797-806. [DOI: 10.1242/dev.129.20.4797] [Cited by in Crossref: 162] [Cited by in F6Publishing: 98] [Article Influence: 8.5] [Reference Citation Analysis]
641 Semela D, Dufour J. Vascular Endothelial Growth Factor Signaling. In: Dufour J, Clavien P, Trautwein C, Graf R, editors. Signaling Pathways in Liver Diseases. Berlin/Heidelberg: Springer-Verlag; 2005. pp. 91-104. [DOI: 10.1007/3-540-27194-5_8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
642 Ferrara N, Alitalo K. Clinical applications of angiogenic growth factors and their inhibitors. Nat Med 1999;5:1359-64. [DOI: 10.1038/70928] [Cited by in Crossref: 726] [Cited by in F6Publishing: 633] [Article Influence: 33.0] [Reference Citation Analysis]
643 Buso G, Depairon M, Tomson D, Raffoul W, Vettor R, Mazzolai L. Lipedema: A Call to Action! Obesity (Silver Spring) 2019;27:1567-76. [PMID: 31544340 DOI: 10.1002/oby.22597] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 16.0] [Reference Citation Analysis]
644 Wang Z, Xu Q, Zhang N, Du X, Xu G, Yan X. CD146, from a melanoma cell adhesion molecule to a signaling receptor. Signal Transduct Target Ther 2020;5:148. [PMID: 32782280 DOI: 10.1038/s41392-020-00259-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 14.0] [Reference Citation Analysis]
645 George ML, Tutton MG, Janssen F, Arnaout A, Abulafi AM, Eccles SA, Swift RI. VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression. Neoplasia 2001;3:420-7. [PMID: 11687953 DOI: 10.1038/sj.neo.7900186] [Cited by in Crossref: 136] [Cited by in F6Publishing: 115] [Article Influence: 7.2] [Reference Citation Analysis]
646 Astin JW, Haggerty MJ, Okuda KS, Le Guen L, Misa JP, Tromp A, Hogan BM, Crosier KE, Crosier PS. Vegfd can compensate for loss of Vegfc in zebrafish facial lymphatic sprouting. Development 2014;141:2680-90. [PMID: 24903752 DOI: 10.1242/dev.106591] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 6.1] [Reference Citation Analysis]
647 Alam A, Herault J, Barron P, Favier B, Fons P, Delesque-touchard N, Senegas I, Laboudie P, Bonnin J, Cassan C, Savi P, Ruggeri B, Carmeliet P, Bono F, Herbert J. Heterodimerization with vascular endothelial growth factor receptor-2 (VEGFR-2) is necessary for VEGFR-3 activity. Biochemical and Biophysical Research Communications 2004;324:909-15. [DOI: 10.1016/j.bbrc.2004.08.237] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 2.8] [Reference Citation Analysis]
648 Debrah AY, Mand S, Specht S, Marfo-Debrekyei Y, Batsa L, Pfarr K, Larbi J, Lawson B, Taylor M, Adjei O, Hoerauf A. Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis. PLoS Pathog 2006;2:e92. [PMID: 17044733 DOI: 10.1371/journal.ppat.0020092] [Cited by in Crossref: 118] [Cited by in F6Publishing: 92] [Article Influence: 7.9] [Reference Citation Analysis]
649 Achen MG, McColl BK, Stacker SA. Focus on lymphangiogenesis in tumor metastasis. Cancer Cell. 2005;7:121-127. [PMID: 15710325 DOI: 10.1016/j.ccr.2005.01.017] [Cited by in Crossref: 235] [Cited by in F6Publishing: 191] [Article Influence: 14.7] [Reference Citation Analysis]
650 Yin Q, Ma J, Han X, Zhang H, Wang F, Zhuang P, Zhang Y. Spatiotemporal variations of vascular endothelial growth factor in the brain of diabetic cognitive impairment. Pharmacol Res 2021;163:105234. [PMID: 33053446 DOI: 10.1016/j.phrs.2020.105234] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
651 Salven P, Mustjoki S, Alitalo R, Alitalo K, Rafii S. VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells. Blood. 2003;101:168-172. [PMID: 12393704 DOI: 10.1182/blood-2002-03-0755] [Cited by in Crossref: 256] [Cited by in F6Publishing: 227] [Article Influence: 13.5] [Reference Citation Analysis]
652 Künnapuu J, Bokharaie H, Jeltsch M. Proteolytic Cleavages in the VEGF Family: Generating Diversity among Angiogenic VEGFs, Essential for the Activation of Lymphangiogenic VEGFs. Biology (Basel) 2021;10:167. [PMID: 33672235 DOI: 10.3390/biology10020167] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
653 Lim L, Bui H, Farrelly O, Yang J, Li L, Enis D, Ma W, Chen M, Oliver G, Welsh JD, Kahn ML. Hemostasis stimulates lymphangiogenesis through release and activation of VEGFC. Blood 2019;134:1764-75. [PMID: 31562136 DOI: 10.1182/blood.2019001736] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
654 Jain RK, Chauhan VP, Duda DG. Vascular and Interstitial Biology of Tumors. Abeloff's Clinical Oncology. Elsevier; 2014. pp. 108-126.e5. [DOI: 10.1016/b978-1-4557-2865-7.00008-4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
655 Drosos I, Pavlaki M, Ortega Carrillo MDP, Kourkouli A, Buschmann K, Konstantinou F, Gogiraju R, Bochenek ML, Chalikias G, Tortopidis C, Vahl CF, Mikroulis D, Tziakas D, Münzel T, Konstantinides S, Schäfer K. Increased Lymphangiogenesis and Lymphangiogenic Growth Factor Expression in Perivascular Adipose Tissue of Patients with Coronary Artery Disease. J Clin Med 2019;8:E1000. [PMID: 31324038 DOI: 10.3390/jcm8071000] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
656 Defnet AM, Bagrodia N, Hernandez SL, Gwilliam N, Kandel JJ. Pediatric lymphatic malformations: evolving understanding and therapeutic options. Pediatr Surg Int 2016;32:425-33. [DOI: 10.1007/s00383-016-3867-4] [Cited by in Crossref: 42] [Cited by in F6Publishing: 22] [Article Influence: 8.4] [Reference Citation Analysis]
657 Feng D, Nagy JA, Brekken RA, Pettersson A, Manseau EJ, Pyne K, Mulligan R, Thorpe PE, Dvorak HF, Dvorak AM. Ultrastructural Localization of the Vascular Permeability Factor/Vascular Endothelial Growth Factor (VPF/VEGF) Receptor-2 (FLK-1, KDR) in Normal Mouse Kidney and in the Hyperpermeable Vessels Induced by VPF/VEGF-expressing Tumors and Adenoviral Vectors. J Histochem Cytochem 2000;48:545-55. [DOI: 10.1177/002215540004800412] [Cited by in Crossref: 90] [Cited by in F6Publishing: 83] [Article Influence: 18.0] [Reference Citation Analysis]
658 Chapouly C, Tadesse Argaw A, Horng S, Castro K, Zhang J, Asp L, Loo H, Laitman BM, Mariani JN, Straus Farber R, Zaslavsky E, Nudelman G, Raine CS, John GR. Astrocytic TYMP and VEGFA drive blood-brain barrier opening in inflammatory central nervous system lesions. Brain 2015;138:1548-67. [PMID: 25805644 DOI: 10.1093/brain/awv077] [Cited by in Crossref: 69] [Cited by in F6Publishing: 59] [Article Influence: 11.5] [Reference Citation Analysis]
659 Sundar SS, Ganesan TS. Role of lymphangiogenesis in cancer. J Clin Oncol 2007;25:4298-307. [PMID: 17878481 DOI: 10.1200/JCO.2006.07.1092] [Cited by in Crossref: 90] [Cited by in F6Publishing: 39] [Article Influence: 6.4] [Reference Citation Analysis]
660 Otrock ZK, Makarem JA, Shamseddine AI. Vascular endothelial growth factor family of ligands and receptors: review. Blood Cells Mol Dis. 2007;38:258-268. [PMID: 17344076 DOI: 10.1016/j.bcmd.2006.12.003] [Cited by in Crossref: 224] [Cited by in F6Publishing: 193] [Article Influence: 16.0] [Reference Citation Analysis]
661 Foster RR, Satchell SC, Seckley J, Emmett MS, Joory K, Xing CY, Saleem MA, Mathieson PW, Bates DO, Harper SJ. VEGF-C promotes survival in podocytes. American Journal of Physiology-Renal Physiology 2006;291:F196-207. [DOI: 10.1152/ajprenal.00431.2005] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
662 Campbell KT, Hadley DJ, Kukis DL, Silva EA. Alginate hydrogels allow for bioactive and sustained release of VEGF-C and VEGF-D for lymphangiogenic therapeutic applications. PLoS One 2017;12:e0181484. [PMID: 28723974 DOI: 10.1371/journal.pone.0181484] [Cited by in Crossref: 33] [Cited by in F6Publishing: 19] [Article Influence: 8.3] [Reference Citation Analysis]
663 Li X, Kumar A, Zhang F, Lee C, Tang Z. Complicated life, complicated VEGF-B. Trends Mol Med. 2012;18:119-127. [PMID: 22178229 DOI: 10.1016/j.molmed.2011.11.006] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]
664 Barone F, Nayar S, Buckley CD. The role of non-hematopoietic stromal cells in the persistence of inflammation. Front Immunol 2012;3:416. [PMID: 23335923 DOI: 10.3389/fimmu.2012.00416] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
665 Bock F, Maruyama K, Regenfuss B, Hos D, Steven P, Heindl LM, Cursiefen C. Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases. Prog Retin Eye Res 2013;34:89-124. [PMID: 23348581 DOI: 10.1016/j.preteyeres.2013.01.001] [Cited by in Crossref: 90] [Cited by in F6Publishing: 78] [Article Influence: 11.3] [Reference Citation Analysis]
666 Xu Y, Yuan L, Mak J, Pardanaud L, Caunt M, Kasman I, Larrivée B, Del Toro R, Suchting S, Medvinsky A. Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3. J Cell Biol. 2010;188:115-130. [PMID: 20065093 DOI: 10.1083/jcb.200903137] [Cited by in Crossref: 212] [Cited by in F6Publishing: 196] [Article Influence: 19.3] [Reference Citation Analysis]
667 Karkkainen MJ, Petrova TV. Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis. Oncogene. 2000;19:5598-5605. [PMID: 11114740 DOI: 10.1038/sj.onc.1203855] [Cited by in Crossref: 266] [Cited by in F6Publishing: 236] [Article Influence: 13.3] [Reference Citation Analysis]
668 Huang WC, Nagahashi M, Terracina KP, Takabe K. Emerging Role of Sphingosine-1-phosphate in Inflammation, Cancer, and Lymphangiogenesis. Biomolecules. 2013;3. [PMID: 24286034 DOI: 10.3390/biom3030408] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 5.4] [Reference Citation Analysis]
669 Yamazaki T, Yoshimatsu Y, Morishita Y, Miyazono K, Watabe T. COUP-TFII regulates the functions of Prox1 in lymphatic endothelial cells through direct interaction. Genes to Cells 2009;14:425-34. [DOI: 10.1111/j.1365-2443.2008.01279.x] [Cited by in Crossref: 80] [Cited by in F6Publishing: 75] [Article Influence: 6.7] [Reference Citation Analysis]
670 Titze J, Machnik A. Sodium sensing in the interstitium and relationship to hypertension. Curr Opin Nephrol Hypertens 2010;19:385-92. [PMID: 20571401 DOI: 10.1097/MNH.0b013e32833aeb3b] [Cited by in Crossref: 79] [Cited by in F6Publishing: 31] [Article Influence: 7.2] [Reference Citation Analysis]
671 Young AJ. The physiology of lymphocyte migration through the single lymph node in vivo. Semin Immunol. 1999;11:73-83. [PMID: 10329494 DOI: 10.1006/smim.1999.0163] [Cited by in Crossref: 91] [Cited by in F6Publishing: 87] [Article Influence: 4.1] [Reference Citation Analysis]
672 Gale NW, Thurston G, Davis S, Wiegand SJ, Holash J, Rudge JS, Yancopoulos GD. Complementary and coordinatedroles of the VEGFs and angiopoietins during normal and pathologic vascular formation. Cold Spring Harb SympQuant Biol. 2002;67:267-273. [PMID: 12858549 DOI: 10.1101/sqb.2002.67.267] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
673 Mitsuhashi A, Suzuka K, Yamazawa K, Matsui H, Seki K, Sekiya S. Serum vascular endothelial growth factor (VEGF) and VEGF-C levels as tumor markers in patients with cervical carcinoma. Cancer. 2005;103:724-730. [PMID: 15637689 DOI: 10.1002/cncr.20819] [Cited by in Crossref: 62] [Cited by in F6Publishing: 53] [Article Influence: 3.9] [Reference Citation Analysis]
674 Said AM, Parker MW, Vander Kooi CW. Design, synthesis, and evaluation of a novel benzamidine-based inhibitor of VEGF-C binding to Neuropilin-2. Bioorg Chem 2020;100:103856. [PMID: 32344185 DOI: 10.1016/j.bioorg.2020.103856] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
675 Shin WS, Rockson SG. Lymphangiogenesis: Recapitulation of Angiogensis in Health and Disease. In: Forough R, editor. New Frontiers in Angiogenesis. Dordrecht: Springer Netherlands; 2006. pp. 159-202. [DOI: 10.1007/1-4020-4327-9_8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
676 Wülfing P, Kersting C, Buerger H, Mattsson B, Mesters R, Gustmann C, Hinrichs B, Tio J, Böcker W, Kiesel L. Expression patterns of angiogenic and lymphangiogenic factors in ductal breast carcinoma in situ. Br J Cancer 2005;92:1720-8. [PMID: 15841074 DOI: 10.1038/sj.bjc.6602567] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
677 Farhat FS, Tfayli A, Fakhruddin N, Mahfouz R, Otrock ZK, Alameddine RS, Awada AH, Shamseddine A. Expression, prognostic and predictive impact of VEGF and bFGF in non-small cell lung cancer. Crit Rev Oncol Hematol 2012;84:149-60. [PMID: 22494932 DOI: 10.1016/j.critrevonc.2012.02.012] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 5.2] [Reference Citation Analysis]
678 Wiley DM, Kim JD, Hao J, Hong CC, Bautch VL, Jin SW. Distinct signalling pathways regulate sprouting angiogenesis from the dorsal aorta and the axial vein. Nat Cell Biol 2011;13:686-92. [PMID: 21572418 DOI: 10.1038/ncb2232] [Cited by in Crossref: 135] [Cited by in F6Publishing: 116] [Article Influence: 13.5] [Reference Citation Analysis]
679 Lee JY, Kim HJ. (Lymph)angiogenic influences on hematopoietic cells in acute myeloid leukemia. Exp Mol Med 2014;46:e122. [PMID: 25412683 DOI: 10.1038/emm.2014.72] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
680 Siegfried G, Basak A, Cromlish JA, Benjannet